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ABSTRACT 
 
Efficacy of DVD Technology in Chronic Obstructive Pulmonary Disease Self-
Management Education of Rural Patients.  
(December 2008) 
Michael Leland Stellefson, B.S., The University of Pittsburgh; 
M.S., Texas A&M University 
Chair of Advisory Committee: Dr. Danny Ramsey Ballard 
 
Despite the efficacy of pulmonary rehabilitation programs which assist patients 
in managing chronic obstructive pulmonary disease (COPD), the high costs and lack of 
availability of such programs pose considerable barriers for underserved COPD patients, 
such as those living in rural communities. Because of this, patients are encouraged to 
actively self-manage COPD. Unfortunately, COPD patients have reported dissatisfaction 
with the self-management education they are provided. This mixed methods study 
assessed the self-management learning needs of COPD patients treated at a Certified 
Federal Rural Health Clinic through conducting focus group interviews (n = 2) to inform 
the development a targeted self-management education DVD. The effectiveness of 3 
distinct educational treatments (DVD vs. Pamphlet vs. DVD + Pamphlet) was evaluated 
by comparing outcomes related to informational needs, self-management self-efficacy, 
and generic/lung-specific HRQoL in a randomly-assigned, multiple-group pretest-
posttest design with a control group (n = 41). 
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 Focus group data was analyzed using three qualitative analysis tools. Findings 
from the interviews indicated that patients viewed self-management as simply taking 
prescribed medications and reducing activity. Patients reported a lack of knowledge and 
skill development related to rehabilitative activities such as controlled breathing and 
stress reduction.  
A multivariate analysis of covariance was conducted to determine the effect of 3 
educational treatments on multiple outcome measures. Three nontrend orthogonal 
planned contrasts were tested to determine selected contrast effects. The data analysis 
revealed that participants receiving a DVD reported statistically significantly higher 
levels of lung-specific physical functioning as compared to those in the Pamphlet group. 
Additionally, the DVD group revealed clinically significant improvements on the 
physical (+19.01) and emotional (+10.74) functioning dimensions of lung-specific 
HRQoL; whereas, no such improvement occurred within the Pamphlet and control 
groups.   
Results also suggested that providing patients with a Pamphlet alone was more 
effective than providing participants with both interventions concurrently to increase 
self-management self-efficacy. The simultaneous provision of both interventions did, 
however, enhance generic HRQoL more so than the provision of one of the two 
treatments alone. Finally, any type of self-management education as compared to usual 
care did not statistically significantly improve outcome variables among this small 
sample of rural patients.   
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CHAPTER I 
INTRODUCTION TO THE PROBLEM 
Chronic obstructive pulmonary disease (COPD) is a preventable and treatable 
disease, characterized by progressive airflow limitation that is not fully reversible and is 
associated with an abnormal inflammatory response of the lung to noxious particles or 
gases (Rabe, Hurd, & Anzueto, 2007). The chronic airflow limitation characteristic of 
COPD is caused by a unique mixture of small airway disease (chronic bronchitis) and 
parenchyma destruction (emphysema), the relative contributions of which differ from 
person to person (Buist et al., 2007). This causes an obstruction of air leaving the lungs, 
and consequently, prolonged episodes of coughing (National Heart, Lung, & Blood 
Institute, 2007a).  
Disease Pathology 
In the human body, lungs provide the surface area that facilitates the bodily 
exchange of carbon dioxide and oxygen. When oxygen is breathed into the body, it 
travels down a windpipe (trachea) and then through airways known as bronchial tubes.  
At the ends of these bronchial tubes are balloon-like air sacs known as alveoli, which  
act as the venue for oxygen to pass into the bloodstream. The alveoli are surrounded by 
blood vessels that carry oxygen through the body and transport carbon dioxide out of the 
blood. In normal functioning lungs, the bronchial tubes and alveoli are elastic and allow 
for air to move in and out of the lungs quickly. In the lungs of those diagnosed  
____________ 
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with COPD, the elastic quality of the bronchial tubes and alveoli are diminished, causing 
the bronchial tubes to collapse and the alveoli to remain inflated. This, along with a 
cellular increase in sputum production, causes an obstruction of airflow out of the lungs 
(National Heart, Lung, & Blood Institute, 2007a).   
The inflammatory response of the lung results due to exposure to respiratory 
irritants such as cigarette smoke. This contact is amplified by oxidative stress and an 
excess of proteinases (i.e., specific enzymes) in the lung. COPD patients present several 
systemic features, such as muscle fatigue and dynamic hyperinflation, which both have a 
major impact on survival, especially in patients with severe disease (Agusti, 2005; 
Wouters, Creutzberg, & Schols, 2002). Hyperinflation of the lungs is one of the major 
precursors to dyspnea (i.e., shortness of breath) and exacerbations in COPD patients 
(O’Donnell, Revill, & Webb, 2001). Exacerbations are defined as events in COPD 
characterized by change in patients’ baseline dyspnea, cough, chest tightness and/or 
sputum that is beyond normal day-to-day variations and acute in onset (Burge & 
Wedzicha, 2003). Lung infections and environmental irritants cause the majority of 
exacerbations (Fein & Fein, 2000; Sethi, 2000; White, Gompertz, & Stockley, 2003), but 
the cause of about 1/3 of all other exacerbations can not be currently identified (Rabe et 
al., 2007). Exacerbations worsen over time with prolonged exposure to a causative agent 
(e. g. tobacco smoke, atmospheric pollution, occupational dust, etc.) (Zock et al., 2001). 
The number and nature of COPD exacerbations varies greatly from patient to patient, 
given that COPD is a heterogeneous disease process with respect to lung pathology 
(Mannino & Buist, 2007). 
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COPD patients who experience shortness of breath when engaging in their daily 
activities are more likely to disengage from activities they used to participate in, because 
they are fearful of experiencing exacerbations. This avoidance causes further 
deconditioning which can aggravate dyspnea even further (Reardon, Lareau, & 
ZuWallack, 2006). As the severity of COPD increases, dyspnea and fatigue begin to 
impact everyday life activities, especially following exacerbations. Symptoms of COPD 
can also include chronic cough and sputum production, both of which may or may not 
precede the development of airflow obstruction and dyspnea (Rabe et al., 2007).  
Classification of Disease Severity 
 
COPD progresses through different stages of decline in lung function, usually in 
the absence of compelling symptoms (Pauwels et al., 2001; Rabe et al., 2007). The 
disease is often silent and unrecognized until lung function is morbidly impaired (Rabe 
et al., 2007). This is usually because patients who suffer from COPD either attribute 
symptoms to the aging process or are unaware that bronchconstriction is present (Marks 
et al., 1996). In fact, only half of the estimated 24 million U.S. adults with evidence of 
impaired lung function have reported physician-diagnosed COPD (Mannino et al., 
2002). Dyspnea, or shortness of breath, is the hallmark symptom of COPD and is a 
major cause of disability and anxiety associated with the disease.   
Airflow limitation in COPD patients is best measured by spirometry. The 
spirometric classification of COPD severity includes 4 stages: stage I, mild; stage II, 
moderate; stage III, severe; and stage IV, very severe (Rabe et al., 2007). This 
classification system recommends the use of fixed ratio post-bronchodilator measures to 
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define disease severity, which is determined by dividing forced expiratory volume in one 
second (FEV1) by forced vital capacity (FVC) after patients inhale bronchodilator 
medications. The efficacy of this taxonomy has been supported in the literature (Agusti, 
2005). However, in some epidemiologic studies, pre-bronchodilator lung function (i.e., 
without the use of inhaled medication) has been used to classify COPD grade (Mannino 
& Davis, 2006). This strategy can reportedly overestimate airflow obstruction by up to 
50% (Johannessen et al., 2005; Kim et al., 2006). Although post-bronchodilator lung 
function is the recommended diagnostic measure of COPD severity, we do not know 
whether the post-bronchodilator measure is better or worse at predicting COPD 
morbidity and mortality (Mannino & Buist, 2007). Rather, lung function alone (Mannino 
et al., 2006), and in combination with body-mass index, dyspnea and exercise level 
(quantified as a BODE index), has been shown to accurately predict mortality in COPD 
patients (Celli et al., 2004). Interestingly, spiromteric measures have not been 
recommended for monitoring treatments for COPD (Yohannes & Hardy, 2003). 
All classes of COPD patients exhibit FEV1 / FVC ratios of < 0.70.  To further 
classify COPD grade, patients’ actual FEV1 levels are compared against predicted FEV1 
values that are contrived based on age (especially for older adults), height, sex and race 
(Hardie et al., 2002; Pellegrino et al., 2005). Actual FEV1 is divided by predicted FEV1 
to determine a percentage which quantifies the patients’ actual FEV1 in comparison to 
their predicted FEV1. This percentage is then used as the marker which distinguishes 
disease stage. Table 1 describes the spirometric classification table adapted from Rabe 
and colleagues (2007) which categorizes COPD stages. This classification table does not 
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include “restrictive” spirometry, which is characterized as an FEV1 / FVC ratio ≥ 0.70 
and an FEV1 < 80% of the patient’s predicted value. It has been argued that this airflow 
limitation indicator should be apart of the classification system due to its prevalence 
among patients who go on to develop COPD (Kohler et al., 2003). 
 
Table 1  
Spirometric classification of COPD  
Stage Post-bronchodilator FEV1 Symptoms 
Mild (I) Actual FEV1 ≥ 80% predicted Chronic cough and 
sputum possible; patient 
usually unaware of 
abnormal lung function 
 
Moderate (II) 50% predicted ≤ Actual FEV1 < 80% 
predicted 
 
Shortness of breath upon 
exertion; patients seek 
medical attention due to 
symptoms 
 
Severe (III) 30% predicted ≤ Actual FEV1 < 50% 
predicted 
 
Greater shortness of 
breath; reduced exercise 
capacity; repeated 
exacerbations 
 
Very Severe (IV) FEV1 < 30% predicted or FEV1 < 
50% predicted plus chronic 
respiratory failure 
Quality of life 
significantly impaired; 
exacerbations life 
threatening 
Source:  Rabe et al., 2007 
 
For older patients with Stage I (mild) COPD, the fixed post-bronchodilator lung 
function ratio is not always an accurate measure for COPD diagnosis, because the 
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process of aging differentially affects readings of lung function. Furthermore, fixed ratio 
post-bronchodilator has the tendency to over diagnose COPD in older patients (Hardie et 
al., 2002; Rabe et al., 2007). For patients diagnosed with at least Stage II COPD, the 
following tests are recommended to confirm diagnosis and monitor disease status: 
bronchodilator reversibility testing, chest x-ray and arterial blood gas measurements 
(Rabe et al., 2007). Co-morbidities afflicting patients with COPD may also bias clinical 
diagnosis. Some experts believe that COPD and all its systemic effects (e. g. muscle 
wasting, heart disease, some cancers, hypertension) should come under a new umbrella 
term known as “chronic systemic inflammatory syndrome” (Agusti, 2005; Lopez et al., 
2006).   
Epidemiology 
 COPD prevalence, morbidity and mortality are generally directly related to the 
prevalence of tobacco smoking and increased age, both of which contribute to 
diminished lung function (Mannino & Davis, 2006). The prevalence of COPD is 
substantially higher among individuals who have a history of smoking, are older than 40 
and male (Fukuchi et al., 2004; Halbert et al., 2006; Menezes et al., 2005).  COPD is the 
fourth leading cause of death in the United States (following heart disease, cancer, and 
stroke) claiming the lives of 118,171 Americans in 2004 (National Center for Health 
Statistics, 2006). Morbidity measures, such as doctor visits, emergency room visits, and 
hospitalizations, increase with age and are greater in men than in women (Mannino et 
al., 2002; Soriano et al., 2000). COPD is the only major cause of death in America for 
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which no significant decreases in morbidity or mortality have been observed in the past 
20 years (Norwood, 2006).   
In 2004, about 3.6 million people in the United States reported suffering from 
emphysema, and 9 million reported a physician diagnosis of chronic bronchitis 
(American Lung Association, 2007a). It has been estimated that COPD is the 7th leading 
cause of disability-adjusted life years (i.e., measure of the time lived with disability and 
the time lost due to premature mortality) in high income countries (Lopez et al., 2006). 
In 2005, 11.6 million Americans (aged 18 and over) were estimated to have COPD, yet 
there is evidence suggesting an under diagnosis of the disease (National Center for 
Health Statistics, 2007). Taking into account the expected aging of the U.S. population 
over the next 20 years and the past/current epidemic of smoking in America, it is highly 
unlikely that there will be any decline in the number of Americans with COPD, as the 
risk for COPD proliferation is substantial (Mannino & Buist, 2007; Jemal et al., 2005).  
By the year 2020, COPD is estimated to be the 3rd leading cause of death and the 5th 
leading cause of disability in the world (Feenstra et al., 2001; Lopez et al., 2006; 
Michaud, Murray, & Bloom, 2001; Sullivan, Ramsey, & Lee, 2000). 
The World Health Organization (WHO) Global Burden of Disease Project 
reported that more than 2.5 million people die from COPD every year, which is about 
the same number as for HIV/AIDS.  
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 In third world countries, the incidence of COPD is rising rapidly, which 
prompted the WHO to formally recognize COPD as a major disease threat (Pauwels et 
al., 2001). In nations of low and middle income, COPD was the sixth leading cause of 
death, accounting for 4.9% of all total deaths (Lopez et al., 2006). Results from the 
Burden of Lung Disease (BOLD) study revealed that South Africa, a country with an 
abnormally high prevalence of tuberculosis, possesses the highest prevalence of COPD 
as compared to 17 other countries studied (Buist et al., 2007). The BOLD study, and the 
Latin American Project for the Investigation of Obstructive Lung Disease (Menezes et 
al., 2005), both discovered that there is wide variability in COPD prevalence. This being 
true, mortality rates are quite similar among countries with disparate prevalence rates, 
which suggest there are differential diagnostic criteria affecting COPD diagnoses 
(Mannino & Buist, 2007). Table 2 reflects estimates of deaths and disability-adjusted life 
years (DALYs) due to COPD for the 25 most populous nations in the world (Lopez et 
al., 2006). 
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Table 2  
World estimates of COPD deaths and disability-adjusted life years (DALYs)  
Country Age-adjusted death per 100,000 
people 
Age-adjusted DALYs per 100,000 
people 
Japan 4.4 120 
France 12.0 270 
Germany 12.5 291 
Italy 13.7 191 
Russia 16.2 242 
United Kingdom 23.1 442 
Iran 26.3 395 
Philippines 26.7 282 
Mexico 26.8 247 
United States 27.2 426 
Ukraine 31.6 477 
Egypt 35.9 302 
Turkey 40.3 521 
Brazil 42.2 504 
Thailand 48.0 245 
Congo 49.4 297 
Nigeria 49.4 296 
Ethiopia 55.4 330 
Myanmar 56.4 570 
Indonesia 58.4 613 
Bangladesh 66.4 559 
Pakistan 71.1 584 
India 73.2 667 
Vietnam 86.4 488 
China 130.5 622 
Source: Lopez et al., 2006 
 
Gender 
The relationship between gender and COPD development and progression has 
been widely researched (de Torres et al., 2005; Mannino & Buist, 2007). Thought once 
to be a predominantly male disease, COPD is now rising among women, possibly due to 
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that fact that women may be more susceptible to tobacco smoke than men (Watson et al., 
2006). From 1999 to 2004, the number of women dying from COPD surpassed the 
number of men dying from COPD, and some reports even indicate that self-reported 
COPD is higher in females than among males (National Center for Health Statistics, 
2006). Throughout the world, the prevalence of COPD is now almost equal across both 
males and females (Buist et al., 2007). 
Race/Ethnicity 
  The prevalence of COPD among African Americans is lower than that among 
non-Hispanic Whites (See Table 3). The age-adjusted COPD mortality rate for African 
Americans was 27.3 per 100,000 in 2003, which was 40 percent less than non-Hispanic 
Whites (American Lung Association, 2007b). Although African Americans have lower 
COPD mortality and prevalence rates than Whites, they tend to have higher rates of 
hospitalization and emergency room visits due to COPD complications. African 
Americans may be highly susceptible to cigarette smoke and acquire more severe 
obstructive lung disease for a given degree of smoking than do susceptible non-Hispanic 
Whites (Chatila, Wynkoop, Vance, & Criner, 2004). In 2004, African American men 
had a higher rate of emphysema than African American women (National Center for 
Health Statistics, 2006). 
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Table 3  
Current adult prevalence and mortality rates of COPD  
 Total Non-Hispanic 
White 
Non-Hispanic 
Black 
Hispanic Non-Hispanic 
 Number Rate Number Rate Number Rate Number Rate Number Rate
Males 59,221 51.2 52,762 54.5 3,763 42.1 1,566 26.0 57,492 52.5
Females 63,062 36.2 58,190 40.5 2,850 18.9 1,309 14.4 61,618 37.5
Totals 122,283 41.9 110,952 45.9 6,613 27.3 2,875 18.9 119,110 43.3
Sources: National Center for Health Statistics, 2006; American Lung Association, 2007b 
Notes:  (1) Rates are per 100,000 population and age-adjusted mortality rates are per 
100,000 population. 
(2) Hispanics are not mutually exclusive from Whites, African Americans, 
Asians/Pacific Islanders and American Indians/Alaska Natives. 
 
 
Rates of COPD among Hispanics were significantly lower than in other ethnic 
groups. The prevalence of COPD among Hispanic Americans was far lower than among 
Whites (20.0 per 1,000) and African Americans (9.8 per 1,000); however, almost 
700,000 Hispanic Americans (25 per 1,000 persons) were diagnosed with chronic 
bronchitis in 2004 (American Lung Association, 2007b). Mexican Americans who 
worked in office buildings, agricultural settings, construction sites and service industries 
were found to be 2 to 4 times more likely to develop COPD than those not working in 
these settings (Hnizdo et al., 2002).   
There is a paucity of COPD research on Asian Americans, Native 
Americans/Pacific Islanders and American Indians/Alaska Natives (American Lung 
Association, 2007b), which lends us little evidence on the disease epidemiology among 
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these ethnic groups. It is interesting to note that individuals of Asian decent may have a 
genetic component that reduces their risk of acquiring COPD regardless of their smoking 
habits (Barnes, 1999). 
Risk Factors 
Smoking is the most commonly reported risk factor for COPD development.  
Cigarette smokers have a higher prevalence of lung function abnormalities and a greater 
COPD mortality rate than do non-smokers (Rabe et al., 2007). Recent studies have 
shown that upwards of 50% of smokers go on to develop COPD (Mannino et al., 2006; 
Rennard & Vestbo, 2006). The WHO estimates that, in high income countries, 73% of 
COPD mortality is related to smoking (Lopez et al., 2006). Accordingly, smoking 
cessation has been shown to prevent further deterioration in lung function (Scanlon et 
al., 2000). Smoking cessation is the single most effective and cost-effective intervention 
to stop the progression of COPD; yet, even within best-practice programs, less than one-
third of smokers achieve sustainable abstinence from smoking (Anthonisen et al., 1994; 
Ebrahim & Smith, 1997). Additionally, among those already diagnosed with COPD, 
disease symptoms persist even if smoking cessation is realized (Domagala-Kulawik, 
Maskey-Warzechowska, Kraszewska, & Chazan, 2003). Moreover, if every smoker in 
the world were to stop smoking in the immediate future, rates of COPD incidence and 
prevalence would most likely continue to rise for the next 20 years (Kojima et al., 2007; 
Lopez et al., 2006). Second hand smoke may also contribute to COPD by increasing the 
lungs’ exposure to toxic particles and gases (Eisner et al., 2005). The evidence in support 
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of this notion has not been overwhelming, however (U.S. Department of Health and 
Human Services, 2006a).   
There are other lung irritants which contribute to the progression of COPD as 
well. Occupational dusts/chemicals, and indoor/outdoor pollution, have been identified 
as COPD risk factors (Behrendt, 2005; Celli, Halbert, Nordyke, & Schan, 2005), 
especially if these irritants contain high levels of sulphur and nitrogen oxides (Dockery 
& Brunekreef, 1996; Schwartz, 1995), and even among individuals who never smoked 
cigarettes (Hnizdo, Sullivan, Bang, & Wagner, 2002; Trupin et al., 2003). In low and 
middle income countries, indoor pollution from biomass cooking and heating in poorly 
ventilated houses is a significant risk factor for COPD development (Lopez et al., 2006; 
Sezer et al., 2006). Within low-income nations, exposure to indoor air pollution causes 
most cases of COPD. Outdoor pollution, especially in urban areas of low-income 
countries, may also cause COPD (Rabe et al., 2007), but it is not as pivotal a risk factor 
as indoor air pollutants (Lopez et al., 2006). In a similar vein, there has been evidence 
that risk for developing COPD is inversely related to socioeconomic status (Anto, 
Vermeire, Vestbo, & Sunyer, 2001); however, confounding variables such as crowding, 
poor nutrition, lack of access to health care and smoke exposure may be responsible for 
this association (Lawlor, Ebrahim, & Davey, 2004; Shohaimi et al., 2004). While the 
link between COPD and socioeconomic status is tenuous, the general perception of 
health professionals is that COPD is a disorder affecting more socio-economically 
disadvantaged older adults (Mannino et al., 2002). 
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While most patients with COPD are or have been cigarette smokers at some point 
in their lives, over 15% of those afflicted with the disease are non-smokers (National 
Center for Health Statistics, 2006). It is important to note that smoking prevalence in 
men has been falling since the mid 1960s, yet COPD mortality in men has been 
increasing since the 1970s (Mannino et al., 2002). Furthermore, not all smokers develop 
clinically significant COPD, which lends credence to the genetic influence on the disease 
(Smith & Harrison, 1997). There is a hereditary risk factor known as α (alpha)1-
antitrypsin deficiency (also known as familial emphysema) (Stoller & Aboussouan, 
2005), which occurs mainly in northern Europeans of Caucasian descent (Blanco et al., 
2006). Alpha1-antitrypsin is a protein in the blood that inactivates destructive proteins.  
When α1-antitrypsin is not present in the human body, the destruction of the lungs 
ensues, and evidence of COPD follows. Alpha1-antitrypsin deficiency accounts for 
between 1 and 5% of COPD patients and is estimated to afflict 100,000 Americans 
(Alpha-1 Foundation, 2007; Stoller & Aboussouan, 2005).   
Economic Costs 
In 2000, about 10 million Americans were diagnosed with COPD, and the 
disease was responsible for 8 million general practice and outpatient visits, 1.5 million 
emergency room visits, and 726,000 patient hospitalizations (Mannino et al., 2002).  
During this time frame, total direct medical costs of COPD were estimated at $6.6 
billion (Ward et al., 2000). Severe exacerbations of COPD required frequent medical 
attention resulting in extensive health care expenditures, estimated at $37.2 billion in 
2004 alone (American Lung Association, 2007a). In 2005, medical costs related 
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specifically to COPD were estimated at $2,700-5,900 per patient, with hospital 
admissions identified as the largest contributor to direct medical costs (Foster et al., 
2006). In 2007, the cost of COPD in America was approximately $42.6 billion, including 
$26.7 billion in direct health care expenditures, $8.0 billion in indirect morbidity costs 
and $7.9 billion in indirect mortality costs (National Center for Health Statistics, 2007).  
In the European Union, the direct costs of lung disease makes up approximately 6% of 
their total health care budget (roughly 38.6 billion Euros), with COPD accounting for 
56% of these expenditures (European Respiratory Society, 2003). From a societal 
perspective, COPD causes numerous inpatient and outpatient expenses. 
Health care utilization among COPD patients is between two and three times 
greater than that of age- and sex-matched controls (Kersten, 2001; Mapel et al., 2000). 
The WHO projects that costs per quality-adjusted life year (i.e., adjustment taking into 
account quality and quantity of life lived) for COPD range from $6,700 to $238,200 
depending on the course of treatment prescribed (Lopez et al., 2006). Hilleman and 
colleagues (2000) demonstrated that direct costs of COPD differ according to disease 
stage, with average costs nearly tripling from Stage I to Stage II ($1,681 to $5,037 per 
patient) and more than doubling from Stage II to Stage III ($5,037 to $10,812 per 
patient). Other studies have corroborated the nature of medical care costs skewed toward 
severe COPD, with the most expensive 20% of patients accounting for almost three-
quarters of all direct costs (Strassels, Smith, Sullivan, & Mahajan, 2001). More than half 
of medical costs are caused by COPD exacerbations (Andersson et al., 2002). 
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Health care costs associated with COPD are expected to grow even more 
burdensome in the coming years (Wouters, 2003), as there is no cure for COPD.   
Economic modeling assumes that cost-effective treatment of declining lung function is a 
long-term strategy (requires upwards of 20 years to elapse). A shorter term plan aimed at 
limiting the quantity of exacerbations is modeled to be more lucrative (Borg et al., 
2004). Accordingly, Goal 9, objective 24, of Healthy People 2010 (U.S. Department of 
Health and Human Services, 2000, p. 24-20) and the Centers for Disease Control and 
Prevention (U.S. Department of Health and Human Services, 2006b) have addressed the 
need for 1) limiting health problems associated with COPD and 2) reducing the adult 
(age > 45) mortality caused by COPD. Despite the expected ongoing classification of 
COPD as a significant cause of disability and health care costs for older adults, reports 
indicate that COPD research is the least funded chronic disease in relation to illness 
burden in the United States (Gross, 2001). 
Clinical Treatment and Pharmacologic Therapy 
  
As lung function further deteriorates, pharmacologic treatments are introduced to 
limit the impact of this debilitating disease. Once FEV1 falls below approximately 50% 
of what is predicted, the patient is at risk for severe disability and/or other morbid 
complications associated with declining lung function. When selecting a treatment plan 
for COPD, the benefits, risks, and costs (both direct and indirect) to the individual are 
considered (Rabe et al., 2007). Dyspnea measures and self-reports prove useful for 
prescribing treatments, as spirometry measures are not necessarily useful for guiding 
pharmacologic treatment regimens (Yohannes & Hardy, 2003). While there is not yet 
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any convincing evidence that drugs can alter the natural course of COPD (Rabe et al., 
2007), a stepwise approach to therapy can improve symptoms, activity levels and health-
related quality of life (HRQoL).   
The most basic clinical recommendation for COPD is that patients receive 
influenza and pneumococcal immunizations (Jackson et al., 2003; Sin, McAlister, Paul 
Man, & Anthonisen, 2003). An initial primary clinical treatment guideline suggests the 
use of bronchodilator drugs (e.g. inhaled anticholinergics, β2-agonists or theophyllines) 
on an as needed basis for relief of persistent symptoms. Short-acting β2-agonists and 
short-acting anticholinergics are commonly prescribed to patients as rescue medications 
for use in the home (Celli & MacNee, 2004; Rennard & Calverley, 2003). Regular 
treatment with long-acting bronchodilators ((e.g., β2-agonists such as salmeterol 
(commercially known as Serevent) and tiotropium bromide (commercially known as 
Spiriva)) is more effective than treatment with short-acting equivalents (Dahl et al., 
2001; Oostenbrink,  Rutten-van Molken, Van Noord, & Vincken, 2004; Vincken et al., 
2002; Yohannes & Hardy, 2003). There is little evidence, however, that these 
medications slow the decline in lung function (Anthonisen et al., 1994) and/or increase 
survival rates (Anthonisen et al., 2002). It is unknown whether therapy which combines 
the use of both long-term β2-agonists and anticholinergics concurrently is superior to 
using each alone (Sin, McAlister, Paul Man, & Anthonisen, 2003). Concurrent use of 
salmeterol (Serevent), tiotropium bromide (Spiriva) and fluticason (a steroid which 
guards against bronchial inflammation) has been shown to maintain lung function, 
enhance quality of life, and decrease hospitalizations, but failed to reduce the number of 
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exacerbations experienced by patients (Aaron et al., 2007). While combination therapy 
may produce additional benefits in terms of lung function and health status, concurrent 
use of multiple medications usually increases the costs of treatment (Yohannes & Hardy, 
2003). 
Inhaled corticosteroid therapy is a hotly contested prescription for COPD patients 
(Barnes, 2000; Calverley, 2000) and is considered the next primary step in 
pharmacological treatment. For patients with stage III or IV COPD, the reduction of 
exacerbations is the main justification for introduction of inhaled corticosteroids, such as 
prednisolone. Its use, combined with long-acting β2-agonists, has been shown to slow 
down declines in disease specific HRQoL (Sin, McAlister, Paul Man, & Anthonisen, 
2003). Critics of this treatment have argued that glucosteroids should be avoided due to 
an unfavorable risk-to-benefit ratio (Decramer, Lacquet, Fagard, & Rogiers, 1994; 
Wood-Baker, Walters, & Haydn Walters, 2006; Yohannes & Hardy, 2003). 
For patients with severe COPD (stage IV), the final step in pharmacological 
treatment is long-term oxygen therapy. This treatment has increased survival rates of 
patients with severe COPD (Tarpy & Celli, 1995). The goal of oxygen therapy is to 
maintain partial pressure of oxygen in arterial blood (SaO2) greater than or equal to 90% 
at rest. It is important to note that patients with less severe COPD show no improvement 
in survival after being treated with oxygen therapy (Chaouat et al., 1999; Gorecka et al., 
1997). The proper, prescribed use of pharmacologic therapy, in general, results in lower 
healthcare costs for COPD patients (Friedman & Hilleman, 2001), especially for those 
with advanced stages (III & IV) of the disease (Miller, George, & Halbert, 2005).   
 19
Surgery may also be beneficial in patients with certain types of emphysema.  
Lung volume reduction surgery is particularly effective for people with heterogeneous 
emphysema, hyperinflation and poor exercise capacity (Naunheim et al., 2006). Another 
type of surgery, known as a bullectomy, is also effective at reducing dyspnea and 
improving lung function (Mehran & Deslauriers, 1995). In addition, lung transplantation 
is an option for patients with very advanced COPD whose projected survival is less than 
2 to 3 years (Arcasoy & Kotloff, 1999). It should be noted that these surgical procedures 
are extremely expensive, have not been shown to improve mortality, and can only be 
recommended in very select patients who suffer from stage IV COPD (Rabe et al., 
2007). Even if surgery is performed, the potential for patients to suffer from 
complications after surgery is great, which makes surgery an option that is not often 
recommended.    
Disease Management 
COPD patients are faced with multiple health responsibilities, such as preventing 
and managing COPD exacerbations and handling prescribed medications. COPD is a 
progressive disease and lung function is expected to deteriorate over time. Accordingly, 
symptoms need to be monitored to inform therapeutic regimens and identify pending 
complications. It has been suggested that healthcare professionals focus attention on the 
care processes for managing and preventing complications that arise due to COPD 
(Miller, George, & Halbert, 2005). Disease management is an approach which 
coordinates resources across the health care system with the aim of fostering continuity 
of care and increased patient knowledge and control over disease (Hunter & Fairfield, 
 20
1997). The idea of COPD management has received much attention. World COPD Day 
is held annually on the third Wednesday in November to raise awareness about COPD 
management and advocate for a comprehensive care system which has the capacity to 
direct the optimal management of COPD (Rabe et al., 2007). 
The Global Initiative for Chronic Obstructive Lung Disease (GOLD) in 
partnership with the WHO’s Global Alliance Against Chronic Respiratory Diseases 
(GARD) initiated a worldwide collaborative effort which teamed healthcare personnel 
with policymakers in order to develop an expanded COPD research agenda dedicated to 
improving the management of COPD. One of the major projects involved the 
development of a comprehensive report entitled, Global Strategy for the Diagnosis, 
Management, and Prevention of COPD (Rabe et al., 2007). This reports describes 
evidence-based research on best practices associated with COPD management. The 
management of COPD is separated into four components: (1) assess and monitor 
disease, (2) reduce risk factors, (3) manage stable COPD, and (4) manage exacerbations. 
The overall goals of COPD management are listed in Table 4. It has become clear that 
improvements in the management of COPD will result as a function of well-designed 
behavioral-oriented interventions (van der Palen, Monninkhof, & van der Valk, 2004). 
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Table 4  
Goals of COPD management  
Primary goals of COPD Management 
 Relieve symptoms 
 Prevent disease progression 
 Improve exercise tolerance 
 Improve health status 
 Prevent and treat complications 
 Prevent and treat exacerbations 
 Reduce mortality 
Source: Rabe et al., 2007 
 
Using these four component parts as a framework, empirical models have been 
developed (cf. Adams et al., 2007; Endicott et al., 2003) and evaluated (Adams et al., 
2007) to determine how to best structure, implement and evaluate COPD management 
programs. Studies have shown that integrating at least 2 of the aforementioned 
management components into programs results in less health care utilization (Adams et 
al., 2007). Both secondary and tertiary prevention strategies exist for COPD (Mannino & 
Buist, 2007). Modifying exposure to risk factors (secondary) and prevention of 
complications associated with COPD progression (tertiary) are strategies used to manage 
COPD (Bednarek et al., 2006; Celli et al., 2006; Croxton & Bailey, 2006). As with 
treatment, COPD prevention should be individualized to address specific symptoms and 
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HRQoL concerns (Rabe et al., 2007). The implementation of prevention strategies 
within the course of disease management ought to be assimilated into health services 
comprehensively, with careful attention to placed on the cost-effective prevention of 
exacerbations and disease-related complications (Lopez et al., 2006; Wagner, 2004).  
Improving quality of care through disease management can include the distribution of 
simple, easy to follow management guidelines through multiple communication 
channels (Miller, George, & Halbert, 2005).   
Pulmonary Rehabilitation 
 
Pulmonary rehabilitation is a structured (usually hospital run) program of 
supervised and monitored physical activity, breathing therapy, behavioral management 
and modification (e.g., smoking cessation), nutrition counseling and disease education 
that has been shown to improve quality of care for COPD patients. The goals of 
pulmonary rehabilitation are to reduce symptoms, increase participation in daily 
activities, and reduce the impact of disease-related complications and exacerbations on 
HRQoL (Rabe et al., 2007). To achieve these goals, pulmonary rehabilitation programs 
are generally offered to patients with advanced COPD (Stages II – IV), as these patients 
are more prone to exercise deconditioning, social isolation, depression, muscle wasting 
and weight loss.  
Most pulmonary rehabilitation programs are sponsored by pulmonologists. 
Before beginning a pulmonary rehabilitation program, patients normally undergo a 
battery of baseline assessments in order to target areas for improvement, and provide 
comparative measures for impact and outcome evaluations. Baseline assessments 
 23
traditionally entail spirometry measures (before and after use of a bronchodilator), 
exercise capacity assessments, and measurements of HRQoL and dyspnea (Rabe et al., 
2007). The time span of most programs lasts approximately 20-30 sessions, with 
optional maintenance sessions offered following completion of the primary program. 
Program participants attend rehabilitation sessions approximately 3-4 times per week for 
about one hour each session. 
After a warm up period of approximately 5-10 minutes, therapists and nurses 
direct participants through exercise training circuits on weight resistance machines, 
treadmills and stationary bicycles for a period of 45-50 minutes. While participants 
move from machine to machine, trained medical professionals monitor and record the 
blood pressure and pulse oximetry of patients to ensure that levels remain within an 
acceptable range throughout the duration of the training session. Patients are encouraged 
to work towards intensity levels commensurate with their self-imposed level of 
achievement. Most aerobic training is targeted at 60% to 90% of the predicted maximal 
heart rate for a period of approximately 30 minutes (American Thoracic Society, 1999). 
In addition to these exercise sessions, there are approximately 3-5 educational sessions 
offered to patients (lasting approximately 30-45 minutes each) during the program cycle. 
These sessions cover topics such as normal and abnormal lung function, stress 
management, medication adherence, and dietary considerations. 
To evaluate the impact of pulmonary rehabilitation programs, outcome data from 
the rehabilitation sessions (e. g. pulse oximetry, blood pressure measures, weight 
resistance machine settings, elapsed time of exercise, perceived level of difficulty, 
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measurements of HRQoL and dyspnea) are compared to baseline data collected before 
the program’s inception. This information is shared with the patient’s pulmonologist and 
primary care physician to update patient progress. Impact evaluations of pulmonary 
rehabilitation programs demonstrate improved functional performance, exercise 
tolerance, HRQoL and dyspnea levels among COPD patients (Nici, Donner, Wouters, & 
Zuwallack, 2006; Rabe et al., 2007; Yohannes & Hardy, 2003). However, these 
improvements are occasionally only visible when patients continually participate in 
programs or recently complete a rehabilitation cycle. This contributes to findings which 
indicate that pulmonary rehabilitation does not improve hospitalization rates (Griffiths et 
al., 2001). 
The first enrollment in pulmonary rehabilitation is normally covered by Medicare 
for patients who qualify; however, patients who wish to continue rehabilitation after the 
first round of therapy must usually pay for it out of pocket. This type of maintenance 
program can prove to be quite costly for patients, especially those with limited monetary 
resources. Therefore, attempts at COPD self-management in the home environment, with 
no requirements for specialized facilities or group meetings, have been encouraged 
(Gravil et al., 1998). 
COPD Self-Management 
 
Because of limited access to hospital-based pulmonary rehabilitation for 
underserved patients, practical self-management programs have been implemented to 
improve the overall management of COPD. COPD self-management refers to: engaging 
in activities that promote adequate inhalation technique, build physiologic reserves, and 
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prevent adverse health outcomes; interacting with healthcare providers and complying 
with recommended treatment protocols; monitoring respiratory and emotional status and 
making appropriate management decisions on the basis of this self-monitoring; and 
managing the effects of illness on self esteem and coping skills (Von Korff et al., 1997). 
Chronic disease self-management programs promote active patient participation and 
focus on acquisition and implementation of learned skills and enhancing patient self-
confidence related to disease management decision making (Bourbeau & Nault, 2007). 
In recent systematic reviews of the efficacy of COPD self-management education 
programs, an association was established between self-management education and 
improved HRQoL, with no indication of detrimental effects on other related health 
outcomes (Effing et al., 2007).   
In light of the effectiveness of some COPD self-management programs, health 
educators have been encouraged to develop and test cost-effective, readily accessible 
interventions which (1) define the true effective educational elements of COPD self-
management and (2) facilitate the acquisition of self-management skills. There are still 
many unanswered questions which need to be addressed with respect to COPD self-
management education and skill acquisition, however.  Previous work indicates that 
adults use a variety of strategies to adapt to chronic disability (Falter, Gignac, Brooks, & 
Cott, 2002), each of which may impact health and HRQoL in unique and disparate ways, 
often in a reciprocal fashion. Moreover, understanding self-management behaviors is 
complex and represents a “black box” for health care professionals (Cicutto, Brooks, & 
Henderson, 2004). 
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Health Related Quality of Life (HRQoL) 
 
COPD has a major effect on HRQoL (Ferrer et al., 1997; McDowell & Newell, 
1996; Yohannes, 2005). HRQoL has been defined as the physical, psychological, and 
social domains of health that are unique to each individual (Testa & Simonson, 1996). 
This construct is measured in various ways to describe physical and social functioning 
and general health perceptions (Ware, 1995). HRQoL is an important marker for 
measuring 1) the impact of chronic disease (Patrick & Erickson, 1993), 2) the effect of 
interventions designed to treat chronic disease (Wennberg, 1990), and 3) intervention 
cost-effectiveness (Kaplan & Ries, 2005). Patient interpretations of chronic conditions 
and adaptations to disease-associated problems must be taken into account when 
assessing HRQoL (Kaplan & Ries, 2005). Assessments of HRQoL can quantify the 
impact of disease on everyday life activities (functional status) and well-being (Reardon, 
Lareau, & ZuWallack, 2006), as HRQoL has been shown to be a strong predictor of 
COPD exacerbation frequency (Wilson et al., 1997). Over time, lung function improves 
after an exacerbation episode, yet HRQoL remains relatively stable following an 
exacerbation which requires hospitalization (Andenaes, Moum, Kalfoss, & Wahl, 2006).   
There has been an increased interest in examining HRQoL among patients with 
COPD, due to practitioner and patient concern about symptoms and functionality more 
so than objective lung function (Mahler, 2000). Objective measures of lung function 
may not accurately predict disability (Pitta et al., 2005) and/or even be related to HRQoL 
(Arnold et al., 2005; Killian, Summer, Jones, & Campbell, 1992; Hesselink et al., 2006; 
Jones, 2001; van Schayck et al., 1992; Williams, 1989). Furthermore, HRQoL and 
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pulmonary function may highlight different aspects of COPD and provide 
complementary information about disease severity (Hesselink et al., 2006). This is not 
necessarily surprising considering that improvements in symptoms, “cannot be inferred 
reliably from spirometric changes” (Jones, 2001, pp. 885).    
There are two main approaches to assessing HRQoL: psychometric and decision 
theory (Kaplan & Ries, 2005). The psychometric approach provides a profile of the 
different domains related to HRQoL (but does not classify domain relevance and 
importance), while decision theory weights the different dimensions of health to provide 
a single HRQoL index (Kaplan & Ries, 2005). Questionnaires are developed using items 
that reflect various domains or dimensions which discriminate experiences and 
behaviors that impact HRQoL (Guyatt, Feeny, & Patrick, 1993). Measures can be 
generic (to measure general HRQoL) or disease specific (to measure aspects of HRQoL 
which are only specific to patients with a unique condition). Specific HRQoL measures 
have been suggested for distinct health conditions, because there is greater potential for 
more responsiveness when only relevant aspects of HRQoL are included for assessment 
(Guyatt et al., 1993).   
In addition, minimal clinically meaningful differences have been established for 
a variety of disease specific HRQoL instruments (Jones, 2001). There is no single gold 
standard for the measurement of HRQoL, so investigators are encouraged to select 
responsive instruments which meet research goals in a practical manner (Puhan et al., 
2007). As noted by Mahler (2000), “the responsiveness of an evaluative instrument is 
essential to evaluate the impact/benefit of a specific intervention on the outcome of 
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health status” (pp. 55S). Furthermore, assessing HRQoL in patients with COPD has 
become a major goal of disease management (Monninkhof et al., 2004a). 
Information Needs 
It is known, however, that targeted health education plays a vital role in 
improving skills, coping ability and HRQoL among patients with COPD (Celli, 1995; 
Gallefoss, 2004; Mannino & Buist, 2007). Targeted patient education may not improve 
exercise tolerance or lung function specifically, but it can have a dramatic impact on 
patients’ ability to deal with disability caused by COPD. Programs which teach self-
management skills and provide comprehensive educational services to patients reveal 
better outcomes than programs which simply use follow-up appointments to monitor 
disease status (Sin et al., 2003). Consequently, Gulsivik and colleagues (2006) stress that 
educational messages should be made prominent within all COPD home-care and 
outreach activity. Likewise, Rabe and colleagues (2007) argued that, “Education should 
be [directed at] the needs…of the patient, interactive, directed at improving quality of 
life, simple to follow, practical and appropriate to the intellectual and social skills of the 
patients” (p. 541). Patients’ educational level, cultural outlook, socioeconomic status and 
willingness to apply disease management education are all important individual-level 
factors which vary amongst specific priority populations. This is just one of many 
important considerations (e.g., external factors such as environment, social 
circumstances, etc.) when developing educational messages and programs. Topics 
relevant for disease management education include dyspnea management techniques, 
decision making during exacerbations, and advice on when to seek medical attention.   
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As COPD progresses, it becomes more complex and spirals into an abstract 
complex of interrelated physical, emotional and psychosocial problems. Patients are in a 
constant process of learning as they endure, manage and adapt to the changing nature of 
the disease. They must learn to cope not only with the physical symptoms of COPD, but 
also with the psychological and social problems caused by COPD pathology. 
Psychological co-morbidity, especially anxiety and depression, is seen frequently among 
patients with COPD (Cleland, Lee, & Hall, 2007; Stage, Middelboe, & Pisinger, 2003). 
Depression is aggravated by worsening dyspnea and perceived poor health, both of 
which contribute to diminished functional capacity (Yeh, Chen, Liao, & Liao, 2004). 
The prevalence of depression and anxiety in patients with COPD has been estimated at 
upwards of 80% (Kunik et al., 2005). Younger (< 60 years of age) patients report higher 
levels of depression and anxiety (Cleland, Lee, & Hall, 2007); yet currently, less than 
1/3 of COPD patients receive treatment for their depressive and/or anxiety-related 
symptoms (Kunik et al., 2005). Furthermore, COPD patients who are depressed have 
difficulty learning and implementing treatment plans which limit exacerbations 
(Dowson, Town, Frampton, & Mulder, 2004). Research has shown, however, that 
willing participants of dyspnea self-management programs significantly improve 
depressive symptoms (Nguyen & Carrieri-Kohlman, 2005). Accordingly, educational 
methods must be readily adjusted to suit the self-management learning needs and disease 
status of individual patients (Bourbeau, 2003).   
Patient-centered education developed in accordance with patients’ specific needs 
is a key factor in managing COPD (Neish & Hopp, 1988; O’Donnell et al., 2004; 
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Redman, 2004). There are two ways of assessing patients’ learning needs in regards to 
COPD: (1) knowledge and (2) information needs (Bourbeau, Nault, & Dang-Tan, 2004; 
Steward et al., 2001; White et al., 2006). Patients differ in terms of the depth and type of 
information that they seek (Dowson et al., 2004), so guidelines recommend that 
educational development take into account differing needs of patients (National 
Collaborating Centre for Chronic Conditions, 2004). Information needs assessments 
attempt to ascertain the opinions of learners regarding what information they want to 
learn, what educational topics they believe are important and which self-management 
topics need to be addressed (Murray, Boyd, & Sheikh, 2005).    
Research has shown that evidenced-based COPD self-management involves 
appropriate prescription of education to patients who are able to make use of prescribed 
information. An array of instructional materials can be provided to patients regarding a 
variety of self-management skills such as: the use of respiratory therapy equipment, 
proper breathing techniques, bronchial drainage and physical activity (Redman, 2004). 
Developing innovative educational materials which promote self-management behaviors 
is the only way self-management education can have a long term impact on patients with 
COPD. As a result, constructs such as self-efficacy are important to measure both before 
and after program implementation (Effing et al., 2007).   
Self-Efficacy 
Self-efficacy is a person’s belief in their capabilities to carry out a particular 
action or behavior which fulfills a task that produces a desired result. Personal efficacy 
beliefs can influence an individual’s motivation, course of action, resolution, cognitive 
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thoughts, emotional response and attribution of accomplishment and failure (Bandura, 
1978). Efficacy beliefs are powerful predictors of behavioral adherence to prescribed 
management strategies (Eakin, 1992) and vice-versa (Bandura, 1978). It has been argued 
that the effects of a self-management education program on HRQoL results from 
behavior change that is caused by enhanced self-efficacy, skill building and a reduced 
need for self-management information. To facilitate enhanced self-efficacy, it is 
suggested that instructional processes take into account four sources of efficacy 
information: (1) performance mastery, (2) vicarious experience or modeling, (3) 
emotional or physiological arousal, and (4) verbal persuasion (Bandura, 1997), all of 
which help contribute to efficacy beliefs for specific tasks.  
Statement of the Problem 
 
Despite the efficacy of hospital-run pulmonary rehabilitation programs which 
assist patients in medically managing COPD (Griffiths et al., 2000; Lacasse, Goldstein, 
Lasserson, & Martin, 2002), the high costs and lack of availability of such programs 
pose considerable barriers for underserved COPD patients looking to maintain and 
improve HRQoL. Due to the scarce availability and high expense of hospital-run 
pulmonary rehabilitation programs, primary care physicians generally encourage patients 
to actively self-manage COPD. Given time constraints, the majority of primary care 
physicians are unable to provide sufficient “in-person” education to patients regarding 
COPD self-management. In addition, some physicians do not feel prepared to teach 
patients within the clinical environment due to the low priority that patient education is 
given by managed care administrators. The absence of third-party reimbursement to 
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support patient education makes teaching and learning between provider and patient 
quite difficult to achieve. This is problematic, because patients report not having their 
disease-related concerns addressed during routine consultations (Tate et al., 1999).  
Because of this, some COPD patients do not feel connected to their health care 
providers. This feeling of disconnect affects patients’ decision making regarding disease 
management (Leidy & Haase, 1996). COPD patients prefer to be involved in their own 
medical decision making and respond better if they are included in the process 
(Bourbeau, Nault, & Dang-Tan, 2004; Worth & Dhein, 2004).   
There are considerable unmet educational needs for patients looking to manage 
COPD effectively (Elkington & White, 2002). COPD patients report widespread 
dissatisfaction with the self-management education they are provided (Barr et al., 2005; 
Gore, Brophy, & Greenstoe, 2000; Jones, Hyland, Hanney, & Erwin, 2004). Most 
notably, there seems to be a paucity of patient-centered interventions that take into 
account patients’ perspectives and knowledge of disease management by way of a needs 
assessment (Woo et al., 2006). This is disappointing, given that approaches to 
community-based, chronic disease self-management are purported to focus on enabling 
additive guidance which will achieve self-management goals (Bandura, 2004). In order 
to adequately self-manage COPD, patients must not only be educated in appropriate 
COPD self-management skills, but they must also confident that they can employ the 
knowledge and skills learned (Boot et al., 2005; Brooks, Lacasse, & Goldstein, 1999).   
Moreover, the limited information patients receive during short interactions with 
their primary care physician does not correspond with their learning needs for COPD 
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self-management (Elkington & White, 2002; Suhonen, Nenonen, Laukka, & Valimaki, 
2005). There are various skills to develop and barriers to overcome before COPD self-
management can be applied in everyday life (Suhonen, Nenonen, Laukka, & Valimaki, 
2005). Rehabilitative behaviors such as: breathing retraining, medication management, 
energy conservation, relaxation, visual imagery and paced walking have all been noted 
to be suboptimal among COPD patients, largely due to patients’ lack of self-
management education (Cicutto & Brooks, 2006). Thus, it is important to identify 
effective educational strategies for enhancing self-efficacy among COPD patients who 
need to manage their disease.   
Few investigations have examined the relationship between COPD disease self-
management and patient self-efficacy in making behavioral modifications, but those 
which have revealed promising results. Self-efficacy has been shown to be a predictor of 
participation in COPD self-management activity (Gormley, Carrieri-Kohlman, Douglas, 
& Stulbarg, 1993; Kaplan, Ries, Prewitt, & Eakin, 1994), and interventions which 
provided information to patients regarding COPD self-management increased patients’ 
self-efficacy for managing COPD in some studies (Scherer & Schmieder, 1997; Tsang, 
2000; Zimmerman, Brown, & Bowman, 1996), but not all (Scherer, Schmieder, & 
Shimmel, 1998).  Atkins and colleagues (1984) showed that COPD patients exhibited 
statistically significant improvements in self-efficacy judgments when exposed to 
cognitive and behavioral modification strategies. From these initial studies, however, it 
is unclear as to what type of educational treatment optimally increases feelings of self-
efficacy regarding COPD self-management. A better understanding of the actual nature 
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of the educational treatment delivered and its ability to reduce information needs, 
increase perceived efficacy towards self-management,  and enhance HRQoL is important 
to understand, and should be the focus of future research (van der Palen et al., 2004). 
Older adults suffering from COPD have unique preferences for the manner in 
which they obtain self-management education (Carlson et al., 2006; Van Wynen, 2001). 
It has been suggested that older COPD patients appreciate and learn well from home-
based educational programs which use audiovisual media to transmit targeted self-
management instruction (Boxall, Hons, Sayers, & Caplan, 2006; Constantinidou & 
Baker, 2002; Finklestein & Ratner, 2006; Nguyen et al., 2003; Petty et al., 2006).  
Interventions designed to provide mastery experiences for COPD self-management can 
increase a patient’s efficacy beliefs for accomplishing self-management behaviors 
(Tsang, 2000). In light of this, translational research should focus on disseminating 
innovative educational material which can utilize readily available technology to provide 
underserved COPD patients with customized educational resources that can (a) satisfy 
informational needs regarding COPD self-management, (b) enhance self-efficacy 
regarding COPD self-management, and thereby (c) positively impact HRQoL. Figure 1 
provides a conceptual model of this idea. The DVD modality is optimal for segmenting 
and illustrating educational information according to different skills and behaviors 
necessary for self-managing COPD.   
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Figure 1. Conceptual model of research study 
Adapted from: Bourbeau & Nault, 2007 
 
The effect of peer modeling for COPD patients may be an important area for 
further research endeavors (Davis et al., 2006).  Do patients need exposure to audio-
visual directives, which show individuals how to engage in COPD specific self-
management activities?  Are directives relayed through traditional text formats 
instructive enough?  Is it more effective to couple the use of audio-visual directives with 
text-based guidelines?  Some of these questions have been answered to a limited degree, 
but more research questions need to be developed and tested to explore answers related 
to these important questions.   
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Purpose 
 
Primary Aim   
The primary aim of the present study was to measure and specifically compare 
the effect of three COPD self-management education dissemination strategies (and a 
control strategy) on relative differences in generic and disease-specific HRQoL, COPD 
information needs and COPD self-management self-efficacy. The four educational 
treatments were: 
1. Targeted RVision™ DVD segments (RVision™ Corporation, 2007)  
2. Pre-produced written Pamphlet, Breathing Better With a COPD Diagnosis 
(National Heart, Lung and Blood Institute (NHLBI), 2007b) 
3. Targeted RVision™ DVD segments and Breathing Better With a COPD 
Diagnosis  
4. Usual care (control) 
Secondary Aim  
The secondary aim of the present study was to assess the self-management 
learning needs, experiences and perspectives of COPD patients who were treated at 
Choctaw Urgent Care, a Certified Federal Rural Health Clinic in rural Butler, Alabama. 
This was undertaken to inform the development of the targeted intervention materials. 
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Hypotheses 
Secondary Aim 
Hypothesis # 1:  Patients will identify experiences underlying the major theme of 
surviving life with COPD, with two sub themes being adjusting physically and 
emotionally (Cicutto et al., 2004).  
Hypothesis #2: Patients will discuss the balance between living life and 
managing disease, with practicing breathing exercises and medication 
management emerging as the two most effective and readily accepted disease 
management activities (Cicutto et al., 2004). 
Primary Aim 
Hypothesis # 3: Patients exposed to targeted DVD segments (Treatment 1) will 
outperform patients exposed to the educational Pamphlet (Treatment 2) on 
outcome variables related to COPD Informational Needs, COPD Self-
Management Self-Efficacy, and HRQoL (Boxall, Hons, Sayers, & Caplan, 2006; 
Constantinidou & Baker, 2002; Finklestein & Ratner, 2006; Nguyen et al., 2003; 
Petty et al., 2006).     
Hypothesis # 4: Patients exposed to the targeted DVD and educational Pamphlet 
(Treatment 3) concurrently will underperform as compared to patients exposed to 
the DVD (Treatment 1) and educational Pamphlet alone (Treatment 2), on 
outcome variables related to COPD Informational Needs, COPD Self-
Management Self-Efficacy, and HRQoL (Consumer Information Processing 
Theory (CIPT); Rudd & Glanz, 1990).     
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Hypothesis # 5: Patients exposed to targeted DVD segments (Treatment 1), 
educational Pamphlets (Treatment 2), and both DVD segments and educational 
Pamphlets concurrently (Treatment 3) will outperform patients exposed to the 
usual care (control) condition (Treatment 4) on outcome variables related to 
COPD Informational Needs, COPD Self-Management Self-Efficacy, and 
HRQoL (Self-efficacy Theory; Bandura, 1997; Effing et al., 2007).   
Delimitations 
This study was delimited to a diverse population of male and female adults over 
the age of 50, who suffered from varying stages of COPD and whom which were 
patients of Choctaw Urgent Care in Butler, Alabama. The investigation was limited to 
testing the effects of different educational intervention strategies on health related 
outcomes in a rural population of older adults. The health-related outcome measures 
were delimited to the ones identified above. Participants were required to comprehend 
English, and were not allowed to have a roommate, housemate or family members also 
participating in the study. This was done to reduce contamination and diffusion effects, 
are both threats to internal validity.  
Assumptions 
 
The following assumptions were made: 
1. The educational treatments were viewed and reviewed as prescribed 
before the posttest measurement. 
2. The patients self reported measures of HRQoL, COPD Informational 
Needs, and COPD Self-Management Self-Efficacy were honest and accurate. 
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Operational Definitions 
Self-Management  
Self-management is defined as any formalized patient education program aimed 
at teaching skills needed to carry out medical regimens specific to a disease, guide 
health behavior change and provide emotional support for patients to control their 
disease and live functional lives (Bourbeau, 2003) 
Self-Management Education  
 Self-management education is defined as a program which transfers information 
about COPD and treatment of COPD in either written, verbal, visual or audio 
formats (Effing, 2007).  
COPD Self-Management Self-Efficacy  
COPD self-management self-efficacy is defined as a patient’s confidence in their 
ability to carry out a variety of skills necessary to effectively self-manage COPD 
COPD Information Need 
COPD information need is defined as the level of self-perceived need for 
information related to the self-management of COPD 
Health Related Quality of Life (HRQoL)  
HRQoL is defined as the physical, psychological, and social domains of health 
that are unique to each individual (Testa & Simonson, 1996). This construct 
measured in general and disease-specific ways to describe physical and social 
functioning and general health perceptions (Ware, 1995). 
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CHAPTER II 
THEORETICAL FRAMEWORK AND LITERATURE REVIEW 
The term self-management has become commonplace in health education and 
health promotion circles, and it is attached to numerous patient education programs 
(Lorig & Holman, 2003). Creer, Renne, and Christian (1976) first coined the term in the 
mid-1960s, and described it as patients being active in the treatment of their own chronic 
illness. Self-management has more recently been defined as any formalized patient 
education program aimed at teaching skills necessary to carry out medical regimens 
specific to a disease, guide health behavior change and provide emotional support for 
patients to control their disease and live functional lives (Bourbeau, 2003). Chronic 
disease self-management is especially important for chronically ill patients who act as 
the sole provider of their personal daily care (Lorig & Holman, 2003). Due to rising 
health care costs stemming from increased use of chronic disease health services, there is 
growing pressure placed on health systems to find strategies which limit, ration and 
delay health service utilization among populations who suffer from chronic disease.  
Effective chronic disease self-management is one such strategy. In fact, Bandura (2004) 
stated that, “if the huge health benefits of these few health habits (chronic disease self-
management) were put into a pill, it would be declared a scientific milestone in the field 
of medicine” (pp. 143). 
Self-management programming fulfills the demand for health programs that limit 
complications caused by chronic disease. The emergence of these types of programs is 
reflective of the growing shift from the medical management model, which emphasizes 
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compliance with prescriptive regimens, to a more collaborative self-management model 
of health and health care (Maes & Karoly, 2005).  Figure 2 illustrates how programs are 
delivered using this model. The self-management model emphasizes mastery of self-
regulatory skills such as: self-monitoring health-related behavior and its socio-cognitive 
precepts; setting goals to guide management strategies and routines; and procuring 
incentives and social support to help sustain healthy action (Bandura, 2003). This 
revisionist approach uses a process model which focuses on how psychosocial means 
affect health.   
 
 
 
Figure 2. Self-management model for program delivery 
Adapted from: Debusk, Miller, & Superko, 1994 
 
 
Five core self-management skills have been identified in the literature: (a) 
problem solving, (b) decision making, (c) resource utilization, (d) forming partnerships 
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problems from multiple sources, implementing only sound solutions, and evaluating the 
results of solution(s) implementation. Thus, the self-management of COPD is multi-
faceted in nature. Decision making refers to contemplating the daily choices which arise 
based on the changing pathology of chronic disease. For adequate decision making to 
take place, patients must have enough and appropriate information from suitable 
resources (Lorig & Holman, 2003). The practitioner develops key messages which 
encourage proper decision making, while making use of resources provided to the 
patient. Utilizing suitable resources requires that patients are able to navigate through all 
possible sources of health information and hone in on information that is most important 
for their own, personal needs. Health professionals are tasked with teaching patients to 
(a) make informed decisions about treatment, (b) report the trends and tempo of their 
disease, and (c) discuss disease-related experiences with health care providers (Lorig & 
Holman, 2003). To be effective, self-management education must be developed in 
accordance with a mutually understood care plan agreed upon between the patient and 
provider (Bourbeau & Nault, 2007). 
A self-management skill often ignored is the ability to take action and apply self-
management skills and knowledge to one’s own self (Lorig & Holman, 2003). While 
studies have shown that self-management education interventions improve patients’ 
knowledge level regarding disease, improved knowledge has seldom been associated 
with improved HRQoL and reduced health service utilization. Mazzuca (1982) showed 
that efforts to improve health by improving knowledge alone were rarely successful, 
while behaviorally-oriented programs which outlined specific patient education 
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regimens were more effective in limiting the progression of chronic disease. Simply put, 
patients may need to know less about the pathophysiology of their disease and more 
about how to assimilate self-management behaviors into their daily lifestyles. Health 
educators are directed to target information in a self-management education program 
towards patients’ particular risk factors, so that patients master self-management tasks 
which are truly important. 
Due to the importance of self-regulatory action within the self-management 
model, self-management programs strive to keep the patient keenly involved in efforts 
aimed at achieving and maintaining wellness, not merely treating bouts of illness. The 
treatment of chronic disease focuses on self-management of both physical and emotional 
conditions over time (Bandura, 2004). Effective health promotion programs geared 
towards disease self-management include four main components: (a) provision of 
information, (b) translating information into preventive action, (c) self-efficacy building, 
and (d) creating support for desired health behavior change. Health promotion programs 
that include these components can reduce and prevent deleterious health habits 
(Bandura, 2004). The provision of self-management education can facilitate the first 3 of 
these 4 components and assist in cultivating support for potential long-term behavioral 
modification.  
Best Practices for COPD Self-Management 
Integrating chronic disease self-management programs into our pre-existing 
health care system is a daunting, but not impossible task. Three recommendations for 
integration are: (a) preparing the system, (b) preparing patients, and (c) developing 
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payment mechanisms. Self-management education is best initially conducted in 
conjunction with a clinical setting, because this type of collaboration fosters an ongoing 
patient-provider relationship (Lorig & Holman, 2003). This accommodation proves 
difficult, however, given that few health education practitioners exist within the 
infrastructure of current clinical care settings and systems. Even if health educators do 
exist to provide self-management education services, they are sometimes viewed as 
subsidiaries not central to the treatment of patients. This auxiliary view of health 
education is further exposed when resources are not allocated to evaluate the impact of 
self-management education provided to patients. When health education becomes 
unregulated, quality control efforts are nearly impossible, and self-management 
education disintegrates from within clinical care protocols. 
Lorig and Holman (2003) discuss several solutions which can overcome barriers 
to self-management education program implementation in the clinical setting. First, ideal 
populations should be identified through a systematic needs assessment. Second, 
evidence-based programs must be sought out and implemented according to practice-
based guidelines. Next, qualified personnel must be put in place to maintain program 
fidelity and implement and evaluate the program. Lastly, the program itself must be 
assimilated into other mainstays of health care service, such as pharmacy and laboratory 
services (Lorig & Holman, 2003).   
Bourbeau and Nault (2007) suggest that the development of patient centered self-
management education programs requires four main planning requirements. Health 
educators should ensure that: (a) interactions between the learners and educators will 
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occur; (b) education is based on the learning styles and needs of patients and provided in 
a format highly conducive to behavioral response; (c) mastery of self-management skills 
is placed at a premium; and (d) evaluation of patient outcomes is completed. It is 
important to understand what patients know about their disease, what their concerns or 
problems are related to the disease, and which coping skills they are currently using to 
live with the disease (Weston-Eborn & Sitzman, 2005). Educational topics of interest to 
the patients must be integrated into instructional sessions, and these sessions should be 
weaved into an educational process that supports the natural diffusion of pertinent 
information. The practitioner is encouraged to use a variety of educational methods to 
disseminate information, as multiple methods are more likely to ensure information 
retention (Nault et al., 2002). Table 5 lists efficient self-management educational 
methods used to instruct individuals with COPD. 
 
Table 5  
 
Efficient COPD self-management education methods  
 
Educational Methods 
 Interactive lecturing 
 Motivational interviewing 
 Going through case scenarios and determining how to handle specific disease-
related situations 
 Demonstrations and practice of self-management techniques 
 Constructive feedback and reinforcement 
 Learning contract which specify goals for self-management 
 Distribute population-specific written material to improve health literacy 
Adapted from:  Bourbeau & Nault, 2007 
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In regards to content within COPD self-management education programs, topics 
worth addressing include: proper use of prescription medication, breathing control, 
energy conservation, recognition and treatment of exacerbations, stress management and 
disease-adapted physical activity. These are just a few of the variety of behaviors which 
are encouraged for COPD self-management. Behavioral adaptations for COPD patients 
require the mastery of specific skills (See Table 6 for Health behaviors and skill sets in 
COPD self-management). 
 
Table 6  
Health behaviors and skill sets in COPD self-management 
 
Self-management behaviors (in bold) and requisite skill sets (in italics) 
Live in a lung irritant-free environment 
-Quit smoking 
-Avoid second-hand smoke 
Manage medications 
-Take medications as prescribed and with proper technique 
Manage breathing 
-Purse-lip breathing 
-Postural positioning 
-Controlled coughing 
Energy conservation 
-Plan your daily activities 
-Prioritize most important activities first 
-Pace yourself while carrying out activities of daily living 
Stress management 
-Relaxation and imagery techniques 
-Maintain positive outlook 
-Problem solving 
Exacerbation management 
-Get influenza vaccinations every year 
-Know when to call the doctor 
-Avoid activities and situations that make you feel worse  
Active living 
-Maintain walking, stair climbing, and other physical activity using purse-lip breathing 
-Choose activities that you enjoy and do them 
-Pace yourself 
-Know your limits 
-Be active in environments that will not aggravate symptoms 
Healthy eating 
-Eat smaller meals more often (5-6 per day) 
-Eat foods high in protein 
Source: Bourbeau & Nault, 2007 
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Patient Perspectives 
When developing self-management programs, it is advisable that practitioners 
recognize the dissimilar concerns that are brought to light across different diseases and 
populations, and even within individuals residing in similar populations (Lorig & 
Holman, 2003). Patients report being satisfied with a shared decision making model that 
they share with their physician when making decisions about their disease; however, 
they note that some of their disease-related questions are not answered due to lack of 
time with their physician (Barr et al., 2005; Cicutto &, Brooks, 2006). This may 
contribute to the increased symptom burden of COPD and resultant hospitalizations and 
emergency care visits by patients (Barr et al., 2005).   
Patient motivation for self-managing COPD includes feeling better after 
engaging in activity, fearing the repercussions associated with non-compliance with 
recommendations (Cicutto &, Brooks, 2006) and physician directives (Eakin & 
Glasgow, 1997). Some of the reasons for lack of compliance with self-management 
guidelines include limited knowledge acquired from a physician (Barr et al., 2005; 
George et al., 2005; Jones, Hyland, Hanney, & Erwin, 2004; Koning, Maille, Stevens, & 
Dekker, 1995), having never attended a structured educational and/or pulmonary 
rehabilitation program (Barr et al., 2005; Cicutto &, Brooks, 2006), and having a 
perceived, personal lack of influence on COPD progression (Dowson et al., 2004). 
Patients who are able to cope with shortness of breath are more likely to be satisfied with 
the health services they are provided (Fan et al., 2005). Survival skills, such as what to 
do during an exacerbation, how to prevent COPD from becoming worse, and how to 
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maintain ability to complete activities of daily living, are of primary interest among 
COPD patients (Carlson et al., 2006). Patients must learn to engage in various activities 
that promote health during the spiraling progression of COPD (Bourbeau & Nault, 
2007). It is important to be cognizant of the fact that generic health knowledge is fairly 
easy to transmit, but changing self-efficacy and the value patients place in preventive 
behavior can take strategic effort and tactical planning.   
Theoretical Background 
There are two conceptual frameworks that inform the research project described.  
The first framework uses psychosocial theories of self-efficacy that explain and predict 
one’s ability to engage in behavior. The second framework uses Consumer Information 
Processing Theory (CIPT) to explain and predict health promoting behaviors.  
Self-Efficacy Theory 
Self-efficacy refers to one’s confidence in their ability to control, organize and 
execute a course of action required for performing specific tasks that will lead to certain 
outcomes, and is a core determinant of behavior under social cognitive theory (Bandura, 
1997). While knowledge of health risks and benefits creates a precondition for change, 
there are important self-influences (such as self-efficacy) in play which help individuals 
initiate health behavior change and sustain changes over the duration of their lives 
(Bandura, 2004). Self-efficacy is an important determinant within social cognitive 
theory, because it affects health behavior directly and impacts other determinants of 
behavior change such as expectancies (both positive and negative). Beliefs of self-
efficacy expectancies play an integral role in chronic disease self-management, because 
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individuals need to feel empowered to successfully perform activities which can lead to 
positive disease-related outcomes. Studies have shown that those with low self-efficacy 
shy away from health behavior change even if they are knowledgeable about the positive 
behavioral impacts on disease and feel vulnerable to the consequences of illness (Rimal, 
2000; 2001). Moreover, higher perceived self-efficacy scores are reported among older 
adults who actively manage chronic disease (Clark & Dodge, 1999).    
 Belief in one’s efficacy to exercise control is a common pathway through which 
psychosocial influences affect the adoption and maintenance of health behavior change 
(Bandura, 2004). Working in concert with the assumptions of human capability and 
expectancy (Bandura, 1977), all cognitive and behavior change activates through an 
individual’s perceived self-efficacy (Bandura, 1997). Individuals must not only believe 
that their behavior can cause a positive outcome, but they must also believe that they 
have the capability to accomplish the behavior completely and successfully (Bandura, 
1977). Self-efficacy theory has the unique theoretical characteristics of both predicting 
behavior change and guiding interventions which have the capacity to change health 
behaviors (Bandura, 1997).  
Self-efficacy beliefs shape the outcomes people expect their efforts to produce 
(Bandura, 2004). Efficacy expectancy is the steadfast belief that one can perform a 
behavior which produces a desired outcome. Expectancies govern whether or not an 
individual will engage in behavior. Outcome expectancy refers to the belief that certain 
behaviors will lead to certain outcomes. Expectancies play an important role in 
determining which activities or situations a patient will perform or avoid during disease 
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self-management, because patients’ expectancies help determine whether or not they will 
attempt to self-manage their disease. Taking action usually follows enhanced feelings of 
self-efficacy for executing skills that have been mastered and can be undertaken 
effectively. Self-efficacy must be considered for a variety of self-management domains, 
each of which has its own, associated efficacy belief and expectation (Bourbeau et al, 
2004). Patients with strong efficacy beliefs are able to persist and accomplish complex 
tasks (Bandura, 1978).   
It is important to note that perceived self-efficacy can influence behavioral 
compliance, and successful behavioral adaptation can influence perceived self-efficacy 
(Kaplan, Atkins, & Reinsch, 1984a). Bandura (1982) stated that perceived self-efficacy 
is one integral link between knowing what to do and actually doing something; 
therefore, it is important to cultivate perceived efficacy. Successful self-changers 
combine efficacy beliefs with outcome expectations that benefits will outweigh 
disadvantages that come with lifestyle changes (Bandura, 2004). Individuals are more 
motivated to act when past accomplishments are causally attributed to personal abilities, 
and failures are attributed to lack of effort (Weiner, 1985). Individuals with high self-
efficacy related to a particular task will associate failure with external hindrances or 
reduced effort, while those with low self-efficacy will attribute failure with lack of 
ability (Bandura, 1997).  
 Sources of Efficacy Information. Expectations about self-efficacy are based on 
four sources of information: (a) performance mastery experience, (b) vicarious 
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experience or modeling, (c) emotional or physiological arousal, and (d) verbal 
persuasion (Bandura, 1997).   
Performance mastery (i.e., information derived from mastery of tasks through 
personal experience) is believed to be the most reliable source for self-efficacy 
expectations. It involves getting people actively involved in behavior change, by 
advocating the development and adoption of a specific action plan geared towards 
achieving a specific goal (Lorig & Holman, 2003). Information that is gathered 
following the mastery of a task offers people assurance that the information is indeed 
reliable (Bandura, 1997). When specific tasks are completed successfully, perceived 
self-efficacy is enhanced, which confirms an individual’s capabilities. Task specific 
efficacy beliefs increase as the patient masters new skills and behavioral modifications.  
When specific tasks are completed unsuccessfully, self-efficacy beliefs are damaged if 
the individual associates the poor performance with an inadequate personal skill set 
(Bandura, 1997). If low self-efficacy is reported, problem solving strategies are used to 
alter the plan in such a manner that self-efficacy is maximized. A common 
misconception exists related to the idea that older adults (the primary sufferers of 
COPD) may possess low personal efficacy beliefs regarding behaviors they feel are 
difficult. This is not necessarily the case, as increased age does not reduce the 
relationship between efficacy beliefs and behavior (Ferrini, Edelstein, & Barrett-Corron, 
1994).   
Modeling, or experiencing an activity by way of observing another (i.e., 
vicariously experiencing the activity), is another, less influential, source of self-efficacy 
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information. This source of information shows an individual performing a certain 
behavior successfully, when encountering a specific situation. Self-efficacy information 
can be vicariously derived through experiences of others by noting others’ performance 
and the consequences stemming from these performances (Bandura, 1997). Learners 
judge their capability to perform an activity based on how their abilities correspond with 
that of the model. Models that are seen as similar to oneself have the greatest impact 
when delivering efficacy information, because model identification is strengthened by 
observing similar attributes portrayed by like models (Bandura, 1982). Examples of 
modeling include the use of videotapes, books and Pamphlets to show individuals how 
to carry out activities (Bandura, 1986). All written and video-based materials depicting 
models should be developed in accordance with the characteristics of the priority 
population (Lorig & Holman, 2003). It is preferable to illustrate models overcoming any 
trials and tribulations associated with behavioral adaptations, as this portrayal has been 
shown to produce more positive influences on self-efficacy (Bandura, 1977; Strecher, 
McEvoy-Devellis, Becker, & Rosenstock, 1986). 
Personal efficacy information is also acquired through somatic indicators, such as 
physiological, physical and affective states, all of which can affect intentions to carry out 
health behaviors (Bandura, 1997). Physiological and emotional arousal and feedback can 
drastically influence expectations regarding self-efficacy. For example, positive 
biofeedback about exercise capacity can positively influence personal efficacy beliefs 
and outcome expectancies regarding physical activity limitations. However, high 
physiological arousal such as dyspnea, pain, and weakness can diminish self-efficacy 
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beliefs by impairing physical activity performance. Physiological arousal resulting in 
reduced performance can be interpreted as vulnerability and be accompanied by 
psychological distress (Carrieri-Kohlman, Douglas, Gormley, & Stulbarg, 1993) and 
negative self-efficacy beliefs (Toshima, Kaplan, & Ries, 1992). If physical and 
emotional states are causally associated with activity, then behavioral strategies may be 
avoided altogether. Hence, health educators are encouraged to reshape negative 
interpretations of sensory information through education, specifically to enhance 
personal efficacy (Carrieri-Kohlman, Douglas, Gormley, & Stulbarg, 1993). Symptoms 
should be explained as having multiple causes, thus leading to multiple strategies that 
patients can use to manage symptoms (Lorig & Holman, 2003). 
A final source of self-efficacy information is gathered through verbal persuasion 
or social influence. This information is provided through verbally convincing an 
individual of their own ability to achieve their goals or exerting a social influence to 
enable persuasive action. Verbal persuasion can be the primary motivator for action or 
leveraged through advice which endorses sustained effort (Gormley et al., 1993). The 
persuader must be respected, knowledgeable and provide information in a manner 
conducive to enhancing personal efficacy (Tsang, 2000). It is suggested to not address 
the amount of effort needed to acquire skill development (Schunk, 1983); rather, any 
extenuating effort involved in realizing the attainment of a skill should be experienced 
by the learner. It is important to note that using verbal persuasion to increase self-
efficacy for achieving unrealistic goals can have a detrimental impact on the efficacy 
development process.  
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Efficacy information becomes significant and affects human action through 
cognitive processes (Bandura, 1997). Cognitive processes include cognitive construction 
and inferential thinking, which can both precede courses of action (Tsang, 2000).  
Cognitive construction involves individuals picturing behavioral scenarios before they 
take place and predicting the nature of the outcomes (successful/unsuccessful) 
resonating from action. Inferential thinking refers to judging how actions may predict 
potentially volatile outcomes. Those with high self-efficacy expectancy normally expect 
more favorable outcomes than those with low self-efficacy expectancies. Individuals 
with strong self-efficacy can persevere through obstacles or barriers and stay focused on 
a task in order to realize a desired outcome. Bandura (1978) stated that behavior change 
is more often abandoned by those with negative cognitive bias and low self-efficacy due 
to personal doubt in the ability to carry out tasks and/or a non-belief that a task will 
inevitably affect a desired outcome. Efficacy beliefs regarding control of outcomes plays 
an important role in mediating emotions such as anxiety.   
 Self-Efficacy Dimensions. Self-efficacy expectations vary on specific dimensions, 
including level, strength and generality. Each of these dimensions has an impact on 
performance (Bandura, 1997). Level of self-efficacy refers to ordering of a task 
according to its difficulty (Tsang, 2000). A specific task within a particular domain of 
functioning may differ in regards to difficulty and thus influence corresponding efficacy 
beliefs regarding a task (Bandura, 1997). Efficacy beliefs can be affected by external 
factors (e. g. different settings and situations) that differentially influence an individual’s 
ability to carry out unique tasks. Consequently, external variables should be taken into 
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consideration during intervention development, as they can affect the levels of threat and 
self-regulatory requirements encountered by individuals (Tsang, 2000). Strength of self-
efficacy expectations is also important, because expectations lie along a continuum from 
very low to very high and correlate highly with diligence when completing a task 
(Bandura, 1977). The generality dimension of self-efficacy refers to the extent to which 
efficacy beliefs can be generalized from one task or domain to another. For example, a 
COPD patient may have very high efficacy beliefs regarding the use of rescue breathing, 
which may generalize to purse-lip breathing while walking. It is important to remember 
that efficacy beliefs may not generalize with different activities, or even within the same 
activities, if activities are carried out under dissimilar conditions (Bandura, 1977; 
Strecher et al., 1986). In sum, objectives of structured education should be developed to 
account for the various dimensions of self-efficacy in order to enhance self-efficacy 
expectations (Kara & Asti, 2004).     
 Self-Efficacy and HRQoL in COPD Patients. Changes in self-efficacy have been 
shown to associate with changes in HRQoL among patients afflicted with chronic 
conditions (Bandura, 1997; Lorig, Gonzalez, & Ritter, 1999; Lorig et al., 1989). Kohler, 
Fish, and Greene (2002) examined the correlates of quality of life among a group of 
COPD patients, with particular interest on the influence of objective lung function 
measures and psychosocial outcomes (most notably perceived self-efficacy) on HRQoL. 
A recursive path model was used to investigate direct and indirect relationships between 
and among objective measures of lung function, psychological measures, and measures 
of HRQoL. The results from this study corroborated others (Arnold et al., 2005; Kaplan 
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et al., 1984a; Kaplan et al., 1984b; Scherer & Schmieder, 1997; van Schayck et al., 
1992), and suggested that the relationship between objective lung function and HRQoL 
is mediated by other psychosocial factors, such as self-efficacy. Self-efficacy for coping 
with COPD has been to shown to highly correlate with HRQoL (Tu et al., 1997) and 
influences HRQoL more so than measures of objective lung function (Kaplan et al., 
1984a; Kohler et al., 2002).  These findings support a generalized hypothesis suggested 
by Bandura (1997), who posited, “functional limitation may be governed more by beliefs 
of capability than by degree of actual physical impairment” (p. 300). Stated another way, 
individuals with similar levels of physical impairment may achieve different levels of 
functional outcomes based on their level of self-efficacy. From the research of Kaplan et 
al. (1984a) and Kohler et al. (2002), the value of assessing psychosocial constructs such 
as self-efficacy (in addition to biomedical measures) is evident. 
Consumer Information Processing Theory 
Health communication has been found to raise efficacy beliefs related to health 
behaviors and thereby foster the adoption of healthy lifestyles (Meyerowitz & Chaiken, 
1987). Moreover, health communication can focus on key social cognitive determinants, 
such as self-efficacy, to develop customized health promotion programming, which can 
be distributed on a broad scale (Bandura, 2004). Mass communication technologies can 
be utilized to provide patients with self-management skill development products that can 
help enhance self-management self-efficacy beliefs.   
Theories of consumer information processing provide a framework for 
understanding why people do or do not pay attention to, understand, and make use of 
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consumer health information (Rudd & Glanz, 1990). CIPT postulates that information 
must not only be available but also be wanted and believed useful by the consumer.  
Further, the consumer must possess the time and level of comprehension necessary to 
process information presented, because consumer decision making involves multiple 
stages of acquiring, processing, learning, using and evaluating information (Bettman, 
1979; Rudd & Glanz, 1990). A central premise of CIPT is that individuals can process 
only a limited amount of information at one time (Bettman, 1979). Thus, the information 
must be presented in such a way that the patient is receptive to information that is 
comprehensible and usable. Consumer Information Processing Theory (CIPT) is most 
often applicable during individual-level interventions (Glanz & Eriksen, 1993).   
Both the quality and quantity of health information influence the choices 
consumers make regarding their own health behaviors. Therefore, it is important that 
quality educational material directly addresses patients’ health concerns in a targeted 
format. This is especially important for older adults who suffer from chronic disease.  
Older adults have limitations in the amount of information they can acquire, use and 
remember at a given period of time (Constantinidou, & Baker, 2002; van Wynen, 2001), 
so information must be designed and packaged in a clear, deliberate fashion which 
facilitates information processing and action. When an abundance of information is 
presented to older consumers in a condensed period of time, information acquisition and 
processing can be limited, thereby attenuating the quality of the information presented. 
The ability to synthesize key health information and provide it to consumers through a 
medium which is appealing to their needs can greatly augment information retention. To 
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facilitate health information acquisition, CIPT also suggests the use of quality 
technologies which can distribute accessible messages and enhance the transmission of 
relevant health information (Rudd & Glanz, 1990).   
Systematic Review of COPD Self-Management Education 
Effing et al. (2007) published a systematic review and meta-analysis of 
controlled trials examining the effects of self-management education on health outcomes 
and health care utilization among patients with COPD. This work consumed other 
previous reviews of COPD self-management (Bourbeau, 2003) and COPD self-
management education (Monninkhof et al., 2003b). Effing et al. served as an update of a 
previous review done by Monninkhof et al. in 2003. In the former review, no 
conclusions about the effectiveness of COPD self-management could be stated, because 
of the numerous outcome measures that were tested in a very few controlled trials.     
Only randomized controlled clinical trials and controlled clinical trials with a 
usual care control group were included in the work of Effing et al. Non-randomized 
controlled clinical trials and non-controlled clinical trials and results from pulmonary 
rehabilitation programs were excluded. All of the studies took place after 1985. See 
Effing et al. for a description of the search methods and terms used to identify pertinent 
studies and for characteristics of all included trials.  
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The methodological quality of each study was assessed according to criteria set 
forth by Jadad (1996), and outcomes were analyzed by computing weighted or 
standardized mean differences (WMDs or SMDs) with 95% confidence intervals (CIs) 
for interval level data and pooled odds ratios (ORs) for categorical level data. Statistical 
variation between studies was evaluated using the I-square statistical measurement 
(Higgins, Thompson, Deeks, & Altman, 2003). 
Fourteen published data sources met the criteria for inclusion in this review 
(Blake et al., 1990; Bourbeau et al., 2003; Boxall, Barclay, Sayers & Caplan, 2006; 
Cockcroft et al., 1987; Coultas et al., 2005; Emery, Schein, Hauck, & MacIntyre, 1998; 
Gallefoss, Bakke, & Rsgaard, 1999; Gourley et al., 1998; Howland et al., 1996; 
Littlejohns, Baveystock, Parnell, & Jones, 1991; Martin et al., 2004; Monninkhof et al., 
2003a; Rea et al., 2004; Watson et al., 1997). The modes of education varied some, with 
4 studies implementing group education, 9 studies using individual education and one 
using written education only (See non-italicized items in Table 7). The content included 
within each intervention was variable (See non-italicized items in Table 8).   
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Table 7  
COPD self-management education delivery modes and length 
Research study Educational delivery mode Length of education 
Blake et al., 1990 Individual education + patient 
brochure + audiotape 
1-4 hours 
Bourbeau et al., 2003 Individual home-based sessions + 
telephone calls 
7-8 weeks @ 1 hour each week 
Boxall et al., 2006 Exercise program + home-based 
educational sessions 
Exercise program – weekly, 
fortnightly; educational sessions 
– 6 per week 
Cockcroft et al., 1987 Home visits 10 hours 
Coultas et al., 2005 Nurse assisted management 15 session @ approximately 20 
minutes each 
Davis et al., 2006 Dyspnea self-management 
program + individualized home 
walking prescription 
3 hours  
Emery et al., 1998 Group education 26 hours 
Gallefoss et al., 1999 Patient brochure + group sessions Maximum of 6.5 hours per 
patient 
Howland et al., 1996 Group education Stage II-IV: Six 2 hour sessions 
(12 hours); Stage I: Three 2 hour 
sessions  (6 hours) 
Kara & Asti, 2004 Group education 4 weeks of 3-4 sessions per week 
for about 35-40 min each session 
Littlejohns et al., 1991 Individual education Over a 12 month period 
Martin et al., 2004 Individual care plan after 
interview 
Respiratory nurse visits every 3 
and 6 months for 12 months 
Monninkhof et al., 2003a Group education 5 sessions @ 2 hours each 
Nault et al., 2002 Workbook + telephone follow-up 
+ case manager available for 
questions 
1 hour per week over 7-8 weeks 
Petty et al., 2006 Customized videotape, standard 
videotape, or usual care 
16 weeks 
Rea et al., 2004 Individual meetings Monthly meeting + one home 
visit 
Soler et al., 2006 Group educational session + 
health care visit 
One educational session + 
monthly visit 
Watson et al., 1997 Action plan and patient brochure Less than 1 hour (40% of patients 
spent 10-20 min; 35% spent 20-
30 min) 
 
Adapted from: Blackstock & Webster, 2006; Effing et al., 2007 
Note: Studies retrieved through author’s primary literature search are in italics. 
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Table 8  
 
Selected content covered within COPD self-management education 
 
Research study Content areas 
Blake et al., 1990 Relaxation, guided imagery, stress management 
 
Bourbeau et al., 2003 Breathing and coughing techniques, energy conservation, relaxation, 
inhalation technique, simple home exercise, using action plan 
 
Boxall et al., 2006 Anatomy/physiology of lungs, respiratory devices, breathing 
techniques, secretion removal techniques, energy conservation, stress 
management  
 
Cockcroft et al., 1987 COPD knowledge, symptoms, coping 
 
Coultas et al., 2005 Not described 
 
Davis et al., 2006 Purse-lip and diaphragmatic breathing to manage shortness of 
breath 
Emery et al., 1998 COPD knowledge, coping, interpreting pulmonary function tests, 
understanding arterial blood gases, stress management 
 
Gallefoss et al., 1999 COPD knowledge, medication, exacerbations, inhalation technique, 
relaxation, coping 
 
Howland et al., 1996 Stage II – IV: COPD knowledge, nutrition, exercise; Stage I: 
prevention, smoking cessation, physical endurance, managing stress 
 
Kara & Asti, 2004 Breathing techniques, coughing techniques, relaxation, medication, 
diet, exercise 
 
Littlejohns et al., 1991 COPD knowledge, inhalation technique, disability 
 
Martin et al., 2004 Medication, oxygen, using action plan 
 
Monninkhof et al., 2003a COPD knowledge, inhalation technique, coping, exercise, nutrition, 
energy conservation, action plans 
 
Nault et al., 2002 Using inhaler devices and performing diaphragmatic and purse-
lipped breathing techniques 
Petty et al., 2006 Education on disease-specific exercise  
Rea et al., 2004 Manage symptoms, when to call doctor, use of inhalers, 
immunizations, action plans 
 
Soler et al., 2006 Use of inhalers, exercise, nutrition, sleeping habits 
Watson et al., 1997 COPD knowledge, exercise, coping, nutrition 
 
Adapted from: Blackstock & Webster, 2006; Effing et al., 2007 
Note: Studies retrieved through author’s primary literature search are in italics. 
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Follow up time between treatments ranged from 2 to 24 months. All but two of 
the studies were randomized control trials, and only two studies failed to report a 
description of participant withdrawals and dropouts. Just over ¾ of the studies scored the 
maximal score for methodical quality (i.e. 3) as assessed by the criteria set forth in Jadad 
(1996). What follows is a description of the meta-analytic findings pertaining to the 
impact of self-management education on HRQoL and objective lung function, as these 
outcomes are of interest for the purposes of this investigation. It is important to note that 
outcomes regarding COPD self-management self-efficacy and information needs were 
not identified or included in this review. 
HRQoL      
 The St. George’s Respiratory Questionnaire (SGRQ), developed by Jones, Quirk, 
Baveystock and Littlejohns in 1992, was used to measure disease-specific HRQoL in 
seven of the reviewed studies (Bourbeau et al., 2003; Boxall et al., 2006; Coultas et al., 
2005; Gallefoss et al., 1999; Martin et al., 2004; Monninkhof et al., 2003a; Watson et al., 
1997).  
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 The data from all studies except for Martin et al. (2004) were subjected to a 
meta-analysis which determined the effect of self-management education on disease-
specific HRQoL (See Table 9). The SGRQ-total and -domain scores in the self-
management groups were all lower (indicating a better disease-specific HRQoL) or 
equal to the scores in the usual care control groups. The differences on the SGRQ-total 
(WMD -2.58; 95% CI (-5.14 to -0.02)) and impact scores (WMD -2.83; 95% CI (-5.65 
to -0.02)) reached statistical significance at the .05 level, but did not reach a level of 
clinical significance (i.e., an improvement of 4 points). No statistically or clinically 
significant differences were found on either the SGRQ-symptom (WMD-1.45; 95% CI (-
4.41 to 1.51)) or -physical activity (WMD -2.88; 95% CI (-5.9 to 0.13)) scores to 
indicate that self-management groups were better no off than control groups on these 
dimensions (Effing et al., 2007).  
 Rea et al. (2004) used the Chronic Respiratory Questionnaire (Guyatt et al., 
1987) to assess disease-specific HRQoL. 
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Table 9  
Selected meta-analytic comparisons between self-management and control groups for 
differences in HRQoL and lung function  
Outcome 
scales and 
subscales 
Number 
of 
studies 
Number of 
participants 
Statistical 
method 
Test for 
overall 
effect 
Effect size 
HRQoL: 
SGRQ total 7 698 
 
WMD 
(Fixed) w/ 
95% CI 
 
z = 1.98,  
P = 0.05 
-2.58 [-5.14,      
-0.02] 
HRQoL: 
SGRQ 
symptoms 
7 698 
 
WMD 
(Fixed) w/ 
95% CI 
 
z = 0.96,  
P = 0.3 
-1.45 [-4.41, 
1.51] 
HRQoL: 
SGRQ 
activity 
7 698 
 
WMD 
(Fixed) w/ 
95% CI 
 
z = 1.87,  
P = 0.06 
-2.88 [-5.90, 
0.13] 
HRQoL: 
SGRQ 
impacts 
7 698 
 
WMD 
(Fixed) w/ 
95% CI 
 
z = 1.97,  
P = 0.05 
-2.83 [-5.65,      
-0.02] 
Gen. 
HRQoL: SIP 
total 
2 249 
 
WMD 
(Fixed) w/ 
95% CI 
 
z = 0.14,  
P = 0.9 
0.30 [-4.00, 
4.60] 
Lung 
function: 
pred. 
FEV1% 
6 552 
 
SMD (Fixed) 
w/ 95% CI 
z = 0.52,  
P = 0.6 
0.04 [-0.12, 
0.21] 
 
Note: Statistically significant findings at the α = .05 level are in bold 
Source:  Effing et al., 2007 
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When patients were exposed to self-management education, they revealed statistically 
significant improvements within two of the four dimensions in this scale (fatigue and 
mastery). The Medical Outcomes Short Form-36 survey instrument (Ware & 
Sherbourne, 1992) was used to assess general HRQoL in two of the reviewed studies 
(Coultas et al., 2005; Rea et al., 2004), but there were no differences found between 
educational treatment and control groups (Effing et al., 2007). General HRQoL was also 
measured by the Sickness Impact Profile (Gilson et al., 1975) in three studies (Blake et 
al., 1990; Emery et al., 1998; Littlejohns et al., 1991). Findings from these studies were 
inconsistent, but two of the three (Blake et al., 1990; Littlejohns et al., 1991) showed the 
educational intervention group to exhibit better physical function. The collective data 
from the three Sickness Impact Profile studies were not suitable for meta-analysis 
(Effing et al., 2007). HRQoL was also measured by a variety of other instruments in 4 
other studies (Cockcroft et al., 1987; Coultas et al., 2005; Gourley et al., 1998; Howland 
et al., 1996). Only Gourley et al. (1998) and Coultas et al. (2005) found improved 
HRQoL among participants receiving self-management education. 
Objective Lung Function    
 Six studies (Bourbeau et al., 2003; Emery et al., 1998; Gallefoss et al., 1999; 
Littlejohns et al., 1991; Rea et al., 2004; Watson et al., 1997) assessed lung function as 
the percentage of actual FEV1 in relation to predicted FEV1 (predicted FEV1 was 
calculated based on age, gender, and height). No statistically significant difference in 
deterioration of FEV1%-predicted was seen between the self-management intervention 
and control groups (SMD 0.04; 95% CI (-0.12 to 0.21)). 
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Summary 
       In regards to HRQoL, a positive trend was observed, indicating that exposure to 
self-management education results in better HRQoL outcomes. The improvement was 
regarded as too small, however, to reach clinical significance. In addition, self-
management education was found to have no effect on lung function. Given that the 
modification of declining lung function in patients with COPD is very difficult (even 
with long-term pharmacotherapy) (Yang et al., 2007), it should come as a no surprise 
that lung function did not improve over the courses of these study periods (Effing et al., 
2007). 
Another Systematic Review 
 Blackstock and Webster (2006) conducted a systematic review to determine the 
benefits of disease-specific health education for patients with COPD.  They conducted 
database searches of Medline, CINAHL, PsyINFO, Embase, Cochrane Library, and 
Physiotherapy Evidence Database; however, their search did not retrieve many unique 
articles not evaluated by Effing et al. (2007).  In addition, Blackstock and Webster 
(2006) reported being unable to conduct a meta-analysis due to, “a very broad variety of 
outcomes and follow-up periods” (pp. 703). Of the 13 articles they reviewed, 11 were 
included in the systematic review and meta-analysis conducted by Effing and colleagues 
(2007). As with the systematic review conducted by Effing et al. (2007), only 
randomized or clinical control trials were included in the review by Blackstock and 
Webster (2006).   
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The methodological qualities of these studies were assessed using a modified 
version of the PEDro scale (cf. Blackstock and Webster, 2006; Physiotherapy Evidence 
Database, 1999). The methodological quality scores obtained were comparable to the 
scores calculated by Effing et al. (2007) for the studies which overlapped between the 
two systematic reviews. Within the Blackstock and Webster (2006) review, patient 
education was delineated into two types: 1) self-management and 2) didactical 
education. Didactical education was characterized as instruction disseminated, “in a 
passive lecture format, with opportunity to interact, but no focus on health behavior 
change” (pp. 704-705). Of the two educational programs not assessed in Effing et al. 
(2007), one was a self-management program that took place in a group setting (Kara & 
Asti, 2004), and the other was didactical and designed for individual use (Tougaard et 
al., 1992).    
While there was little unique data presented and/or evaluated in Blackstock and 
Webster (2006), there was one study reviewed, which examined the relationship between 
COPD self-management education and COPD self-management self-efficacy (Kara and 
Asti, 2004). Within-group improvement in self-efficacy was found among all study 
participants (including those exposed to a control condition), yet there was no between-
group difference in self-efficacy found between participants exposed to self-management 
education versus a control condition (See Tables 7 and 8 for educational delivery mode 
and intervention content respectively).  This could have been due to the study design or 
because an a priori power analysis was not conducted to determine the adequate number 
of study participants needed to detect statistically significant differences (n = 60).        
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Studies Not Included in Systematic Reviews 
 Several other peer-reviewed manuscripts were retrieved by the researcher 
through a primary search of the literature. A majority of these manuscripts included self-
efficacy measures as outcomes; yet, some were not randomized or clinical controlled 
trials, which precluded their inclusion. Like the systematic reviews, however, the 
following studies primarily examined the effects of self-management education on 
health outcomes among patients with COPD; studies of the effects of pulmonary 
rehabilitation programs were not included. All of the studies took place between 1996 
and 2006. In order to generate a sample of empirical studies, a search of electronic 
databases was conducted. These databases included EBSCO, ERIC, PsychINFO, Health 
Source, MEDLINE, Cambridge, and CSA. The key terms that were used to conduct the 
literature search were: self-management, self-management education, self-care, chronic 
obstructive pulmonary disease, COPD, emphysema, and chronic bronchitis.   
 Four articles (Davis et al., 2006; Nault et al., 2002; Petty et al., 2006; Soler et al., 
2006) were added to the list of articles reviewed in the two systematic reviews 
(Blackstock and Webster, 2006; Effing et al., 2007). The educational delivery mode and 
content delivered within the educational interventions are described in Tables 7 and 8 
respectively (in italics). Follow up time between treatments ranged from 4 weeks to 12 
months. What follows is a description of the pertinent findings from each study related 
to the impact of self-management education on applicable outcomes. 
Nault et al. (2002) used the educational program “Living Well with COPD©” to 
test its impact on teaching covered inhaler and breathing techniques. The education 
 69
program was originally developed at the Montreal Chest Institute, in conjunction with 
the Respiratory Health Network of the Fonds de la Recherche en Santé du Québec 
Boehringer Ingelheim. The intervention was a disease-specific self-management 
program, consisting of approximately 1 hour per week of skill-oriented teaching over a 
period of 7-8 weeks. After participating in this program, patients did not perform better 
when using the inhaler devices; however, they did exhibit better techniques for both 
pursed lip and diaphragmatic breathing. 
Soler et al. (2006) conducted a one-year randomized control trial of 26 patients to 
determine the effects of an educational intervention and monthly health visits as 
compared to standard care for COPD patients. Patients exposed to the experimental 
intervention demonstrated a statistically significant improvement in HRQoL at the end 
of the one-year study (as measured by the SGRQ). Specifically, the symptoms domain of 
the SGRQ showed marked improvements over the course of the study. These 
improvements in HRQoL were also associated with a reduced number of COPD 
exacerbations over the course of the study. This study did not report statistically 
significant improvements in lung function (as measured by FEV1) over the study 
duration. Limitations of the Soler et al. study included a small sample size and limited 
study design (i.e., did not allow for the exploration of effect educational component 
versus monthly health care visits had on outcomes). 
Davis et al. (2006) published a randomized clinical trial undertaken to determine 
the effect of three types of interventions on self-efficacy to manage dyspnea in COPD 
patients. This study was presumably based on/from the dissertation project conducted by 
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Tsang in 2000, entitled, EFFECTIVENESS OF THREE STRENGTHS OF 
EDUCATION AND EXERCISE ON SELF-EFFICACY FOR WALKING AND SELF-
EFFICACY FOR MANAGING DYSPNEA IN PATIENTS WITH CHRONIC 
OBSTRUCTIVE PULMONARY DISEASE. One-hundred and two participants received 
one of three self-management interventions. One of the three interventions consisted of a 
dyspnea self-management program comprised of 3 hours of education and an 
individualized home walking prescription. The program included sessions that were 
designed to enhance the four primary sources of self-efficacy information discussed 
earlier. Enactive mastery experiences were provided with respect to physical activity, 
modeling was used to demonstrate proper breathing techniques, verbal persuasion was 
used to encourage self-management behaviors and participants were taught to monitor 
their own physiological and affective states during physical activity.   
Within the Davis et al. study, self-efficacy for managing dyspnea and HRQoL 
were among the dependent variables subjected to investigation.  These outcome 
measures were assessed using valid and reliable disease- and condition-specific 
instruments (cf. Davis et al., 2006); however, multiple, univariate repeated measures 
analyses of variance (ANOVA) were used to assess the effect of treatment (three 
interventions) and time (2 months) on each of four dependent variables at pre and post 
test.  For a multiple group pretest-posttest design testing multiple dependent variables, it 
is suggested that a multivariate analysis of covariance (MANCOVA) on post-test scores 
be conducted, with pretest scores used as the covariate(s) (Dugard & Todman, 1995; 
Huberty & Olejnik, 2006). Nevertheless, participants who completed the education 
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program exhibited greater dyspnea management self-efficacy at post test on one of the 
two validated measures of self-efficacy. This occurred even after a severe bonferroni-
adjustment was infused to account for the two main effects and one interaction effect (P 
< .004, note: this bonferroni adjustment was not reported in the study). In sum, patients 
exposed to an education based treatment revealed improved self-efficacy for managing 
shortness of breath. 
Petty et al. (2006) conducted a study to compare the effects of customized 
videotape education versus a standard videotape and usual care on HRQoL and 
functional ability among 3 groups of patients with COPD. Patients were categorized 
based on the severity of their disease and then randomized in a block fashion into 1 of 3 
groups: (a) customized videotape, (b) standard videotape, and (c) usual care (i.e., no 
videotapes). The customized videotapes contained footage thought to improve physical 
activity behaviors in COPD patients. These video segments were designed based on 
input from either patients’ physicians or pulmonologists and specifically adapted based 
on the disease status of patients. Participants in the standard group received a set of 2 
standard videotapes on exercise and educational information. Two hundred and fourteen 
patients completed self-administered questionnaires at baseline, 4 and 8 weeks on three 
outcome measures including HRQoL as assessed by the SOLQ (Fan et al., 2002). Over 
the eight week study period, participants receiving the customized videotape education 
demonstrated a statistically significant improvement within the emotional functioning 
and coping skills subscales of the SOLQ as compared to the two other treatment groups.   
After implementing a severe bonferroni-correction (P = .05 / 3 = .01, note: this 
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bonferroni adjustment was not reported in the study) to account for the increased 
probability of type I error, the statistically significant difference between the treatment 
group remained in regards to coping skills. Thus, we can remain relatively confident that 
the customized videotape education did influence the coping skills necessary to 
positively affect HRQoL. It is important to note, however, that patients in the 
customized videotape group reported at least a 5-point change in all 4 subscales of the 
SOLQ, which has been empirically shown to associate with a functional change in a 
patient’s daily life (Tu et al., 1997). 
Qualitative Inquiries 
 One qualitative study was conducted to discover the important self-management 
issues (Cicutto et al., 2004) as described from the perspective of patients with COPD.  
Other qualitative inquiries (Camp, Appleton, & Reid, 2000; Monninkhof et al., 2004a) 
evaluated patient perspectives of COPD self-management program activities and 
outcomes associated with these activities. Each of these studies gathered information on 
the viewpoints of patients pertaining to self-management and self-management 
education.   
 Cicutto et al. (2004) conducted focus groups with a purposive sample of patients 
suffering from COPD in order to understand the self-management activities of COPD 
patients and the meaning that patients attribute to these activities. Constant comparative 
analysis was used to dissect the focus group transcripts. The major theme which 
developed from these focus group sessions centered on the idea of “surviving COPD,” 
which ultimately included adjusting physically and emotionally to the disease in order to 
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achieve a satisfactory level of HRQoL. A common adjustment adopted by patients was a 
shift towards more planning, pacing, and prioritizing for activities of daily living and 
disease management (Cicutto et al., 2004). Planned, energy-saving activities included 
breathing exercises, slow walks and more sedentary forms of recreation. Breathing 
exercises, along with medication management, were identified as useful strategies for 
enabling activities of daily living, while aerobic and strengthening exercises were 
identified as dispensable due to lack of motivation and unpleasant feelings following 
exertion. Patients expressed being liberal with their prescribed physical activity 
regimens; whereas, strict attention was paid to prescribed medication adherence. This 
finding is important, given that shared decision making during all aspects of disease 
management is encouraged (Clark, Nothwehr, & Gong, 1995). In regards to care and 
information availability, patients reported the desire to have individualized treatment and 
education provided by a variety of health professionals. One limitation is this study was 
the lack of representation among racial and ethnic minorities, whom may have separate 
and distinct perspectives of COPD self-management.   
 In order to understand statistically non-significant results of a quantitative 
investigation measuring change in HRQoL (Monninkhof et al., 2003a), Monninkhof and 
colleagues (2004a) conducted in depth interviews with a purposive sample of 20 
participants. Interviews were audio taped, transcribed and analyzed according to 
grounded theory. Patients reported that self-management education helped them 
distribute energy evenly, control symptoms more effectively and manage medication 
intake. Increased self-confidence and self-determination was also reported, which 
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corroborated findings by Camp and colleagues (2000), who noted self-confidence as an 
important mediating variable along the continuum of self-management skill adoption 
and HRQoL improvement. Patients reported no benefits from educational sessions 
regarding healthy nutrition and weight management. Additionally, the qualitative study 
showed that the instrument used to assess HRQoL in their quantitative study (SGRQ) 
may have failed to detect important aspects of patients’ HRQoL. Thus, other measures 
which assess HRQoL in COPD patients should be consulted.              
Gaps in Understanding 
Further research is needed to refine education strategies designed to facilitate 
behavioral modification in COPD self-management. When developing self-management 
programs, it is advisable that the practitioner recognize the dissimilar concerns that are 
brought to light across different populations, and even within individuals residing in 
similar populations (Lorig & Holman, 2003). To be effective, self-management 
education must be developed in accordance with a mutually understood care plan agreed 
upon between the patient and provider (Bourbeau & Nault, 2007). Methods are required 
to develop self-management programs which suit the long-term maintenance needs of 
patients, so that patients can optimally adjust both physically and emotionally to COPD 
and achieve a satisfactory level of HRQoL. Health educators are directed to target 
information in an educational program towards patients’ unique risk factors so that 
patients master the self-management skills which are truly important. There have been a 
limited number of qualitative studies undertaken to advance this understanding (Camp et 
al., 2000; Cicutto et al., 2004; Monninkhof et al., 2004a). Given the paucity of patient-
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centered interventions which take into account patient perspectives of COPD (Woo et 
al., 2006), qualitative inquiry can assist practitioners in developing programs which 
address self-management issues deemed important by the patient. 
Intermediate outcomes such as COPD information needs and self-management 
self-efficacy are important predecessors to health effects, thus should be reported and 
compared within COPD self-management education studies.  It is important to explore 
how various instructional strategies affect (a) patients’ COPD information needs, (b) 
COPD self-management self-efficacy, and (c) HRQoL. Only a limited number of 
randomized or clinical control trials have examined the relationship between COPD 
disease self-management education and COPD self-management self-efficacy, and no 
such studies have examine the relationship between self-management education and 
COPD information needs. Moreover, the results of the studies which have assessed these 
variables have been generally inconclusive. In addition, the assessment of HRQoL in 
patients with COPD is very important, because objective measures of lung function may 
not accurately predict disability (Pitta et al., 2005) and/or even be related to quality of 
life (Arnold et al., 2005; Killian, Summer, Jones, & Campbell, 1992; Hesselink et al., 
2006; Jones, 2001; van Schayck et al., 1992; Williams, 1989).    
 It is unclear as to what type of educational treatment optimally increases feelings 
of self-efficacy regarding COPD self-management. A better understanding of the actual 
nature of the educational treatment delivered and its relationship to perceived efficacy 
towards self-management and HRQoL is important to understand and is encouraged for 
future research efforts (van der Palen et al., 2004). Past research efforts have not 
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addressed these outcomes in an appropriate multivariate context (Davis et al., 2006; 
Petty et al., 2006).    
Conclusions 
 
Due to rising health care costs stemming from increased use of health services to 
control COPD, there is growing pressure placed on health systems to find ways to limit, 
ration and delay health service utilization among COPD patients. Effective chronic 
disease self-management is one such way to reduce health services utilization and 
improve HRQoL. In light of the effectiveness of some COPD self-management 
programs, health educators have been encouraged to develop cost-effective, readily 
accessible COPD self-management education programs which focus on a) defining the 
true effective elements of COPD self-management education and b) describing self-
management skills and behavior change. This call to action is not without its difficulties, 
however. Understanding COPD self-management behaviors is complex and represents a 
black box for health care professionals (Cicutto et al, 2004). While transmitting generic 
health knowledge is fairly easy, changing self-efficacy and the value patients place in 
preventive behaviors can take considerable planning and effort. Patients must be taught 
to self-manage their disease, rather than told to learn to live with it (Bourbeau, 2004). A 
customized intervention using audio-visual based technologies could offer a stabilizing 
effect for COPD progression and thus positively impact HRQoL. This innovative 
intervention could be especially important for patients who do not have access to costly 
pulmonary rehabilitation programs (Petty et al., 2006). 
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As Blackstock and Webster (2006) noted, “…self-management education results 
in greater improvements in health outcomes, and as such future research into educational 
programs should focus on this educational strategy and may like to base their programs 
on the framework of the Social Cognitive Theory of Health Behavior” (pp. 715). 
Programs designed to impact behavior and the precepts of behavioral adoption through 
educational means seem to represent the most supportive and practical strategy to initiate 
and sustain improvements in COPD self-management. Research examining the most 
effective and efficient self-management education delivery modes, forms and content is 
now recommended for future research endeavors (Blackstock & Webster, 2006; Effing 
et al., 2007). Future studies with sufficient sample size and ample follow up time should 
look at the acquisition of self-management skills and behavioral change and determine 
the crucial elements of COPD self-management programming (Effing et al., 2007).   
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CHAPTER III 
 
METHODS 
 
Overview of Design and Methods 
 
This study assessed the self-management learning needs and perspectives of 
COPD patients through focus group interviews, and took what was learned during these 
interviews to help develop a specific, self-management education intervention using 
DVD technology. Following the development of this specific educational intervention, 
the effectiveness of three distinct educational treatments (including the newly developed 
one) was evaluated by comparing outcomes related to (a) COPD informational needs, (b) 
COPD self-management self-efficacy, and (c) generic and lung-specific HRQoL in a 
randomly-assigned, multiple-group pretest-posttest design with a control group. Figure 3 
presents a graphical depiction of the research design. This particular research design 
reduces selection bias and increases analytical efficiency (Huberty & Olejnik, 2006).   
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Study participants recruited, selected and 
provided informed consent 
 
Demographic Information 
LINQ 
SOLQ 
EQ-5D & EQ-VAS 
SEMCD-6 
Baseline 
Assessments 
Group 1 Group 2
RVision™ 
DVD
NHLBI 
Pamphlet 
Randomization 
Sent to 
patients 
Process Evaluation Measures 
LINQ 
SOLQ 
EQ-5D & EQ-VAS 
SEMCD-6 
Follow-up 
assessment at 
2 months 
A multiple-group pretest-posttest design with pre- and post-tests. Group 1 will be 
provided with the edited RVision™ DVD clips.  Group 2 will be provided with the 
NHLBI educational Pamphlet.  Group 3 will receive both educational materials 
concurrently.  Group 4 will not receive any educational materials. 
R
Group 3 
NHLBI 
Pamphlet 
& 
RVision™ DVD  
Usual Care 
(control) 
Group 4 
 
 
 
Figure 3. Multiple-group pretest-posttest study design   
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 The Priority-Sequence Model (Morgan, 1998) was used to assist in the priority 
and sequence decision making for the research design. A Qualitative Preliminary design 
(qual → QUANT) (Morgan, 1998) was incorporated into the research, given that a 
smaller, qualitative study was appropriate to inform the educational content to be tested 
within the primary quantitative study. The utilization of both methods sequentially has 
been recommended for health education research endeavors (Green & Lewis, 1986). It 
was proposed that a qualitative inquiry would improve the effectiveness of instructional 
material by matching educational content to the needs and preferences of a subset of the 
priority population. Moreover, what was learned in the focus groups could add to the 
research design’s overall ability to meet specified study objectives (Morgan, 1998). 
Focus group interviews have proven to be a useful research technique for identifying 
older adults’ beliefs and needs regarding specific health topics (Keller et al., 1987). A 
phenomenological inquiry was conducted in hopes of achieving data saturation (i.e., no 
longer hearing new information), which would provide understanding as to the meaning 
that COPD patients associate with COPD self-management. Qualitative data yield thick 
and rich descriptions which are contextualized based on the multi-causal experiences 
people endure (Onwuegbuzie & Leech, 2004). Thus, this type of inquiry makes sense of 
experiences by uncovering the meanings that people associate with various events 
(Denzin & Lincoln, 2005).   
Setting 
COPD patients were recruited from Choctaw Urgent Care (CUC), located in 
Butler, Alabama, which is situated within the district lines of Choctaw County.  Butler is 
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a rural town, with a low socioeconomic civic makeup. In 2003, it was reported that 
almost 20% of the population of Butler lived below the poverty line (National 
Association of Counties, 2004). Twenty-four percent of Choctaw County is farmland, 
and Choctaw is one of 42 counties classified as “rural” in Alabama (Alabama Rural 
Health Association, 2003). Butler is a diverse municipality, with 43.9% of its citizens 
being of African-American decent, and 52.8% being female. In addition, over 15% of 
Butler’s population is comprised of citizens over 65 (National Association of Counties, 
2004). Choctaw County has been designated as a Health Professional Shortage Area by 
the Federal Office of Health Professions (The Alabama Medical Education Consortium, 
2006). CUC stands as the only rural health clinic in Butler, and it is owned and operated 
by Rush Hospital based in Meridian, Mississippi. While Rush Hospital operates a senior 
health clinic to meet the unique health needs of older adults in Meridian, it is almost 40 
miles away from Butler. This significant geographic barrier limits the accessibility of 
specialized health services for older COPD patients residing in Choctaw County.  
Sample 
Qualitative 
 A purposive, homogeneous sample of patients with COPD was recruited within 
Choctaw County using. Homogeneous sampling was used because participants needed to 
possess a clinical diagnosis of COPD, and because this sampling approach is often used 
to select focus groups (Onwuegbuzie, Jiao, & Bostick, 2004).  Within each of the two 
focus groups, 6 patients were recruited.  This number was selected for each group based 
on three reasons: (a) best practice minimum recommendations for phenomenological 
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research (Krueger, 2000; Morgan, 1997; Morse, 1994), (b) the desire to obtain an in 
depth understanding of the topic and high involvement from the participants (Morgan, 
1998), and (c) the novice skill-level of the moderator.   
Inclusion Criteria. 
1. Adults 50 years of age or older 
2. Clinical diagnosis of COPD  
3. Presence of dyspnea 
4. No formal COPD self-management education exposure within the last 6 months 
5. Provision of informed consent 
Exclusion Criteria.  
1. Participation in structured pulmonary rehabilitation programs wherein self-
management activities were pre-selected 
Quantitative 
A purposive sample of 56 patients was selected upon meeting certain pre-
established criteria (e.g., diagnosis of COPD).  Participants were enrolled in the 
multiple-group, pretest-posttest design study and randomly assigned to treatment groups.  
Inclusion Criteria. 
1. Adults 50 years of age or older 
2. Clinical diagnosis of COPD  
3. Presence of dyspnea 
4. No formal COPD self-management education exposure within the last 6 months 
5. Provision of informed consent 
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Exclusion Criteria. 
1. Participation in structured pulmonary rehabilitation programs wherein self-
management activities are pre-selected 
2. Housemate who previously agreed to participate in study 
3. Being incapacitated to the point where COPD self-management is not feasible 
Procedures 
Qualitative 
Preliminary information, such as patient medical diagnosis and age, was obtained 
through a telephone interview conducted by the principal investigator with potential 
patients. For patient recruitment purposes, promotional advertisements were placed at 
CUC, around prominent community centers, and in the local newspaper (i.e. Choctaw 
Sun) (See Appendix A for sample advertisement). Other proactive recruitment strategies 
included physician referrals and telephone contacts. Interested patients were screened for 
gender and race/ethnicity to ensure comparable numbers of men and women and desired 
diversity of race. Written informed consent was obtained from each participant before 
their participation. Each participant was provided with refreshments during the one-hour 
focus group along with a $20 honorarium for their participation. Institutional Review 
Board (IRB) approval # 2007-0421 was secured from Texas A&M University 
(TAMU)’s Office of Research Compliance on July 31, 2007 and renewed until July 30, 
2009, for all aspects of this study. The consent form provided to all participants can be 
found in Appendix B, and the focus group rubric used to guide the focus group 
interviews is provided in Appendix C.  The focus group sessions were facilitated by the 
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principal investigator at CUC with assistance from a certified nursing assistant. At the 
end of each focus group session, member checking was done to confirm the initial 
interpretations of the moderator (i.e., basic descriptive triangulation, see Leech & 
Onwuegbuzie, 2007) and enhance the descriptive and interpretive validity of the data 
analysis (Maxwell, 2005). Focus group interviews were transcribed using paper and 
pencil with the aid of a digital audio recorder. Following transcription, multiple 
qualitative data analyses were employed in order to understand better the phenomenon 
of interest (Leech & Onwuegbuzie, 2007). Using the data gathered during these focus 
groups, and taking into account input from the Medical Director of CUC, the 
intervention materials and instruments for the quantitative study were adapted and 
developed. 
Quantitative 
Potential participants for the quantitative aspect of the study were initially 
approached by the Medical Director of CUC to determine participation interest. If 
patients agreed to be considered as potential participants, he/she provided written 
confirmation acknowledging their willingness to take part. COPD patients who did not 
visit the rural health clinic for an appointment during the recruitment time period were 
contacted via telephone by a certified nursing assistant at CUC and asked to visit the 
clinic to provide written confirmation should they choose to participate. For patient 
recruitment purposes, an incentive program was initiated to encourage CUC personnel to 
recruit and retain study participants. Following this first phase of recruitment, CUC staff 
was asked to make telephone contact with potential participants to verbally tell patients 
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(a) how the study would be carried out and (b) what the terms of their participation were.  
The principal investigator provided telephone scripts for CUC personnel to use when 
making these telephone calls (See Appendix D for telephone scripts addressing potential 
patients). The staff at CUC was collectively remunerated based on how many phone 
calls were made (i.e., $5 per call). In all, 101 patients were initially contacted.    
Potential participants were then screened to determine their race/ethnicity, 
gender, age, writing ability, educational level, income and marital status via an in-person 
consultation with each patient. Previous pulmonary function tests were also retrieved by 
CUC personnel to confirm diagnosis of COPD, thus ensuring patients’ qualification for 
the study. Eligible patients were selected from those who agreed to participate, as most 
patients in the sample indicated that they had access to a DVD player when initially 
interviewed by CUC staff. Selected patients were sent, via postal mail, a detailed study 
description approved by the TAMU human subjects committee, an informed consent 
document (See Appendix E), and pretest instruments via regular mail. Additional 
information contained in these mailings reminded patients to (a) fill out the enclosed 
survey and return it in the pre-paid postage envelope provided to them and (b) look over 
any educational material provided in the initial mailing.  Appendix F provides a sample 
set of instructions sent to participants in a treatment group. Each participant was offered 
a $40 honorarium for their participation in the study and were asked to review, sign and 
complete each form and return the materials to the principal investigator. The pretest 
instruments included adapted versions of the: 
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1. Lung Information Needs Questionnaire (Hyland, Jones, and Hanney, 2006) 
(Appendix G), 
2. Seattle Obstructive Lung Disease Questionnaire (SOLQ) (Tu et al., 1997) 
(Appendix H), 
3. EuroQol-5 Dimension Scale (EQ-5D) and EuroQoL-Visual Analog Scale (EQ-
VAS) (EuroQoL, 1990) (Appendix I), and the 
4. Self-efficacy for Managing Chronic Disease 6-Item Scale (SEMCD-6) (Lorig et 
al., 2001) (Appendix J). 
 The questionnaire items were completed using paper-and-pencil. Participants 
were provided with a prepaid postage envelope to return their informed consent and 
responses to these pretests to the principal investigator. Participants were also given the 
option to complete the survey items via telephone, whereby a staff member of CUC 
would read through each item with the participant and report the participant’s response 
to each item using pencil and paper. The phone interview decreased errors and missing 
data but required relatively simple survey formats (Guyatt et al., 1993). The completion 
of these surveys was expected to take participants approximately 20 minutes to 
complete. For every completed survey that was ultimately received by the principal 
investigator, the CUC staff members were compensated a set amount of money per 
returned pretest. This was designed to encourage the staff of CUC to actively ensure that 
patients were able to complete and return the pretest surveys that were provided or 
administered to them.    
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Upon receipt of survey responses, participants were randomly assigned into 1 of 
4 groups. Group 1 participants (DVD group) were provided with a targeted RVision™ 
DVD (RVision Corporation, 2007) to view at home. Group 2 participants (Pamphlet 
group) were provided with an educational Pamphlet entitled, Breathing Better With a 
COPD Diagnosis (NHLBI, 2007b) to read at home. Group 3 participants (DVD + 
Pamphlet group) were provided with a targeted RVision™ DVD and an educational 
Pamphlet, Breathing Better With a COPD Diagnosis, to view and read at home. Group 4 
participants (Control group) did not receive any educational intervention and served as a 
usual care control group.   
Treatment Time Period. Participants assigned to Group 1 viewed the RVision™ 
DVD clips over a 2-month time period with the assistance of written instructions 
included in the treatment mailing. These guidelines encouraged the patient to watch the 
clips as often as necessary in order to adequately ascertain the information needed to 
perform the COPD self-management skills and behaviors illustrated on the DVD. If 
participants encountered any technical difficulties when attempting to watch the DVD, 
they were instructed to contact the principal investigator toll free by phone in order to 
get assistance and/or a replacement DVD as needed.   
Participants assigned to Group 2 read the Breathing Better With a COPD 
Diagnosis Pamphlet over the 2-month time period. The Pamphlet was provided to the 
participants in a booklet format, along with written instructions for how to use the 
booklet. The written instructions encouraged the patient to review the material as often 
as necessary in order to adequately ascertain the information needed to perform the 
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COPD self-management skills and behaviors illustrated within the Pamphlet. If 
participants had any difficulties during the 2 month time period when reading the 
Pamphlet, they were able to contact the investigator to get assistance and/or a 
replacement copy as needed.   
Participants assigned to Group 3 viewed the RVision™ DVD clips and read the 
Breathing Better With a COPD Diagnosis Pamphlet as often as necessary over the same 
2 month time period. The written directives were similar to those described above, with 
the difference being that participants were exposed to both modes of instruction. 
Participants in Group 4 were not provided with any educational material, as these 
individuals served as the investigation’s usual care control group. 
 To protect against contamination effects and to control diffusion (Pedhazur & 
Schmelkin, 1991), both of which were threats to internal validity, participants were 
asked to keep the educational material(s) provided to them strictly for their own use in 
order to protect against copyright infringement. After 1 month elapsed during the 
treatment time period, CUC staff contacted participants by phone to assess progress, 
answer any potential questions, and remind patients to review the educational material 
and that a second survey would be mailed to them in the near future. CUC staff members 
were remunerated for making these status and reminder calls as well. Approximately one 
week before completion of the two month duration, each participant was mailed a series 
of follow-up surveys, which were identical to the surveys completed at baseline. As was 
the case during the pretest time period, for every completed survey that was ultimately 
received by the principal investigator, the CUC staff members were compensated a set 
 89
amount of money per returned posttest. Again, this incentive program was designed to 
engage the staff of CUC in the project and also support patients in being able to use the 
educational materials and complete and return the posttest surveys.    
 These surveys were complemented by process evaluation measures (for 
experimental groups) which assessed participants’ perception of educational material(s) 
utility and frequency of instructional resource use.  As such, participants completed the 
following posttest instruments: 
1. LINQ (Appendix G) 
2. SOLQ (Appendix H) 
3. EQ-5D and EQ-VAS (Appendix I) 
4. SEMCD-6 (Appendix J) 
5. Process Evaluation Measures (Appendix K) 
The posttest instruments were expected to take participants 25 minutes to 
complete. After completion, participants mailed back the surveys in an envelope with 
pre-paid postage already attached. Following receipt of all posttests, all study 
participants were sent a debriefing document regarding the study (See Appendix L), and 
CUC staff was sent all extra DVDs and Pamphlets to distribute to their patients suffering 
from COPD.   
Treatment Content. RVision Corporation™ (2007) developed a library of 
education content for home use by patients with COPD. Previous work has shown that 
patient use of this specific content can result in improvements of quality of life, fatigue 
and exercise compliance (Petty et al., 2006). Three COPD self-management educational 
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segments cover almost 70 instructional topics. Topics include: pursed lip and 
diaphragmatic breathing techniques, aerobics and conditioning, infection 
management/treatment, medication management, smoking cessation, energy 
conservation, relaxation techniques, cough controlling, nutrition, and walking for 
exercise. Table 10 lists all content areas covered within each of the 3 segments. These 
segments run for approximately 1 hour, and 30 minutes in length in total. To condense 
these segments and target them to the learning needs of the participants in this study, 
video editing technology was used to compress the relevant patient education topics into 
1 interval of approximately 30 minutes. These pertinent segments were loaded onto 
chapters within a reformatted DVD, so that patients could readily access segments of 
interest, without having to view the entire DVD at each sitting. Within each segment, 
sources of efficacy information included performance mastery techniques, role 
modeling, physiological coping, and verbal persuasion (Bandura, 1997).   
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Table 10  
 
Content covered within 3 RVision™ DVD segments 
 
COPD Education Segment #1 
Content Running Time 
Pursed Lip Breathing 55 sec 
Diaphragmatic Breathing 1 min, 2 sec 
Energy Conservation 1 min, 34 sec 
Introduction to Relaxation Techniques 35 sec 
Deep Breathing 22 sec 
Total Muscle Relaxation 1 min, 39 sec 
Visual Imagery 21 sec 
Helpful Hints for Relaxation 24 sec 
Avoiding Stress 23 sec 
Panic Control Breathing 47 sec 
Bathing and Showering 1 min, 8 sec 
Grooming 32 sec 
Dressing 44 sec 
Aerobics and Conditioning Introduction 23 sec 
Walking for Exercise 2 min, 37 sec 
Breath Saver Tips 37 sec 
Lifting and Breathing 15 sec 
Bending and Breathing 24 sec 
Going Up Stairs 39 sec 
Infection Control 1 min, 41 sec 
Infection Detection 1 min, 1 sec 
Infection Treatment 59 sec 
When to Call Doctor 1 min 17 sec 
COPD Education Segment #2 
Content Running Time 
Medication Introduction 30 sec 
Bronchodilators 36 sec 
Antibiotics 44 sec 
Metered Dose Inhalers 4 min, 10 sec 
Proper Use of Inhaler 41 sec 
Digoxin 33 sec 
Corticosteriods 42 sec 
Side Effects of Prednisone 1 min, 5 sec 
Controlling your Cough 47 sec 
Nutrition 2 min, 39 sec 
Tips for Good Nutrition 6 min, 15 sec 
Increasing Your Fluid Intake 1 min, 29 sec 
High Potassium Foods 1 min, 2 sec 
Diet Hints 49 sec 
Weight Management 1 min, 12 sec 
Eating Out 48 sec 
Avoid Constipation 34 sec 
COPD Education Segment #3 
Content Running Time 
Home Bicycle Program 1 min, 58 sec 
House Keeping 1 min, 11 sec 
Travel 1 min, 55 sec 
Intimate Relations 2 min, 19 sec 
Smoking Cessation 1 min, 22 sec 
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The pre-produced Pamphlet, Breathing Better With a COPD Diagnosis, was 
distributed by the National Heart, Lung and Blood Institute (NHLBI) and available for 
download at: http://www.nhlbi.nih.gov/health/public/lung/copd/campaign-
materials/pub/copd-patient.pdf. This Pamphlet was printed out on a color printer 
(approximately 4 pages in length), and placed into a decorative folder for patients to use.  
The content within the booklet included: facts about COPD, information about the 
pathology of COPD, what to do following a diagnosis, specific action steps for a COPD 
patient, and advice for seeking medical attention.  Table 11 lists content areas included 
in the Pamphlet.  
 
 Table 11  
 
Content covered within Breathing Better With a COPD Diagnosis 
 
Content Headings/Subheadings Page Number(s) 
Did you know? 1 
What is COPD? 1 
What to do when diagnosed with COPD 1 
    -Quit smoking 1 
    -Avoid exposure to pollutants 1 
    -Visit your doctor on a regular basis 1 
    -Follow treatment advice 1 
    -Take precautions against the flu 2 
    -Seek support from other COPD patients 2 
How does COPD affect breathing? 2 
Taking action 2 
    -Medications 2-3 
    -Pulmonary rehabilitation 3 
    -Physical activity training 3 
    -Lifestyle changes 3 
    -Oxygen treatment 3 
    -Surgery 3 
    -Managing complications 4 
Spirometry 3 
When to get emergency help 4 
Learn more breath better 4 
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Measures 
Qualitative and Quantitative Antecedents 
 Demographic information including age, gender, race/ethnicity, 
marital/relationship status, educational level, income and living arrangements were 
collected using a demographic questionnaire.       
Quantitative Outcome Variables 
COPD information need was measured using the Lung Information Needs 
Questionnaire (LINQ). Health related quality of life (HRQoL) was measured with two 
sets of instruments: the Seattle Obstructive Lung Disease Questionnaire (SOLQ) and the 
EuroQoL 5D and VAS (EQ-5D and EQ-VAS). This was done due to the relative ease in 
administering these questionnaires and because one instrument assessed generic HRQoL 
and the other assessed disease-specific (COPD) HRQoL. It is suggested that both generic 
and disease specific measures of HRQoL be assessed in order to understand multiple 
functional outcomes of interventions (Curtis, Deyo, & Hudson, 1994). Other commonly 
used, COPD-specific HRQoL scales such as the Chronic Respiratory Questionnaire 
(CRQ) (Guyatt et al., 1987) and St. George’s Respiratory Questionnaire (SGRQ) (Jones 
et al., 1992) were not used in this research project due to their elevated level of 
complexity (Jones, 2001). COPD Self-Management Self-efficacy was measured using 
two scales: The Self-efficacy for Managing Chronic Disease 6-Item Scale (SEMCD-6) 
and the coping skills subscale of the SOLQ. The SEMCD-6 measures participants’ self-
efficacy for symptom control, role function, emotional function and communication with 
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physicians, while the subscale of the SOLQ measures confidence for dealing with 
breathing difficulty.  What follows is a description of each of the scales:   
LINQ. The LINQ consists of 17 self-reported items that measure the information 
needs of patients with COPD (Hyland, Jones, and Hanney, 2006). The LINQ can be used 
to evaluate the impact of educational interventions and is scored to produce an overall 
score and 6 domain scores (knowledge, medicines, self-management, smoking, exercise, 
diet). For the purposes of the present investigation, the subscales of self-management 
and exercise were measured and summed. The minimum total score of this adapted scale 
was 0 (low information needs), while the maximum total score was 20 (high information 
needs). The length of time needed to complete the adapted version of the questionnaire 
was approximately 2 to 3 minutes. The test scores derived from these subscales have fair 
measures of reliability (α = 0.66 to 0.78) (Hyland, Jones, & Hanney, 2006).    
SOLQ.  The SOLQ consists of 29 items measuring four health dimensions: 
physical function, emotional function, coping skills, and treatment satisfaction. Each 
domain score is transformed on a scale of 0 (worst) to 100 (best). No overall score can be 
computed, thus each scale is computed as a distinct domain measure. Internal 
consistency (α = 0.79 to 0.93), test-retest reliability (r = 0.64 to 0.87), construct validity, 
and responsiveness have been very good when data was collected using all four 
subscales (Belza et al., 2005; Tu et al., 1997). The meaningful clinically significant 
difference in the score of the physical function domain has been estimated to be five 
points (Fan et al., 2002). The coping skills subscale is highly correlated (r = 0.93) with 
another commonly used measure of self-efficacy in COPD patients (cf. Tu et al., 1997; 
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Wigal et al., 1991). The SOLQ is self-administered, written on a fourth grade level, and 
can be completed in 5 to 10 minutes.  
EQ-5D and EQ-VAS. The EQ-5D (EuroQol Group, 1990) was developed as a 
generic instrument for describing and evaluating HRQoL. Five domains of HRQoL are 
assessed, including: (a) mobility, (b) self-care, (c) usual activity, (d) pain, and (e) 
anxiety/depression. For each domain, participants are asked to choose from three 
response option boxes ranging from no problems (level 1) to some problems (level 2) to 
inability or extreme difficulty (level 3). Each unique health state has an associated 5-
digit descriptor ranging from 11111 for perfect health to 33333 for worst possible health 
(35 = 243 possible health states). The descriptive system represents the health state of a 
patient across the five domains of HRQoL mentioned earlier (e.g., health state 11212 
represents a patient that indicates to have some problems on the usual activities and the 
anxiety/depression dimensions). Weights are used to score the responses to the 5 
domains, with scores ranging from 0 to 1 (where a score of 1 represents a perfect state) 
and then converted to a single index value using a value set derived through a Time 
Trade Off (TTO) valuation study which reflects the opinions of the general U.S. 
population (Shaw, Johnson, & Coons, 2005). The EQ-5D valuation measurements have 
shown good test-retest reliability (EuroQol Group, 1990) and generalizability (Van Agt, 
Essink-Bot, Krabbe, & Bonsel, 1994). The data derived from EQ-5D have also been 
reported as internally consistent when measuring HRQoL in rheumatoid arthritis patients 
(Kind et al., 1998). The EQ-5D has also demonstrated construct validity and 
responsiveness to change (Hurst et al., 1997).   
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In addition, the visual analog scale (EQ-VAS) allows patients to rate their current 
health status from 0 (worst imaginable health) to 100 (best imaginable health) by 
drawing a line through a thermometer like measure that indicates where each patient 
falls along a continuum that describes their current health status (EuroQol Group, 1990). 
Scores for the visual analogue scale reflect the position where the participant's line 
crosses the thermometer-like scale (American Thoracic Society, 1990). The EQ-VAS 
scores are patient based and are therefore not representative for the general population. 
EQ-VAS test scores have been reported to be reliable and responsive to measuring 
change in perceived health (Hurst et al., 1997). 
SEMCD-6. The SEMCD-6 (Lorig et al., 2001) is a 6 item scale that measures 
participants’ self-efficacy to manage chronic disease. The score for the scale is the mean 
of the six items. A higher number indicates higher self-efficacy. Within this scale, 
patients are asked to rate their ability to control symptoms, physically and emotionally 
function, and communicate with their physician. The scales for these items range from 1 
(not at all confident) to 10 (totally confident). Test-retest reliability of test scores derived 
from a question included in the SEMCD-6 was adequate (r = 0.87) (Lorig et al., 1996).  
Evidence of construct validity indicated the item to be statistically significantly 
correlated with self-efficacy to manage symptoms (r = 0.62) (Tsang, 2000). The 
reliability of test scores obtained from this measure have been high (α = 0.91) in 
previous studies (Lorig et al., 2001).  Figure 4 depicts a schematic of study variables and 
scale measurements.  
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Figure 4. Schematic of study variables and scale measurements 
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Data Analysis 
Qualitative Analysis 
The hypotheses for the qualitative portion of the study (secondary aim) were as 
follows: 
Hypothesis #1:  Patients will identify experiences underlying the major theme of 
surviving life with COPD, with two sub themes being adjusting physically and 
emotionally (Cicutto et al., 2004).  
Hypothesis #2: Patients will discuss the balance between living life and 
managing disease, with practicing breathing exercises and medication 
management emerging as the two most effective and readily accepted disease 
management activities (Cicutto et al., 2004). 
Focus group data was analyzed using three distinct qualitative analysis tools: (a) method 
of deductive constant comparison; (b) classical content analysis, and (c) word count. 
Three tools were used to analyze the same data at the request of Leech and Onwuegbuzie 
(in press), who stated that using more than one type of analysis can augment the rigor 
and trustworthiness of qualitative findings through methodological triangulation.   
Constant comparison analysis (Glaser & Strauss, 1967) or “coding” was 
undertaken deductively to identify general, underlying themes within the focus group 
data. Prior to analyzing the data, codes were discovered in the qualitative work by 
Cicutto et al. (2004) and then sought out within the data collected.  The entire collected 
data set was read over and chunks of data (i.e., related portions of the transcript) were 
grouped into meaningful parts.  Following this, chunks were deductively fitted into pre-
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existing codes which materialized in the work of Cicutto et al. (2004). When chunks did 
not fit deducted codes, inductive codes were constructed and similar chunks were 
assigned to these emergent codes. After all of the data were coded, similar codes were 
grouped together using pre-existing themes from Cicutto et al. (2004) and newly 
identified thematic groups (i.e., units of data were identified and classified into 
systematic categories that distinguished unique data properties).        
To determine the frequency of themes identified within the data, a classical 
content analysis procedure was employed to further augment the findings from the 
method of constant comparison. Instead of creating themes from established codes, the 
number of times each code emerged was quantified for quantitative saturation across the 
focus group interviews. This was done to understand which codes were used most, thus 
cultivating a greater understanding of the most important concepts as reported by the 
interviewees. If a greater number of codes were identified within a certain thematic 
category, then that category was deemed to be more relevant.   
Lastly, a word count method was used to quantify the number of times a specific 
word was used during the focus group discussions (Leech & Onwuegbuzie, 2007).  
Word count is especially useful for focus group analysis, because counts can help 
identify words spoken the most and those spoken the least (Leech & Onwuegbuzie, 
2007).  More important and noteworthy words were hypothesized to be used more often 
(Carley, 1993), thus providing more meaning from the conversation descriptions 
(Sandelowski, 2001).  Additionally, word count assisted the researcher in identifying 
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patterns, verifying hypotheses and maintaining analytic integrity and rigor (Leech & 
Onwuegbuzie, 2007; Miles & Huberman, 1994).   
Upon completing the focus group interviews, the investigator double entered the 
data into a data-entry interface on a secure computer at TAMU. Each participant was 
indexed with a unique anonymous identification variable. Data checking and cleaning 
was carried out immediately after data entry for each participant. 
Quantitative Analysis 
 
The hypotheses for the quantitative portion of the study (primary aim) were as 
follows: 
Hypothesis # 3: Patients exposed to targeted DVD segments (Treatment 1) will 
outperform patients exposed to the educational Pamphlet (Treatment 2) on 
outcome variables related to COPD informational needs, COPD self-
management self-efficacy, and HRQoL (Boxall, Hons, Sayers, & Caplan, 2006; 
Constantinidou & Baker, 2002; Finklestein & Ratner, 2006; Nguyen et al., 2003; 
Petty et al., 2006).     
Hypothesis # 4: Patients exposed to the targeted DVD and educational Pamphlet 
(Treatment 3) concurrently will underperform as compared to patients exposed to 
the DVD (Treatment 1) and educational Pamphlet alone (Treatment 2), on 
outcome variables related to COPD informational needs, COPD self-
management self-efficacy, and HRQoL (CIPT; Rudd & Glanz, 1990).     
Hypothesis # 5: Patients exposed to targeted DVD segments (Treatment 1), 
educational Pamphlets (Treatment 2), and both DVD segments and educational 
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Pamphlets concurrently (Treatment 3) will outperform patients exposed to the 
usual care (control) condition (Treatment 4) on outcome variables related to 
COPD informational needs, COPD self-management self-efficacy, and HRQoL 
(Self-efficacy Theory; Bandura, 1997; Effing et al., 2007).   
A multivariate analysis of covariance (MANCOVA) was used to determine the effect of 
the three instructional interventions on the outcome variables of interest. Pretest scores 
were used as covariates to adjust for initial differences in the outcome variables. In this 
research situation, there was random assignment to treatment groups, which made 
MANCOVA preferable to either a multivariate analysis of variance (MANOVA) on 
change scores or a repeated measures MANOVA with two repetitions (Dugard & 
Todman, 1995; Weinfurt, 2000). MANCOVA provided a more powerful analysis of the 
group effect (Huck & McLean, 1975), since both the repeated measures analysis and 
gain score analysis required that test occasion measurements be randomized within 
participants. Given that the pre and post test sequentially followed one another and could 
not be randomized within participants (Anderson, 1991), the basic assumption of a 
repeated measures or gain score analysis was violated, thus precluding the use of either 
during this data analysis.  
The overall level of statistical significance for each hypothesis test was set a 
priori at .02 using a Bonferroni correction (α = .05/3) to account for the three contrasts 
being tested and reduce the probability of experiment wise error. Chronbach’s α 
reliability coefficients were examined to determine the appropriate pretest measure to 
use as covariate within the MANCOVA model. Covariates were kept to a minimum, 
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possessed especially high measures of reliability (Thompson, 2006), and possessed 
moderate to strong correlations with the outcome measures (Huberty & Olejnik, 2006). 
Adding a covariate and running a MANCOVA was intended to increase the power of the 
analysis by removing the variance associated with the covariate and reducing the overall 
error variance. The MANCOVA model assumed that the relationship between the pretest 
variable (i.e., covariate) and each of the outcome variables was the same for all levels of 
the grouping variable (Huberty & Olejnik, 2006). Thus, the regression slope vectors of 
the outcome variables on the covariate(s) were to be the same for each treatment group, 
thus meeting the basic “homogeneity of regression” assumption of the analysis of 
covariance (ANCOVA) model. An interaction between the grouping variable and pretest 
covariate would not meet this assumption and forbid ANCOVA. Therefore, a 
multivariate test of the regression slope vectors was called for using the Wilks lambda 
test (λ).   
 Next, a test for the vector of regression slopes that relate the outcome variable to 
the covariate was conducted. This test determined whether the vector of regression 
slopes, relating each posttest to the covariate, was equal to zero (Huberty & Olejnik, 
2006). The covariate chosen was highly correlated to the posttest outcome variables 
(Huberty & Olejnik, 2006); thus, the relationship between the covariate and dependent 
variables and possessed an adequate adjusted effect size (η2adj). Upon confirming that the 
homogeneity of regression was not violated and that the correlation between the 
covariate(s) and posttest variables was relatively strong, a hypothesis test was conducted 
to determine if the vectors of adjusted means were different across the four group 
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centroids. Due to the a priori expectations that (1) those exposed to the novel DVD 
instruction would benefit more than those exposed to traditional text-based instruction, 
(2) those exposed to both the DVD and educational Pamphlet concurrently would benefit 
less than that those exposed to either the Pamphlet or DVD exclusively, and (3) those 
exposed to any COPD self-management educational materials would benefit more so 
than those exposed to no intervention at all, pairwise and complex contrasts were 
constructed initially and tested, foregoing the omnibus MANCOVA. Three separate 
nontrend orthogonal planned contrasts (1 pairwise and 2 complex) were tested. These 
contrasts specifically compared: 
1. The outcome variable mean vectors for individuals in the DVD group, 
compared to the outcome variable mean vectors for individuals in the  
Pamphlet group 
2. The two average outcome variable mean vectors collapsed across individuals 
in the DVD and Pamphlet group, compared to the outcome variable mean 
vectors for individuals in the DVD + Pamphlet group; and 
3. The three average outcome variable mean vectors collapsed across 
individuals in the DVD, Pamphlet, and DVD + Pamphlet groups, compared 
to the outcome variable mean vectors for individuals in the Control group 
(See Table 12). 
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Table 12 
 
Orthogonal nontrend planned contrasts 
 
Group Contrast 1 Contrast 2 Contrast 3 
DVD -1 -1 -1 
Pamphlet 1 -1 -1 
DVD + Pamphlet 0 2 -1 
Control 0 0 3 
 
  
 The following theoretically based hypotheses, which corresponded to the three 
hypotheses, were posed for the three main overarching outcome measures (COPD 
information needs; COPD self-management self-efficacy; HRQoL).   
a. Contrast 1 – DVD hypothesized to outperform Pamphlet group.   
b. Contrast 2 – DVD and Pamphlet groups hypothesized to outperform 
DVD + Pamphlet group.   
c. Contrast 3 – DVD, Pamphlet, and DVD + Pamphlet group hypothesized 
to outperform the Control group.     
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If there were statistically significant differences across the centroids of these contrasts 
and there was an adequate adjusted effect size (η2adj), then the effect was examined by 
consulting the resulting eigenvalue arising from each contrast. The vector of adjusted 
mean differences across the groups included in the orthogonal planned contrasts were 
computed and listed according to each dependent variable under examination. Next, the 
structure coefficients between each dependent variable and canonical variable were 
examined to determine which difference in which outcome measure was most relevant to 
the makeup of the resultant latent functions. The group adjusted mean centroids were 
then determined for each group on each identified dependent measure in order to 
characterize the nature of the group differences on the outcome measures most 
represented within the latent functions. The primary and/or secondary system(s) of 
constructs were then identified to best characterize the underlying nature of the 
canonical variables for each contrast effect.   
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CHAPTER IV 
 
RESULTS 
 
Timeline of Research Events 
 
 Table 13 presents a timeline of research events of the mixed methods study: 
Table 13 
Timeline of research events 
Month                         Activities 
August 31, 2007 ¾ Health Services Research  Dissertation Grant (R36) Awarded by Agency for 
Healthcare Research and Quality 
September 2007 ¾ Principal Investigator (PI) begins introduction (Chapter 1) and literature review 
(Chapter 2) 
¾ Initial conversations begin with CUC staff about qualitative and quantitative 
research protocol 
October 2007 ¾ Work on Chapter 1 and 2 continues; focus group rubric (Appendix C) is 
developed 
¾  November 21 is date set for 2 focus group interviews at CUC 
¾  CUC personnel obtains consent during office visits from 20 patients willing to 
participate in focus groups 
November 2007 ¾ Chapters 1 and 2 are completed by Principal Investigator 
¾ Principal Investigator contacts 20 participants inquiring about participation in 
focus groups 
¾  16 people confirm attendance  
¾ November 21 – PI travels to CUC in Butler, AL to conduct focus groups 
¾ 12 total participants show up in 2 separate sessions (6 in each) lasting 
approximately 1 hour each 
December 2007 ¾ PI submits paperwork to TAMU for patient payment of $20 honorarium 
¾ Focus group data analysis by PI begins and ends 
 
 
January 2008 
¾ PI works with RVision™ video editing personnel to edit DVD and target it to 
self-management learning needs identified in 2 focus groups 
¾ DVD is editing is completed by RVision™ video editing personnel and master 
DVD is sent to PI 
¾ 125 copies of the master DVD are developed at the Office of Health Informatics 
at TAMU 
February 2008 ¾ February 28 - Meeting with doctoral committee regarding quantitative research 
protocol of study in light of focus group feedback 
March 2008 ¾ PI begins writing Methods section (Chapter 3)  
¾ CUC personnel begins recruiting patients during  for quantitative aspect of study 
on March 1, 2008 during patient visits and through telephone contacts 
April 2008 ¾ PI finishes Chapter 3 
¾ April 1 - 101 patients are recruited by CUC staff, randomized into treatment 
groups, and sent pretest instruments, instructions for participating in study, and 
self-management educational materials  
¾ Patent recruitment/retention continues 
May 2008 ¾ Treatment time period 
¾ May 1 - Reminder calls made to patients 
June 2008 ¾ By June 1 – 56 pretests are received by PI 
¾ June 9 – PI sends 56 patients posttest instruments and instructions for filling out 
surveys and returning them to PI 
July 2008 ¾ July 1 - Reminder calls made to patients 
¾ By July 31 – 41 posttests are received by PI 
¾ PI sends out debriefing form to patients completing pre- and post-test 
¾ PI submits paperwork to TAMU for patient payment of $40 honorarium 
August 2008 ¾ Quantitative data analysis begins and ends 
¾ PI writes Chapters 4 and 5 
¾ September 25 defense date is set 
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Focus Groups 
 
The demographic characteristics of the 12 focus group participants are described 
in Table 14. Over half of the participants were female, and the majority did not finish 
high school. All participants reported an annual pre-tax income between $15,000 and 
$24,999; thus, participants were of low socioeconomic status. Half of the focus group 
participants were married, yet an almost equal proportion were widowed or single. The 
overwhelming majority of participants lived with family, and the mean number of years 
participants reported being diagnosed with COPD was variable (mean = 6 years; SD = 
4.43 years). Patients included in each of these focus groups represented both Caucasian 
and African American races.  
Each of the focus groups (n = 2) were held at CUC in a group meeting room. All 
of the participants were patients treated at CUC for COPD. None of the participants had 
prior experience participating in either structured disease self-management education or 
pulmonary rehabilitation. The lack of exposure to these particular health services was 
attributed to the absence of specialized programs within Choctaw County. As stated 
earlier, Choctaw County has been designated a Health Professional Shortage Area by the 
Federal Office of Health Professions (The Alabama Medical Education Consortium, 
2006). Patients reported difficulty traveling to specialized health clinics where focused 
health services are offered.  
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Table 14 
 
Focus group demographic characteristics 
 
Characteristics           n = 12 
Age (mean ± SD) 
 
67 years ± 8.07 years 
Gender  
          Male 
          Female 
 
 
4 
8 
Educational level  
Grade school 
Some high school 
High school graduate 
Some college 
College graduate 
Graduate degree 
 
 
6 
2 
2 
0 
2 
0 
Income  
Less than $14,999 
$15,000 - $24,999 
$25,000 - $34,999 
$35,000 - $49,999 
$50,000 - $74,999 
$75,000 - $99,999 
$100,000+ 
 
 
0 
12 
0 
0 
0 
0 
0 
Marital Status 
        Married  
        Widowed 
        Single 
 
 
6 
4 
2 
Living arrangements 
        With family 
        Alone 
 
 
10 
2 
Number of years since diagnosis (mean ± SD) 
 
6 years ± 4.43 years 
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Results from Constant Comparison Analysis 
Codes reported in the qualitative work by Cicutto et al. (2004) were used to 
deductively chunk and group qualitative data together into one overall theme and three 
meaningful subthemes. The overarching theme retrieved from Cicutto et al. was:  
surviving and living well with COPD. This theme was expressed throughout the data 
collected for these focus groups. In addition, specific subtheme topical areas were 
utilized to assist in grouping codes together into meaningful concepts. Three specific 
subthemes reported in Cicutto et al. were:  (a) adjusting physically to COPD, (b) using 
COPD self-management skills to cope physically, and (c) using COPD self-management 
skills to cope emotionally. These particular subthemes were also expressed throughout 
the present focus group data. One subtheme emerged inductively from the data and was 
described as: coming to terms with COPD and the lifestyle.  
Surviving and Living Well with COPD 
The main theme articulated by focus group members in the present study 
coincided with the predominant theme identified by Cicutto et al. and supported 
Hypothesis #1. Almost all focus group participants spoke about the inherent difficulties 
living life while trying to manage symptoms caused by COPD. A variety of health 
problems were discussed, particularly with regards to patient difficulty balancing their 
lives with disease management. Two participants explicitly reported symptoms such as 
congestion, shortness of breath, difficulty coughing, sinus trouble and wheezing. The 
majority of patients substantiated these symptom claims as being common. Patients also 
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indicated difficulty identifying coping strategies which could ameliorate these specific 
symptoms:       
About 2 months ago, I began to feel pain in my sides, along with shortness of 
breath and more wheezing.  I could feel the mucus in my lungs, but I can’t spit, 
and the cough that I have is a dry cough.  It is like I can feel something in my 
throat, but there is nothing for me to spit out (F2 P1 #1). 
 
I have a terrible cough and congestion at times during the day, which is just plain 
hard to get rid of (F1 P6 #1). 
 
Table 15 summarizes the overall theme and the associated subthemes present within the 
focus group data. In addition, codes used to generate specific subthemes are listed and 
defined in Table 16.  
 Adjusting Physically to COPD. Physical adjustments to symptoms caused by 
COPD were reported by almost all members of the focus groups. Specifically, patients 
discussed their need to reduce the amount of movement that they engaged in from day to 
day. In particular, low intensity physical activity, involving a minimal amount of 
movement, was noted to be suboptimal. 
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Table 15 
Theme and subthemes for data and associated codes  
 
Theme Subthemes Codes 
- Adjusting physically to 
COPD 
 
¾ Reduction in movement 
¾ Inability to carry out 
activities of daily living 
¾ Purposeful action 
 
- COPD self-
management: adjusting 
physically 
 
¾ Learning curve for limiting 
shortness of breath 
¾ Medication management 
¾ Limited behavioral 
modifications 
¾ Smoking cessation 
difficulty 
 
- COPD self-
management: adjusting 
emotionally 
 
¾ Mental anguish 
¾ Peer acknowledgement of 
emotional problems 
¾ Uneasy about seeing a 
psychiatric professional 
 
Surviving and living 
well with COPD 
- Coming to terms with 
COPD and the lifestyle 
 
¾ Beliefs about origin of 
disease 
¾ Need for disease compliant 
lifestyle 
¾ Interest in attaining pre-
disease quality of life  
¾ Acknowledgement of 
progressive disease course 
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Table 16 
 
Definitions of codes 
 
Codes Definition 
Reduction in movement - Limited movement or activity prompted by pending shortness of 
breath 
 
Inability to carry out activities of 
daily living 
- Being unable to perform common daily activities (walking around 
the house, cleaning, bathing, tying shoes, etc.) 
 
Purposeful action - Engaging in thoughtful decision making before any activity is 
attempted; deliberately carrying out all movement 
 
Learning curve for limiting 
shortness of breath 
- Variability in the ability of patients to know what to do to 
successfully manage shortness of breath; those experiencing 
COPD for a longer period of time report being farther along the 
learning curve 
 
Medication management - Using prescribed pharmacologic medications for COPD 
 
Limited behavioral modifications - Undertaking few activities (other than medication ingestion) to 
self-manage COPD 
 
Smoking cessation difficulty - Discussion of the difficult process necessary to quit smoking 
 
Mental anguish - Mental health problems stemming from COPD 
 
Peer acknowledgement of 
emotional problems 
- Group interactions which involved sharing the mental and 
emotional difficulties encountered by COPD patients 
 
Uneasy about seeing a psychiatric 
professional 
- Discomfort with seeing a mental health professional to discuss 
depressive and anxiety-related symptoms  
 
Beliefs about disease origin - Perceptions of how and why patient has COPD 
 
Need for disease compliant 
lifestyle 
- Recognizing that certain activities (medication adherence, rest, 
deliberate movement, etc.) are necessary to cope with COPD 
 
Interest in attaining pre-disease 
quality of life 
- The desire among patients to retrieve the quality of life they 
possessed before being diagnosed with COPD 
 
Acknowledgement of progressive 
disease course 
- Coming to the realization that COPD gets progressively worse 
with time; some stages are worse than others 
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Movements discussed included basic activities of daily living such as: walking around 
the house, up and down stairs, and outside to take out the garbage. Participants also 
reported difficulty simply bending over and standing up straight without losing their 
breath. Because of these physical limitations, participants reported greatly reducing their 
overall activity levels: 
Everything I do I am out of breath and out of air. I find that it’s sometimes worse 
than other times. I feel as if I have poor blood circulation to my legs as well, 
which makes me less wanting to walk around too much.  Now that my oxygen 
level in my blood isn’t what it is supposed to be, I find myself always short with 
air (F2 P2 #1).    
 
Walking?  I can’t really walk too far at all now (F1 P2 #3).   
If I am doing something, anything, and I seem to get real short of breath, then I 
just cut back.  In fact, if you hold your breath a couple seconds longer than you 
should, then you have to try and catch your breath again. I have to get every drop 
of breath that I can (F2 P1 #2). 
 
Every time I straighten up, I feel out of breath, even after I do something simple 
(F2 P1 #9; F2 P1 #2; F2 P2 #1).   
 
Simply put, I am disabled (F2 P1 #1).     
 
In addition, female members of the focus groups talked about their difficulty 
performing daily cleaning chores around the house.  Male members of the focus groups 
corroborated this difficulty working around the house, but their comments focused more 
on the taxing responsibility of completing yard work: 
Work is a lot harder for me now, specifically cooking and cleaning.  I just can’t 
cook and clean the way that I used to because when I try to do so, I lose my 
breath (F1 P3 #2).   
 
For me, being a woman, I am finding that it is hard to sweep the floor.  I have 
problems getting enough air in me when I’m doing it.  When I bend down and 
dust to take care of the house, and I walk from room to room, and it just is so 
hard (F2 P2 #1). 
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The dust in the house and animal hair gives me problems as well.  Using the Pine 
Sol and bleach when I am cleaning sometimes gives me an attack. The Lysol 
spray makes me cough (F2 P1 #2).   
 
I walk 100 feet outside, and I get out of breath.  I do little menial tasks in the 
yard, and I get shortness of breath and feel weak (F2 P1 #1). 
 
Because of the difficulty patients reported accomplishing their activities of daily 
living, some noted the need to purposively plan how they went about moving. Patients 
noted the need to think about what they were going to do before they actually went and 
did it. In addition, they also felt the need to act in a delayed, deliberate manner to ensure 
that their actions did not result in shortness of breath. When patients neglected to engage 
in this thoughtful process, they would accelerate their movements, thus bringing on 
shortness of breath that was unanticipated and prolonged. These exacerbations occurred 
when patients attempted to do the most basic of tasks:  
When I pick up the telephone, sometimes the person on the other end says, “You 
sound like you have been runnin?” They ask me, “Are you running around? Are 
you having trouble breathing?” And when they say this, I realize that all I did 
was get up to get the phone (F2 P2 #1). 
 
I don’t feel it [shortness of breath] coming on.  When it first starts, you don’t 
really pay attention to it, you’re not aware of it. It’s more of a progressive feelin, 
but it makes you feel really uncomfortable when it hits (F2 P1 #2). 
 
Sometimes you don’t really see it yourself, but another person notices your 
problems breathing. It just takes a little time to get your wind back. You just have 
to sit down and get your breath and relax yourself and then try something else. 
You can’t just keep going (F2 P2 #2). 
 
I mean you know what you need to do, but if you push yourself, then you just 
feel worse, so I’ve learned not to do that [push yourself] anymore (F2 P1 #2). 
 
COPD Self-Management: Adjusting Physically.  Patients reported a widespread 
interest in talking about, and wanting to learn more about, disease self-management 
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strategies which have the potential to improve physical symptoms. Specific emphasis 
was directed toward learning what could be done to limit bouts of shortness of breath. 
While some patients reported engaging in some activities to self-manage COPD, others 
reported not knowing anything about what to do in terms of disease self-management.  
This was primarily because, for these patients, COPD was a newly encountered disease. 
For example, two patients expressed concerns about being unsure as to what could be 
done to improve the physical symptoms of COPD:   
I know absolutely nothing about the disease, and I don’t really know how to start 
asking questions.  I don’t know what I could do or what I could take to improve 
the situation.   Like I say, at night, if I start to hurt a lot in my lungs, I get up and 
usually sit up in my recliner, and I’ll sit up part of the night. However, I don’t 
really know what I can do to relieve the pain or the fluid. I have actually been 
scared to do anything.  I didn’t want to start trying different things like over the 
counter stuff to get pressure off my chest or get rid of the mucus. Also, I was 
scared that taking it would do more harm than good (F2 P1 #1). 
 
I actually just found out that I had COPD. I wonder if the disease ever goes 
away?  I don’t know what I could do to help it or anything.  Since I was just 
diagnosed, I am waiting on receiving information and then I can start to help treat 
myself. I see on TV that you are supposed to take longer walks and dance. I 
haven’t tried any of those activities yet though (F2 P2 #1).   
 
Patients who had been living with COPD longer reported being better able to 
self-manage their disease; moreover, any lack of COPD self-management knowledge 
was causally related to the relative exposure that patients had dealing with COPD. 
Because of the variability within this sample in terms of years since diagnosis, the 
variation in COPD self-management knowledge was to be expected. The comments 
offered by the focus group seemed to support a continuum of patient knowledge, ranging 
from little to no knowledge (e.g., reflected by the comments above) to specific 
knowledge about ways to help manage disease-related symptoms. Particularly, patients 
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reported the regimented use of medication. In fact, almost all patients who had been 
dealing with COPD for a number of years reported feeling extremely confident in 
knowing how and when to use prescribed medications:   
I think we all use medication and know how to use the medications.  We feel 
well informed about how to use our medications, whether it be inhalers, 
nebulizers, or decongestant pills.  We always have our pills and medications 
nearby (F2 P1 #2).  
 
I can’t sleep at night unless I have my mask on at night, so I have to know how to 
put that on (F1 P3 #2). 
 
One patient, however, repeatedly noted that certain types of medications (particularly 
nebulizers) were no longer necessary for dyspnea management.  The use of this 
particular medication seemed to irritate the patient:   
I feel like I can do anything that I used to do before, and now I think that I can do 
it better, since I got off that nebulizer (F1 P6 #1). I don’t think that I need the 
nebulizer.  I use my inhaler, and I take my decongestants (F1 P6 #5). 
 
There were few behavioral modifications discussed pertaining to COPD self-
management. One strategy which was discussed relayed the importance of getting an 
adequate amount of rest. Patients noted the value of rest throughout the day and getting 
plenty of sleep at night.  Apart from getting enough rest, patients reported a lack of 
knowledge and skills regarding self-management strategies which did not include taking 
their prescribed medication(s). Of considerable note was the absence of any patients 
practicing breathing exercises or controlled coughing, or using any specific relaxation 
techniques or energy conservation strategies. This was primarily because they had never 
been exposed to any seminars or informational resources which showed them how to 
perform these skills. It was interesting to note that patients were very inquisitive about 
 117
types of activities or lifestyle changes that they could partake in to help reduce COPD 
symptoms. Patients seemed very interested when the conversation transitioned from 
focusing on medication management to focusing more on other self-management 
strategies they were unaware of. Certain passing comments about alternative self-
management strategies seemed to elicit particular interest among uninformed focus 
group participants:   
Physical therapy really helped me a lot, because it helped me lose weight, which 
really helped a lot (F1 P6 #5). 
 
Water or soda helps clear up the mucus (F1 P3 #2).   
 
I got scared of getting my flu shots, but now I need them to help me feel better 
(F2 P1 #2).   
 
I know that the flu shot will help, and the benefits will be good (F2 P2 #1). 
 
Additionally, focus group participants raised certain questions and addressed specific 
learning needs related to COPD self-management. These comments included: 
Is there a certain type of food that you eat that has an effect on your breathing 
(F2 P1 #2)? 
 
I want to learn more about exercise, because I’d like to walk more effectively (F2 
P2 #9). 
 
I want to learn more about relaxation, so I can stay more relaxed.  I feel very 
comfortable saying so too (F1 P6 #5).  
 
I want to be active. I want to do what I have to do to keep going (F2 P1 #2). 
Many patients remarked about how they had been encouraged to quit smoking 
but were unable to due to so. The reasons for being unable to quit ranged from cigarettes 
being too addictive to the excess expense of smoking cessation aids. Even though 
smoking cessation was regarded as extremely difficult, patients noted an expressed 
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desire to “kick” the habit. This desire was motivated by patients associating with peers 
who had successfully stopped smoking:     
I’ve tried to stop smoking, but it is so difficult. I was prescribed medication to 
help me stop, but it is so expensive. I had no idea those medications were so 
expensive. (F2 P1 #1).  
 
I have tried and tried to stop smoking, but I just do not know how to get off 
smoking. I try, but I am not off them.  I don’t know how to do it. It’s hard. Other 
people do it though, so eventually I’ll get it right (F2 P2 #1). 
 
COPD Self-Management: Adjusting Emotionally. Patients in the focus groups 
reported a range of emotional and mental health issues that were dealt with because of 
COPD. Primarily, patients discussed frustration with their continued shortness of breath. 
They also lamented about the depressive symptoms and excessive worry that they felt, 
which they identified as primarily resulting from the fear of impending exacerbations. 
Some patients even noted the need to seek psychiatric counseling to help cope with 
emotional problems caused by COPD: 
I try to do everything I’m told, but I guess I was just worried too much (F1 P6 
#1). 
 
I’m used to providing for myself, but since the diagnosis, I’ve been frustrated 
that I can’t do what I used to. One thing I’ve tried to do is put it in my mind that I 
have to just continue on and do what I gotta do to get right in my head (F2 P1 
#2).  
 
I’ve noticed people with diseases become depressed and not want to take care of 
themselves. You have to watch yourself, because you might start drinking or 
doing drugs just because you feel weak. I’ve thought about going to therapy and 
talking to somebody about what I’m going through. Even though I’m not a big 
talker, if I see something that will help me, and I’ll go buck wild for it (F2 P1 
#2)!   
 
Interestingly, focus group members reported feeling some solace in realizing that 
others experienced emotional trials and tribulations caused by COPD. Many participants 
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acknowledged that uncomfortable psychological feelings were commonly encountered. 
In fact, talking about the emotional scars of COPD seemed to have an almost cathartic 
effect on patients: 
It’s good to know I’m not the only one.  This is serious problem to me, and I get 
fired up when I talk about it (F2 P1 #2). 
 
With this being said, some patients reported feeling uneasy with the idea of being treated 
(by a trained professional) for mental health problems caused by COPD: 
I do feel that going to a psychiatrist is a sign of weakness (F2 P1 #2). 
 
I don’t want to get on nerve pills (F1 P6 #4). 
 
Coming to Terms with COPD and the Lifestyle.  There was one subtheme which 
emerged inductively (i.e., not explicitly referenced in Cicutto et al.) during the constant 
comparison analysis of the focus group data. This subtheme covered how patients 
rationalize their COPD diagnosis and also how they described the lifestyle prompted by 
COPD. Surprisingly, patients had various different beliefs regarding the origin of their 
affliction:  
I think that my diagnosis has something to do with being around fumes when I 
was working.  It’s frustrating, but you know you gotta work, so I guess it was 
gonna happen anyway.  It’s either because of that or some of the stuff I used to 
do as a youngster (F2 P1 #1).   
 
I never had problems until I moved down south, when I got chronic bronchitis 
(F2 P2 #1).  
 
I didn’t know why I had the disease. I never smoke, never drank.  My ex-
husband did, smoke, however.  I was around my ex-husband who smoked a lot.  I 
didn’t think I’d get the disease though, because we had been divorced since 1974 
(F1 P6 #1). 
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 Almost all of the patients in the focus groups acknowledged a need to listen to 
their doctor’s advice regarding the self-care of COPD. Although some patients noted the 
initial tendency to resist doctors’ orders when first diagnosed with COPD, most patients 
reported succumbing to the idea of a “disease-compliant” lifestyle.  Patients began to 
realize that for life to be good, it would have to be different. Most focus group 
participants noted that they never regretted deciding to follow their doctor’s advice: 
Sometimes I wouldn’t listen to my doctor, because I did not want to yield to the 
disease.  I simply refused to believe that the disease was going to get to me.  It 
changes your life though.  If you do even a little something, the fatigue…it just 
wears you out. For the past 4 years, though, I have been “dancing to the music” 
of what the doctor tells me.  I just refuse to let it get me down, even when it 
messes with me (F2 P1 #2).  
 
I didn’t want to claim that I had the disease.  I realized, however, that I was 
hurting myself by not listening (F2 P2 #1).   
 
 There was also mention made about the effect COPD had on so-called 
“enjoyable” life activities. These enjoyable activities ranged from making money to 
support a family to going on vacation with grandchildren. The idea that COPD inhibited 
these enjoyable activities was very troubling to many focus group participants:    
When the kids went to Disneyland, I just wanted to keep up with my 
grandchildren, without having to struggle for air (F2 P2 #1). 
 
It’s really affected my work and, in turn, my finances.  This has made it more 
difficult to take care of my relationships as well.  This disease can affect your 
life, and it doesn’t quit or leave you alone. (F2 P1 #2). 
 
Thinking about what you can’t do is almost worse than not being able to do what 
you want to do (F2 P2 #1). 
 
I try to impress my friends and not let it look like I’m having problems when we 
are together.  Sometimes I feel embarrassed.  It’s a disease though, so I guess it’s 
all part of it (F2 P1 #2).   
 
 121
 While patients reported feeling annoyed by the deleterious impact that COPD 
had on their life satisfaction, they were cognizant that COPD is progressive and can get 
worse. Furthermore, they recognized through observing others that COPD can be 
extremely debilitating. Because of this, patients reported wanting to do everything they 
could to maintain their quality of life at a level superior to those whom they’ve observed 
to be far more affected by the disease:   
I know this [COPD] is not death though. It just works on your nerves and 
changes your whole lifestyle. Some people are a lot worse than me though.  I just 
want every drop of information I can get about this thing [COPD] (F2 P2 #1).   
 
It’s really a day to day kind of disease. Now tomorrow I might try to do more, 
because it might be a better day tomorrow.  I think that trying to do exercises 
might help expand my lungs, so I’ll try to do more on days when I feel good (F2 
P1 #2).   
 
Results from Classical Content Analysis 
To complement the results gleaned from the constant comparison analysis, a 
classical content analysis procedure outlined by Lincoln and Guba (1985) was 
employed.  After all of the data were coded (i.e., units of data were identified and 
classified into systematic categories that distinguished unique data properties), it was 
determined the number of times each code was utilized. The most frequently broached 
concepts included: the inability of patients to carry out activities of daily living, a lack of 
knowledge regarding COPD self-management behavior modification strategies, and the 
differential learning curve for managing shortness of breath.  Participants also frequently 
discussed the idea of not moving in excess for fear of breathlessness. Patients reported 
less frequently discussing the need for purposeful living, which revealed that their 
current lifestyles were not currently conducive to limiting dyspnea exacerbations.       
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Figure 5 presents a chart that compares the frequency of the most commonly 
identified codes present within the focus group data.  While there existed some 
variability in the number of times each code was utilized, there was consensus regarding 
which subthemes (represented via codes) were most prevalent within the data.  All of the 
frequently used codes were used to identify two of the subthemes initially identified by 
Cicutto et al and subsequently identified in the present data.  These commonly identified 
codes contributed to the makeup of two related subthemes: (a) adjusting physically to 
COPD and (b) using COPD self-management to adjust physically to the disease. Thus, 
there was an expressed need for more information regarding physical adjustments 
necessary for effective COPD coping.  
Results from Word Count 
 Finally, a word count method was used to quantify the number of times a specific 
word was spoken during each of the focus group interviews (Leech & Onwuegbuzie, 
2007). The word count was implemented on the final transcript using QSR 
International’s NVivo 7.0 qualitative data analysis software program.  This software 
enabled the seamless identification of word patterns present throughout the qualitative 
data (Leech & Onwuegbuzie, 2007; Miles & Huberman, 1994). 
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 Figure 5. Results from classical content analysis 
  
 
The most commonly used words within the transcript were: breath, know, feel, 
want, and don’t, with breath being the most commonly cited word. Patients 
overwhelmingly mentioned the word breath during the course of the focus groups, which 
revealed how important the maintenance of breath was to both their quality of life and 
overall perception of COPD.  The participants had very strong feelings related to 
wanting their shortness of breath to be limited. Patients were adamant in their desire to 
receive any knowledge that could help limit the onset of dyspnea exacerbations. Figure 6 
graphically depicts the frequency of the most commonly spoken words.   
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 Figure 6. Most frequently used words during focus groups 
 
 
Lesser used, but frequently mentioned, words such as problems, tried, worse, and 
can’t, were also of note.  Focus group participants reported having tried to cope with the 
numerous problems caused by COPD; but, more often that not, patients reported their 
symptoms as becoming demonstrably worse no matter what they tried to do. What is 
more, patients could not readily identify multiple ways to limit the onset of shortness of 
breath. It was also fascinating to note the omnipresence of words such as want and don’t 
as compared to tried and can’t. This differential use of these words may provide unique 
insight into how patients view surviving and living life with COPD. While most all 
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patients reported an expressed desire to want to do something to self-manage COPD, 
their efforts don’t necessarily result in the health outcomes they are looking for.  Thus, 
focus group participants seldom reported that they tried to actively limit their shortness 
of breath. Primarily, this was because patients can’t successfully engage in activities 
(other than taking medications), which actually served to help reduce dyspnea and 
exacerbation incidence. In lieu of this, most patients felt reduced to simply taking their 
medications, with little guidance regarding other options for COPD self-management.   
Implications for DVD Editing and Development 
 In sum, the self-management experiences of COPD patients in these focus groups 
were limited to taking prescribed medications and reducing movement and activity.   
Patients reported widespread confidence in regards to managing and using prescribed 
medications to treat COPD symptoms and also perceived that getting plenty of rest could 
reduce the shortness of breath that they experienced. However, the focus group 
participants did not realize the importance of practicing other COPD self-management 
skills and behaviors, such as practicing breathing exercises. This emergent finding 
contradicted what was hypothesized (Hypothesis #2), as patients reported a lack of 
knowledge and skill development related to controlled breathing and coughing, stress 
reduction, and paced walking/movement. Furthermore, the focus group participants 
expressed an interest in learning more about these and other novel topical areas, which 
have been identified as staples within COPD self-management regimens (Bourbeau & 
Nault, 2007). There were also specific questions raised during the focus group sessions, 
and various COPD self-management learning needs were discussed. 
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Given the learning needs identified above, the low educational levels of many of 
the patients in the sample, and the variability in terms of patient time spent coping with 
COPD, careful attention was paid to developing the DVD instructional tool based on the 
focus group data.  It was imperative to only include segments that were relevant, 
comprehensible, to the point and clear.  In light of this necessity, a variety of basic 
COPD self-management topics were chosen for inclusion on the edited DVD. These 
segments were all produced by RVision™ Corporation (2007). The potential content 
was chosen from among all possible segments developed and produced within 
RVision’s™ library of COPD self-management education DVDs (see Table 10 for a 
complete list of all possible topics).  
The main topics chosen for inclusion were related to effective breathing, 
relaxation, basic movements, infection control, nutrition, performing everyday tasks, and 
smoking cessation. This was due to the fact that there was a multitude of topics included 
within the DVD library and only selected topics could be addressed on the DVD, in light 
of the principal investigator’s intention to make the educational DVD as succinct as 
possible with limited health information which could be processed (Rudd & Glanz, 
1990). Given the extensive depth and breadth of data which was gathered using the 
constant comparison analysis technique (while this data proved incredibly insightful), it 
seemed prudent to utilize the findings from the word count and classical content analysis 
to better condense the findings and apply them to the editing of the DVD.    
 Results from the classical content analysis revealed that carrying out activities of 
daily living, learning how to limit shortness of breath, and behavioral modification were 
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the most often cited codes in the focus group transcript. This justified the inclusion of 
segments on relaxation, purposeful movement, infection control, nutrition, smoking 
cessation and performing basic tasks of daily life. In addition, results from the word 
count indicated that breathing was the most often mentioned phrase, thus 6 segments on 
breathing techniques were included on the DVD. Thus, the quantitative results garnered 
from the qualitative study actually proved useful in determining which topics were most 
prevalent within the focus group needs assessment.  The utilization of multiple 
qualitative data analysis tools (Leech & Onwuegbuzie, 2007) proved especially useful 
for the DVD formatting endeavor.  
It is important to note at this point, however, that only segments which contained 
novel, pertinent COPD self-management education were selected for inclusion. For 
example, there were no segments included on medication management, because most 
patients felt comfortable using their medications, and these segments tended to describe 
specific prescription medication terminology, which may have confused patients who 
did not explicitly remember the names of the medications that they were currently 
taking.  In addition, the edited DVD was not intended to bombard patients with an 
excess of information that they could not remember and use; rather, it was developed in 
hopes of keeping patients’ interest by only including information that they would find to 
be applicable to their disease self-management (Rudd & Glanz, 1990). 
 Table 17 presents the content areas included on the edited DVD and the running 
time for each segment. Each topical area was placed in a unique chapter on each DVD.  
This was done to allow patients to specifically choose which segments they would like 
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to watch, without being forced to watch the entire DVD at each sitting. This was also 
done in recognition that there was going to be variability in the types of topics that 
patients would already be familiar with. The total run time for the entire edited DVD 
was approximately 34 minutes and 18 seconds. This edited DVD was used as the main 
instructional intervention tool tested during the primary multiple-group, pretest-posttest 
study.  
Implications for Quantitative Data Collection  
 
The majority of focus group participants expressed difficulty transporting 
themselves from their homes to the rural health clinic where the focus groups were held. 
Many patients had traveled from remote parts of rural Alabama and could only do so 
with assistance from friends and family members. When discussing with the patients the 
prospect of holding an informational session at the rural health clinic whereby COPD 
self-management education materials would be distributed, many patients expressed 
interest, with the caveat that their participation was exclusively incumbent on a variety 
of variables. 
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Table 17 
 
Final segments included on DVD (edited) 
 
Content Running Time 
Introduction 49 sec 
Pursed Lip Breathing 55 sec 
Diaphragmatic Breathing 1 min, 2 sec 
Energy Conservation 1 min, 34 sec 
Introduction to Relaxation Techniques 35 sec 
Deep Breathing 22 sec 
Total Muscle Relaxation 1 min, 39 sec 
Visual Imagery 21 sec 
Helpful Hints for Relaxation 24 sec 
Avoiding Stress 23 sec 
Panic Control Breathing 47 sec 
Aerobics and Conditioning Introduction 23 sec 
Walking for Exercise 2 min, 37 sec 
Lifting and Breathing 15 sec 
Bending and Breathing 24 sec 
Infection Control 1 min, 41 sec 
Infection Detection 1 min, 1 sec 
Infection Treatment 59 sec 
When to Call Doctor 1 min 17 sec 
Controlling your Cough 47 sec 
Nutrition 2 min, 39 sec 
Increasing Your Fluid Intake 1 min, 29 sec 
House Keeping 1 min, 11 sec 
Smoking Cessation 1 min, 22 sec 
Conclusion 22 sec 
  
Total (approximate) 34 min, 18 sec 
 
 
These variables included: access to the clinic, time of day, day-to-day variation in health 
state, and also familial responsibilities. In light of these obstacles, and due to the 
potential contamination effects (i.e. patients being exposed to a non-intended treatments) 
of bringing the entire pool of participants to one locale in order distribute the educational 
intervention, it was decided that the best strategy was to send the survey instruments and 
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intervention materials to patients via regular mail to reduce any potential complications. 
This plan better ensured that patients were only exposed to one treatment condition (i.e., 
reduce threat to internal validity), would reduce patients’ need to travel, and also deliver 
the educational materials directly to patients at their place of residence (i.e., enhance the 
convenience for the patient). The medical personnel at the rural health clinic agreed with 
this strategy as the best option to most efficiently conduct the multiple group, pretest-
posttest study.  Thus, the instructional strategy shifted from a plan that require limited 
interpersonal interactions with patients to a plan where “distance” education was the 
primary means of instruction transmission.  For the purpose of this study, distance 
education can be defined best by Moore (1990) as, “all arrangements for providing 
instruction through print or electronic communications to people engaged in planned 
learning in a place or time different from that of the instructor or instructors” (p. xv).        
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 Multiple Group Pretest-Posttest Study 
 
 Table 18 presents demographic information for the participants in the 
quantitative aspect of the study. As reported earlier, 101 participants were recruited to 
participate in the multiple-group, pretest-posttest study. Fifty-six pretests were 
completed by willing participants (Pretest Response Rate = 55.4%; Participant Dropout 
Rate = 44.6%). Of the 56 participants completing the pretest surveys, 41 completed and 
returned all posttest surveys (Posttest Response Rate = 73.2%; Participant Dropout Rate 
= 26.8%). The mean age of participants was 61.51 years (SD = 6.29 years). The majority 
of participants were Caucasian (n = 29), yet more than half were female (n = 25), and 
one-third were African American (n = 12).  Most participants reported educational levels 
ranging from only grade school to graduating from high school (cumulative % = 80.4), 
and most participants were married (n = 30). The overwhelming majority of participants 
reported annual incomes of less than $14,999 (70.7%), which may be attributable to this 
demographic group living on a fixed income in a low socioeconomic community.      
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Table 18 
 
Multiple group, pretest-posttest demographic characteristics 
 
Characteristics           n = 41 
Age (mean ± SD) 
 
61.51 years ± 6.29 years  
Gender  
          Male 
          Female 
 
 
16 
25 
Race  
          Caucasian (White) 
          African American (Black) 
 
 
29 
12 
Educational level 
Grade school 
Some high school 
High school graduate 
Some college 
College graduate 
Graduate degree 
 
 
9 
13 
11 
3 
3 
2 
 
Income 
Less than $14,999 
$15,000 - $24,999 
$25,000 - $34,999 
$35,000 - $49,999 
$50,000 - $74,999 
$75,000 - $99,999 
$100,000+ 
 
 
29 
8 
2 
2 
0 
0 
0 
 
Marital Status 
        Married  
        Widowed 
        Single 
 
 
30 
3 
8 
 133
Process Evaluation  
 
 Almost 90% of participants (87.5%) assigned to the intervention groups (n = 28) 
reported that they received the intended educational materials via regular mail. Only the 
participants who correctly identified the educational intervention they actually received 
and reviewed were included in the data analysis to protect against Type III error 
(Schwartz & Carpenter, 1999). Type III Error refers to the notion an intervention has 
limited or no impact on the outcome variables being examined; thus, the researcher is ill 
equipped to assess the hypotheses posed (Basch, 1985). Furthermore, Type III error can 
be defined as, “…when the program is not measured as implemented, when the program 
has not been implemented, or when there is no testable relationship between the program 
activity carried out and the program objectives being measured” (Scanlon et al., 1977, p. 
264). Over the 2-month treatment time period, participants receiving only the DVD 
reported viewing the DVD a mean of 1.75 times (SD = 1.91 times), while participants 
receiving the Pamphlet reported reviewing over it a mean of 2.16 times (SD = 2.76 
times). Participants receiving both the DVD and Pamphlet over the 2-month treatment 
time period reviewed these instructional materials a mean of 3.4 times (SD = 1.71 
times). The participants self-reported viewing the materials as instructed (sometimes 
multiple times); thus, the probability of a Type III error occurring was most likely 
reduced as one can reasonably assume that the educational interventions were utilized 
based on instructions provided to patients, and previous research indicates that 
educational materials such as those provided to patients could help to achieve specified 
study objectives (Effing et al., 2007). The mean number of views over the 2 month 
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period was not statistically significantly different across the treatment groups, F(2, 27) = 
1.38, p = .27, η2 = .09.   
 Participants were also asked to rate on scales from 1 to 10 how useful they felt 
the intervention materials were (1 = not at all useful; 10 = extremely useful) and also 
how understandable they felt the educational materials were (1 = not comprehensible; 10 
= extremely comprehensible). The mean utility scores from participants across all 
treatment groups was relatively high (M= 7.61, SD = 2.36) as were the mean 
comprehensibility scores (M = 8.21, SD = 2.18). While the overall scores on both 
measures were high, their differences were not statistically significant across treatments: 
Utility: F(2, 25) = .526, p = .60, η2 = .04; and Comprehensibility: F(2, 25) = .119, p = 
.89, η2 = .01.  
Pretest and Posttest Data 
Table 19 presents means, standard deviations, and reliability indices for all 
pretest data obtained from the sample of participants who completed both the pre and 
posttest instruments (n = 41). Missing data was accounted for using procedures 
published within the scoring guidelines for each instrument. As an example, for each 
missing item of the SOLQ (for each dimension measured), the user was instructed to 
assign the average value of the non-missing items associated with that particular 
subscale. For the pretest data, the mean across all reliability indexes (α) was 0.83 (SD = 
0.12); thus, the reliability estimates from the pretest data was judged to be acceptable for 
all scales. Additionally, the distribution of scores for all the scales was examined, and 
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the skewness and kurtosis statistics were within the acceptable range to warrant further 
inferential analysis (Tabachnick & Fidell, 2000).  
 Based on the pre-conceived notion that patient self-efficacy for managing COPD 
would be highly correlated with both HRQoL and lung information needs, and given that 
the correlations between the SEMCD-6 pretest and specified outcome variables were 
moderate to high (upon inspection of the pearson r correlation matrix between pretest 
and posttest variables), the SEMCD-6 pretest variable was selected as a covariate to 
statistically adjust for pretest differences which may have existed between treatment 
group members. This decision was further supported by the pretest reliability estimate of 
the SEMCD-6 (α = .97). All other pretest variables showed minimal correlations with all 
outcome measures tested, and therefore were not considered for inclusion as covariates 
due to their limited ability to reduce the overall error variance in the MANCOVA model. 
Also, there did not exist a statistically significant difference in SEMCD-6 pretest scores 
across the treatment groups, F(2, 38) = 1.12, p = .35, η2adj = .01, which indicated that the 
participants were relatively homogeneous with respect to feeling able to self-manage 
their shortness of breath associated with COPD. Further, as with the other pretest 
variables, the data obtained from the SEMCD-6 did not violate the normality assumption 
of MANCOVA: skewness statistic = .27 and kurtosis statistic = -.62 (Tabachnick & 
Fidell, 2000).     
  Table 19 
Descriptive statistics for pretests 
 
Pretests 
 
DVD Pamphlet 
DVD + 
Pamphlet 
Control Group α 
SOLQ        
M 17.83 36.84 29.66 35.67 30.16 
Physical 
SD 14.34 22.63 12.89 14.24 17.49 
.94 
M 35.56 46.67 53.03 54.44 47.69 
Emotional 
SD 24.32 22.44 28.96 13.74 23.63 
.72 
M 33.33 55.83 47.35 57.41 48.61 
Coping 
SD 17.68 20.71 25.09 23.82 23.24 
.66 
M 58.33 68.75 56.82 52.78 59.29 Treatment 
Satisfaction SD 38.53 33.46 30.80 22.34 31.11 
.82 
M 12.44 8 8 7.78 8.97 LINQ-
TOTAL SD 6.06 5.81 4.73 5.78 5.69 
.85 
M 3.44 4.27 4.24 5.48 4.35 
SEMCD-6 
SD 2.67 2.26 2.73 1.91 2.44 
.97 
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 Table 19 
Continued 
 
 
Pretests 
 
DVD Pamphlet 
DVD + 
Pamphlet 
Control Group α 
M .54 .92 .59 .62 .68 
EQ-5D 
SD .20 .99 .23 .18 .57 
.64 
M 33.44 45 47.45 58.44 46.07 
EQ-VAS 
SD 19.99 16.1 17.32 10.17 17.83 
n  9 12 11 9 41 
 
N/A 
 
Note: M =unadjusted means; SD = standard deviation; α = coefficient alpha reliability index
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 Table 20 presents all posttest data.  For all posttests, the adjusted means (i.e., 
means which statistically took into account pretest differences among participants on the 
SEMCD-6) are included. Missing data was accounted for using procedures published 
within the scoring guidelines for each instrument. All of the reliability estimates were 
judged to be acceptable. The mean across all reliability indexes for the posttest data was 
.80 (SD = 0.13). Additionally, the distribution of scores from all the posttest scales was 
examined, and the data did not violate the normality assumption of MANCOVA, as the 
skewness statistics for the data ranged from -.45 to 1.32 and the kurtosis statistics ranged 
from -1.06 to 1.88 (Tabachnick & Fidell, 2001).   
Data Assumptions 
 A multivariate test of the regression slope vectors was conducted using the Wilks 
lambda test (λ) to ensure that the regression slope of the posttest outcome variables on 
the pretest covariate, SEMCD-6 pretest, was relatively equivalent for all groups being 
compared. The test provided little evidence to indicate that the mean vectors differed, as 
Λ = .42, F(24, 76.01) = 1.10, P = .36. Moreover, for each of the outcome variables, there 
was little evidence to indicate that an interaction was present between the grouping 
variable and SEMCD-6 pretest variable. Thus, the homogeneity of regression 
assumption of ANCOVA was not violated when considering the data.  
 
 
 
 Table 20 
Descriptive statistics for posttests  
Posttests 
DVD             
(n = 9) 
Pamphlet        
(n = 12) 
DVD + 
Pamphlet        
(n = 11) 
Control 
(n = 9) 
Group     
(n = 41) 
α 
SOLQ        
M 36.84 20.40 34.81 31.14 30.23 
SD 29.40 18.34 10.97 8.06 18.67 Physical 
AM 39.37 19.93 35.33 28.56 30.80 
.94 
M 46.30 35.00 52.12 51.48 45.69 
SD 30.84 14.11 10.98 17.57 19.75 Emotional 
AM 48.04 34.68 52.48 49.70 46.23 
.74 
M 41.20 37.50 59.47 60.19 49.19 
SD 16.06 12.56 9.88 31.19 20.63 Coping 
AM 43.40 37.09 59.92 57.95 49.59 
.71 
M 45.83 60.42 60.23 65.28 58.23 
SD 30.62 22.51 14.60 23.20 23.15 Treatment 
Satisfaction 
AM 47.68 60.07 60.61 63.39 57.93 
.83 
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 Table 20 
Continued  
 
Posttests 
DVD             
(n = 9) 
Pamphlet        
(n = 12) 
DVD + 
Pamphlet        
(n = 11) 
Control 
(n = 9) 
Group     
(n = 41) 
α 
M 7.33 7.33 9.82 6.89 7.90 
SD 3.46 6.05 5.83 3.48 4.98 LINQ-TOTAL 
AM 7.79 7.25 9.91 6.42 7.84 
.66 
M 4.85 7.19 3.30 5.46 5.25 
SD 2.87 1.59 .67 1.57 2.28 SEMCD-6 
AM 5.10 7.15 3.35 5.21 5.20 
.96 
M .52 .43 .78 .47 .55 
SD .30 .18 .12 .20 .24 EQ-5D 
AM .53 .43 .78 .46 .55 
.69 
M 43.78 67.42 63.64 58.22 59.20 
SD 27 24.95 19.24 15.44 23.17 EQ-VAS 
AM 45.20 67.15 63.93 56.77 58.26 
N/A 
 
Note: M =unadjusted means; SD = standard deviation; AM = adjusted mean centroids; α = coefficient alpha reliability index 
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 To statistically confirm that a relatively strong relationship existed between the 
SEMCD-6 pretest variable and each of the outcome variables, a test of the vector of 
regression slopes which related the outcome variables to the SEMCD-6 pretest variable 
was conducted. Results from this test indicated that there was a non-statistically 
significant relationship between the SEMCD-6 pretest variable and each of the outcome 
variables at the .02 alpha level, Λ = .65, F(8, 29) = 1.88, P = .09, η2 = .35, η2adj = .19. 
However, while this test did not produce a statistically significant result, it did reveal a 
notable effect size (η2adj = .19) which signaled that a relationship did exist to some 
degree between the SEMCD-6 variable and the outcomes variables of interest, thereby 
helping to reduce the error variance in the model and increase statistical power. 
Hypothesis Testing 
 The following hypotheses were tested during the quantitative aspect of this 
mixed methods study.  
Hypothesis # 3: Patients exposed to targeted DVD segments (Treatment 1) will 
outperform patients exposed to the educational Pamphlet (Treatment 2) on 
outcome variables related to COPD informational needs, COPD self-
management self-efficacy, and HRQoL. For hypothesis 1 (contrast 1), the 
observed differences in the adjusted mean vectors of the outcome variables were 
statistically significant among the DVD and Pamphlet groups on the outcome 
variable vectors tested, Λ = .42, F(8, 29) = 4.97, p = .001, η2adj = .48. Table 21 
presents the vector of adjusted mean differences between the DVD and Pamphlet 
groups. 
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Table 21 
Vector of adjusted mean differences between DVD and Pamphlet  
Outcome variable Adjusted mean differences 
SOLQ  
Physical 19.44 
Emotional 13.35 
Coping 6.3 
Treatment Satisfaction 12.4 
LINQ-TOTAL 0.24 
SEMCD-6 2.05 
EQ-5D 0.1 
EQ-VAS 21.95 
 
  
 Upon examining the structure coefficients between each dependent variable and 
canonical variable of this contrast effect, it was determined that the SEMCD-6 (raw 
discriminant function coefficient = -.61, r2s = .14), SOLQ-Physical Function (raw 
discriminant function coefficient = .03, r2s = .13), and EQ-VAS (raw discriminant 
function coefficient = -.02, r2s = .10) outcome variables contributed most to the resultant 
function. While the raw discriminant function coefficients of the physical functioning 
subscale of the SOLQ (i.e., .03) and the EQ-VAS (i.e., -.02) would seem to indicate non-
contribution to the latent function, it is important to recognize that function coefficients 
are influenced by correlations between the outcome variables. Therefore, it is important 
to primarily consult the structure coefficients for the outcome variables (Thompson & 
Borello, 1985). The physical functioning subscale of the SOLQ and the EQ-VAS 
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possessed similar r2ss to that of the SEMCD-6, thus should be considered when 
interpreting the makeup of the function.  
 These results indicate that COPD self-management self-efficacy is the primary 
construct maximizing the differences between the two groups, while generic HRQoL 
and the physical functioning dimension of lung-specific HRQoL are also important 
constructs maximizing the group differences.  Table 22 presents the DVD and Pamphlet 
group adjusted mean centroids for the three primary outcome variables defining the 
function. 
 
 
Table 22 
Group adjusted mean centroids for DVD and Pamphlet groups 
Outcome variable DVD Pamphlet 
SOLQ- Physical 39.37 19.93 
EQ-VAS 45.20 67.15 
SEMCD-6 5.09 7.15 
   
  
 The group adjusted mean centroids suggest that providing this sample with 
DVDs as opposed to Pamphlets was more beneficial in helping to improve lung-specific 
physical functioning among COPD patients, while Pamphlets were more effective in 
increasing self-reported generic opinions of HRQoL. In regards to COPD self-
management self-efficacy, those in the Pamphlet group reported higher self-efficacy than 
those in the DVD group. These results support the hypothesis as it relates to the physical 
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functioning dimension of HRQoL outcome, but does not support the hypothesis with 
regard to generic HRQoL, COPD self-management self-efficacy and COPD information 
needs.  
Hypothesis # 4: Patients exposed to the targeted DVD and educational Pamphlet 
(Treatment 3) concurrently will underperform as compared to patients exposed 
to the DVD (Treatment 1) and educational Pamphlet alone (Treatment 2), on 
outcome variables related to COPD informational needs, COPD self-
management self-efficacy, and HRQoL. For hypothesis 2 (contrast 2), the 
observed differences in the adjusted mean vectors of the outcome variables were 
statistically significant among participants exposed to both interventions 
concurrently (DVD + Pamphlet) versus participants exposed to either the DVD 
or Pamphlet exclusively, Λ = .30, F(8, 29) = 8.35, p < .001,   η2adj = .63. Table 23 
presents the vector of adjusted mean differences between the DVD + Pamphlet 
group and the collapsed average of the DVD and Pamphlet group adjusted mean 
centroids considered together. 
 Upon examining the structure coefficients between each dependent variable and 
canonical variable of the contrast effect, it was determined that the SEMCD-6 (raw 
discriminant function coefficient = -.87, r2s = .23), EQ-5D (raw discriminant function 
coefficient = .02, r2s = .19), and SOLQ-Coping (raw discriminant function coefficient = 
.02, r2s = .10) outcome variables contributed most to the resultant function. 
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 Again, while the raw discriminant function coefficient of the EQ-5D (i.e., .02) 
and coping subscale of the SOLQ (i.e., .02) was very low, the squared structure 
coefficients describing their relationships with the canonical variables are noteworthy. 
Given that the coping skills subscale is highly correlated (r = 0.93) with another 
commonly used measure of self-efficacy in COPD patients (cf. Tu et al., 1997; Wigal et 
al., 1991), these two outcome variables (SEMCD-6 and SOLQ-Coping) can be 
conceptually put together to define COPD self-management self-efficacy as the 
construct that best describes the latent function which underlies this contrast effect. 
 Since the SEMCD-6 performed better than the coping subscale of the SOLQ 
maximizing the differences between the two groups (i.e., DVD + Pamphlet versus the 
collapsed average of the DVD and Pamphlet group adjusted mean centroids considered 
together), all COPD self-management self-efficacy data interpretations focused on 
SEMCD-6 scale results. 
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Table 23 
Vector of adjusted mean differences between DVD + Pamphlet and average of the DVD 
and Pamphlet groups collapsed together 
Outcome variable Adjusted mean differences 
SOLQ  
Physical 5.69 
Emotional 11.12 
Coping 19.68 
Treatment Satisfaction 6.73 
LINQ-TOTAL 2.39 
SEMCD-6 2.77 
EQ-5D 0.3 
EQ-VAS 7.75 
 
  
The EQ-5D variable is an indexed value that weights 5 dimensions of generic HRQoL 
into an indexed value from 0 to 1. It also contributed substantially to the latent function 
underlying the contrast effect. Table 24 presents the DVD + Pamphlet and the average of 
the DVD and Pamphlet group adjusted mean centroids for the SEMCD-6 and EQ-5D. 
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Table 24 
Group adjusted mean centroids for DVD + Pamphlet and the average of the DVD and 
Pamphlet groups collapsed together 
Outcome variable DVD + Pamphlet Average of DVD and Pamphlet groups  
SEMCD-6 3.35 6.13 
EQ-5D .78 .48 
  
 
 In regards to COPD self-management self-efficacy, this result suggests that 
providing this sample with either a DVD or Pamphlet alone was more beneficial than 
providing participants with both interventions concurrently. Furthermore, taking into 
account results from contrast one, the participants in the Pamphlet group self-reported 
the highest levels of COPD self-management self-efficacy. In regards to self-reported 
generic HRQoL; however, this result suggests that providing this sample with either a 
DVD or Pamphlet alone was less beneficial than providing participants with both 
interventions concurrently. In sum, the results from contrast analysis 2 supports the 
hypothesis regarding the superior effect of the individual (i.e., Pamphlet primarily) 
versus the concurrent intervention strategies on COPD self-management self-efficacy, 
but does not support the hypothesis in regards to generic HRQoL; the concurrent 
educational strategy was actually associated with a more beneficial impact on generic 
HRQoL. Table 25 summarizes the statistically significant results from both contrasts 1 
and 2.  
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While COPD self-management self-efficacy and generic HRQoL represented this 
contrast effect, the a priori hypothesis was not supported as regards the other outcome 
variable considered (i.e., COPD information needs), as there were no noteworthy 
structure coefficients linked to the variable describing this construct.  
Hypothesis # 5: Patients exposed to targeted DVD segments (Treatment 1), 
educational Pamphlets (Treatment 2), and both DVD segments and educational 
Pamphlet concurrently (Treatment 3) will outperform patients exposed to the 
usual care (control) condition (Treatment 4) on outcome variables related to 
COPD informational needs, COPD self-management self-efficacy, and HRQoL. 
For hypothesis 3 (contrast 3), the observed differences in the adjusted mean 
vectors of the outcome variables were not statistically significant among 
participants exposed to the DVD, Pamphlet, and/or both interventions 
concurrently (DVD + Pamphlet) versus participants exposed to usual care 
(Control), Λ = .730, F(8, 29) = 1.34, p = .265. 
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Table 25 
Statistically significant test results for contrast analyses 1 and 2 
Effect r2s Std. 
weight Wilks’s Λ 
F p & η2adj 
 
DVD vs. Pamphlet 
 
SOLQ-Physical   .13 .03 
SOLQ-Emotion .05 .04 
SOLQ-Coping .01 .02 
SOLQ-Satisfaction .03 -.03 
LINQ-TOTAL .0001 -.10 
SEMCD-6 .14 -.62 
EQ-VAS .10 -.02 
.42 4.97 p = .001,   
η2adj = .48 
EQ-5D .03 .14    
DVD + Pamphlet vs. the average of DVD and Pamphlet groups together 
SOLQ-Physical   .002 .01 
SOLQ-Emotion .03 .05 
SOLQ-Coping .10 .02 
SOLQ-Satisfaction .01 .008 
LINQ-TOTAL .02 .008 
SEMCD-6 .23 -.87 
EQ-VAS .02 .01 
.30 8.35 p < .001, 
η2adj = .63 
EQ-5D .19 .02    
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 Because no functions were statistically significant at the .02 alpha level, the 
structure coefficients between each dependent variable and canonical variable were not 
examined. Furthermore, the hypothesis that the provision of self-management education 
versus usual care would statistically significantly decrease COPD informational needs, 
and increase COPD self-management self-efficacy and generic/lung-specific HRQoL, 
was not supported by the data.   
Summary 
 
Most participants received and reviewed the educational material that was sent to 
them and perceived these instructional materials as useful and relatively easy to 
understand.   
When comparing the adjusted mean vectors of the DVD versus the Pamphlet 
group participants on the outcome variables of interest, there were statistically 
significant differences found relative to the COPD self-management self-efficacy, lung-
specific HRQoL (i.e., physical functioning dimension), and generic HRQoL constructs. 
The Pamphlet group participants reported higher levels of self-efficacy than the DVD 
group participants; whereas, the DVD group participants reported higher levels of 
physical functioning (i.e., lung-specific HRQoL measure) than the Pamphlet group. 
Interestingly, the participants in the Pamphlet group self-reported greater generic 
HRQoL than did participants in the DVD group.  
When comparing the adjusted mean vectors of the DVD + Pamphlet group 
versus the collapsed average of the DVD and Pamphlet group participants on the 
outcome variables of interest, there were statistically significant differences found 
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relative to the COPD self-management self-efficacy and generic HRQoL outcome 
measures. The results suggested that, in order to increase COPD self-management self-
efficacy, providing this sample with a Pamphlet alone was more effective than providing 
participants with both educational interventions concurrently. In contrast, providing 
patients with both educational interventions concurrently was associated with greater 
self-reported generic HRQoL as compared to providing participants each intervention 
individually.  
When comparing the adjusted mean vectors of the DVD, Pamphlet, and/or both 
interventions concurrently (DVD + Pamphlet) versus participants exposed to the usual 
care control group, there were no statistically significant differences found relative to the 
outcome variables of interest. Thus, the provision of any type of educational material as 
opposed to usual care did not improve the results on the outcome variables of interest 
among this sample of COPD patients.   
Finally, across all three planned contrasts tested, there was no statistically 
significant effect of self-management education, in any format or combination, on 
COPD information needs. 
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CHAPTER V 
DISCUSSION AND CONCLUSION 
 
Introduction 
 
Because of limited access to hospital-based pulmonary rehabilitation for 
underserved patients, COPD self-management education programs have been designed, 
implemented, and evaluated in order to help improve the overall management of COPD.  
The self-management model emphasizes mastery of self-regulatory skills such as self-
monitoring health-related behavior and its socio-cognitive precepts. Effective programs 
geared towards COPD self-management include components such as: (a) provision of 
information, (b) translating information into preventive action, and (c) self-efficacy 
building. The evaluations of the effectiveness of self-management programs can identify 
the true effective educational elements for successful COPD self-management, and thus 
facilitate the acquisition of self-management skills and behavior change.   
Given that (a) previous research noted a lack of patient-centered interventions 
which took into account patient perspectives and knowledge of disease management by 
way of a needs assessment (Woo et al., 2006) and (b) COPD patients have reported 
widespread dissatisfaction with the self-management education they are provided (Barr 
et al., 2005; Elkington & White, 2002; Gore, Brophy, & Greenstoe, 2000; Jones, Hyland, 
Hanney, & Erwin, 2004), this particular study collected and utilized data from 
qualitative focus groups to assess the self-management learning needs and perspectives 
of COPD patients in order to inform the development of a targeted self-management 
educational DVD developed in accordance with patients’ specific COPD self-
153 
 
management needs. Participants represented a sample of underserved patients living in a 
rural community, and not enrolled in formal pulmonary rehabilitation programs due to 
geographic barriers and monetary costs associated with such programs. Consequently, 
these patients were ideal candidates for receiving COPD self-management education 
interventions.   
The DVD modality was chosen as one format to transmit COPD self-
management education, because research has shown that older COPD patients appreciate 
and learn well from home-based self-management educational programs that make use 
of audiovisual media (Boxall, Hons, Sayers, & Caplan, 2006; Constantinidou & Baker, 
2002; Finklestein & Ratner, 2006; Nguyen et al., 2003; Petty et al., 2006). In addition, 
most patients in this rural sample indicated that they had access to a DVD player when 
initially interviewed by a project assistant. It was posited that targeted, audio-visual 
education would best aid patients in their self-management of COPD through building 
self-efficacy for self-managing disease, reducing the need for disease-related 
information, and improving self-reported HRQoL. COPD self-management education 
programs can help enhance patients' self-efficacy through transmitting information that 
address these four sources of efficacy information. It has been argued that the effects of 
a self-management education program on HRQoL results from behavior change that is 
caused by enhanced self-efficacy, skill building and a reduced need for self-management 
information.   
In light of this, the quantitative aspect of this study assessed the effectiveness of 
three distinct educational treatments (including the newly developed one) by comparing 
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outcomes related to (a) COPD informational needs, (b) COPD self-management self-
efficacy, and (c) generic and lung-specific HRQoL in a randomly-assigned, multiple-
group pretest-posttest design with a control group.  
The primary aim of the present study was to measure and specifically compare 
the effect of three COPD self-management education dissemination strategies (and a 
control strategy) on relative differences in generic and disease-specific HRQoL, COPD 
information needs and COPD self-management self-efficacy. The four educational 
treatments were: 
1. Targeted RVision™ DVD segments (RVision™ Corporation, 2007)  
2. Pre-produced written Pamphlet, Breathing Better With a COPD Diagnosis 
(National Heart, Lung and Blood Institute, 2007b) 
3. Targeted RVision™ DVD segments and Breathing Better With a COPD 
Diagnosis  
4. Usual care (control) 
The secondary aim of the present study was to assess the self-management 
learning needs, experiences and perspectives of COPD patients who were treated at 
Choctaw Urgent Care, a Certified Federal Rural Health Clinic in rural Butler, Alabama. 
This was undertaken to inform the development of the edited DVD. 
Conclusions 
 
Qualitative 
The main theme articulated by focus group members coincided with the 
predominant theme identified by Cicutto et al. (2004). Focus group participants spoke 
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about trying to perform basic daily tasks while trying to manage symptoms caused by 
COPD. The three main sub-themes deductively identified in the present focus group data 
were: (a) adjusting physically to COPD, (b) adjusting physically to COPD self-
management activities, and (c) adjusting emotionally to COPD self-management. 
Specifically, patients discussed their need to reduce the amount of movement that they 
engaged in from day to day. In particular, low intensity physical activity, involving a 
minimal amount of movement, was noted to be especially difficult. There was one sub-
theme which emerged inductively from the data analysis and was characterized as 
coming to terms with COPD and the lifestyle. This sub-theme was related to how/if 
patients rationalized their COPD diagnosis and also how they described the lifestyle 
prompted by their diagnosis.  
Patients also discussed a lack of knowledge regarding COPD self-management 
behavior modification strategies. Participants frequently discussed staying sedentary for 
fear that moving would cause breathlessness. The lack of COPD self-management 
implementation suggested that the participants’ current lifestyles were not conducive to 
limiting dyspnea exacerbations, as this type of activity can cause further deconditioning 
which can aggravate dyspnea even further (Reardon, Lareau, & ZuWallack, 2006). 
Moreover, the self-management experiences of COPD patients in these focus groups 
were limited to only reducing movement and activity and taking prescribed medications. 
The participants professed an interest, however, in receiving any knowledge regarding 
other strategies that could help limit the onset of dyspnea exacerbations. 
156 
 
Further, focus group participants did not realize the importance of practicing 
other COPD self-management skills and behaviors, such as practicing breathing 
exercises. This emergent finding contradicted what was hypothesized, as patients 
reported a lack of knowledge and skill development related to controlled breathing and 
coughing, stress reduction, paced walking and planned movement. These, and other 
related topics, were included on the edited DVD provided to selected participants.  The 
paired down list of COPD self-management topics identified as useful for this priority 
population (i.e., underserved rural patients) provides a basis for future audiovisual 
editing efforts geared towards this audience. Furthermore, the utilization of qualitative 
data collection techniques to inform the development of self-management DVDs could 
benefit from using qualitative data analysis techniques which provide quantitative 
insight into the most prevalent self-management topics expressed during focus groups.  
Quantitative 
  Most participants (almost 90%) reported receiving and reviewing the self-
management education material that was sent to them via regular mail. Thus, the 
distribution strategy for the intervention materials proved to be quite effective.  It is 
important to be cognizant, however, of response bias which may have been present 
among a sample receiving remuneration for their active participation in a study. 
Nonetheless, it was encouraging to note that participants found the educational materials 
to be useful and relatively easy to understand. Although the participants self-reported 
positive impressions of the educational materials, the three treatment groups did not 
differ to a statistically significantly degree. Thus, it is inconclusive as to which treatment 
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was most easily utilized and understood among this unique group of rural COPD 
patients.     
There were statistically significant differences found on the COPD self-
management self-efficacy, lung-specific HRQoL (physical functioning dimension), and 
generic HRQoL outcome variables across 2 of the 3 contrast analyses.  
While it was hypothesized that participants in the DVD group would outperform 
participants in the Pamphlet group on all outcome variables tested, the Pamphlet group 
participants reported higher levels of self-efficacy than did the DVD group participants.  
Moreover, findings from contrast 1 suggest that of the two types of self-management 
education interventions tested, text based self-management education may be more 
effective to enhance COPD self-management self-efficacy in a population similar to the 
sample in this study. A few studies noted improvements in self-management self-
efficacy after exposure to self-management education (Atkins et al., 1984; Kara & Asti, 
2004; Scherer & Schmieder, 1997; Tsang, 2000; Zimmerman, Brown, & Bowman, 
1996), yet these studies, for the most part, only found within-group improvement in self-
efficacy among patients exposed to group self-management education as opposed to 
usual care. Studies of this nature did not investigate between group differences among 
participants exposed to different types of educational treatments as the present study did. 
The present research supported different between-group effects of different COPD self-
management educational strategies on COPD self-management self-efficacy.  Moreover, 
this study was the first to specifically identifying Pamphlet distribution alone as the most 
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effective educational strategy to positively influence COPD self-management self-
efficacy among COPD patients.  
In a systematic review of the effectiveness of COPD self-management education, 
a positive trend was observed indicating that education had a positive impact on HRQoL 
(Effing et al., 2007). This overarching finding was somewhat supported within the 
present study when comparing the effect of different self-management educational 
strategies on both generic and lung-specific HRQoL. The DVD group participants 
improved more so than the Pamphlet group in regards to physically functioning with 
COPD. The DVD group participants did not, however, outperform the participants in the 
Pamphlet group on one measure of generic HRQoL. Thus, in regards to the physical 
functioning dimension of lung-specific HRQoL, the data supported the hypothesis 
posed, yet the finding related to generic HRQoL contradicted the a priori hypothesis.  
Of note is the improvement on the physical functioning subscale of the SOLQ for 
participants in the DVD group. DVD group participants reported clinically significant 
improvements in physical and emotional functioning (i.e., an improvement of 5 points, 
see Tu et al., 1997). The same could not be said for the Pamphlet and Control groups. 
Exposure to standard self-management education had previously been associated with 
improvements in physical functioning, but did not reach a level of clinical significance 
in all previous studies (Effing et al., 2007; Kara & Asti, 2004; Soler et al., 2006). Thus, 
the clinically significant improvement in physical and emotional functioning linked with 
exposure to the targeted self-management DVD represents an important finding. The 
present study supports the idea that exposure to audio-visual based education, as 
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opposed to text based education, can clinically impact physical and emotional 
functioning among COPD patients (Petty et al., 2006).  
 It is important to note, however, that the above finding cannot be said in regards 
to generic HRQoL (i.e., HRQoL not specifically associated with a disease), as the data 
from this study did not support increased efficacy of the DVD as opposed to the 
Pamphlet in relation to this more general construct. Furthermore, this study suggests 
there are differential effects of educational treatment on both generic and disease-
specific HRQoL among COPD patients. When specifically comparing the DVD and 
Pamphlet groups’ results on the HRQoL outcome variable, it was determined that the 
influence of how HRQoL was measured (i.e., generically versus disease-specifically) 
had a disparate impact on result interpretation, with the dimensional measurement 
concluding that the DVD education produced superior effects on physical functioning, 
while the Pamphlet produced superior effects when generic HRQoL was assessed. 
 Generic measures of HRQoL have generally been reported as weak among 
COPD patients (Guyatt et al, 1999; Tsukino et al., 2002) and more likely to detect 
effects unrelated to COPD (Curtis & Patrick, 2003). Furthermore, in most studies, but 
not all (Tsukino et al., 2002), disease-specific instruments have been more responsive to 
change (Puhan et al., 2007). It is important to note, however, that the more the content of 
an instrument deviates from the concept under study, the greater the error introduced and 
the lesser the accuracy of inferences (Hajiro, Nishimura, Tsukino, Toru, & Takateru, 
1999). Thus, the results interpreted from the data collected using the COPD-specific 
instrument may be the most accurate for data interpretation purposes. Moreover, the 
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positive effect of the DVD on disease-specific HRQoL (i.e., physical functioning 
dimension) may be the more important finding.    
 When comparing the adjusted mean vectors of the DVD + Pamphlet group 
versus the collapsed average of the DVD and Pamphlet group participants, there were 
statistically significant differences found on the COPD self-management self-efficacy 
outcome measure as well as a measure of generic HRQoL. The results suggested that 
providing this sample with either a DVD or Pamphlet alone was more effective than 
providing participants with both interventions concurrently in order to increase COPD 
self-management self-efficacy. This finding regarding COPD self-management self-
efficacy was notable and supported the hypothesis stating that both treatments 
concurrently would be less effective than distributing only one of the two instructional 
materials to patients. Further, this result concurs with CIPT (Rudd & Glanz, 1990), 
which emphasizes that health consumers can process and use only a limited amount of 
information at one time (Bettman, 1979). This result also builds upon the previous 
findings in contrast 1, suggesting again that the distribution of Pamphlets alone s the 
superior strategy to enhance COPD self-management self-efficacy among a rural sample 
of COPD patients.  
In light of these results regarding the effects of COPD self-management on self-
efficacy, perhaps providing patients with too much information in different formats 
caused an “information overload” for participants and did not allow participants to 
ascertain the information needed to enhance their efficacy beliefs. These findings 
suggest that a “less is more” phenomena may be present and supports a singular 
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educational strategy to enhance self-efficacy among COPD patients, which has been 
primarily studied in the literature (Kara & Asti, 2004; Tsang, 2000). Patients may 
respond better to consistent messages regarding COPD self-management and efforts 
aimed at reducing the potential for contradiction and/or confusion regarding the various 
self-management skills and behaviors included within self-management educational 
material.  As well, most educational interventions designed to enhance COPD self-
management education should usually be supplemented by other support interpersonal 
support from family, peer, health professionals, etc., and not simply by way of 
information dissemination. These possibilities should be considered during the 
educational planning process, as text-based educational materials may or may not be the 
sole resource of choice for populations such as the one in the current study.  
 The test of the above contrast effect also revealed that the provision of concurrent 
educational interventions was associated with enhanced generic HRQoL, thus refuting 
the a priori hypothesis in regards to this outcome variable. Thus, the application of 
different education strategies (e.g., DVD vs. Pamphlet vs. DVD + Pamphlet) possibly 
should be considered depending on which health-related outcome is of interest to the 
practitioner (i.e. increased self-management self-efficacy or enhanced HRQoL). This 
result also builds upon the previous findings in contrast 1, illustrating that patient 
exposure to an educational intervention including a DVD positively influences generic 
HRQoL.  Further, generic HRQoL was statistically significantly higher in contrast one 
when patients were exposed to a Pamphlet alone (versus a DVD); whereas, in contrast 2, 
generic HRQoL was statistically significantly higher when patients were exposed to both 
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treatments concurrently. The data suggests that the DVD may serve as a useful 
educational supplement for the Pamphlet in order to enhance generic HRQoL.   
When comparing the average adjusted mean vectors collapsed across the DVD, 
Pamphlet, and DVD + Pamphlet groups versus the adjusted mean vectors of participants 
exposed to the usual care control group, there were no statistically significant differences 
found relative to any of the outcome variables of interest. Stated differently, the 
provision of self-management education material as opposed to usual care did not 
improve the outcome variables of interest among this sample of COPD patients. This 
finding contradicts the hypothesis that self-management education would be more 
effective than usual care in regards to affecting the outcomes variables tested during this 
study. Furthermore, this particular finding questions the efficacy of self-management 
education (as opposed to usual care) in helping patients enhance their self-efficacy for 
COPD self-management, reduce their informational needs related to COPD, and 
improve their HRQoL.   
There are potential confounding influences, however, especially an insufficient 
sample size, which may have contributed to this lack of contrast effect. It is also 
important to note that patients with Stage I (mild) COPD are more likely to report high 
levels of HRQoL; thus, self-management may have little impact on the overall well-
being of patients (i.e., given that there is little room for improvement). Researchers and 
practitioners should not be all that surprised when self-management education 
interventions do not impact patients with Stage I COPD, as they may be experiencing 
very little disease-related disability (Boubeau, 2004; Worth & Dhein, 2004). Given that 
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disease stage was not utilized as an independent variable in this study, it cannot be 
determined whether this stage effect may have impacted the results of this contrast 
analysis.  
The final conclusion of note is that there were no statistically significant findings 
related to COPD information needs. Across all three planned contrasts tested, there was 
little effect of self-management education on this dependent variable. These results 
suggest that self-management education has little effect on patients’ self-reported need 
for information related to COPD self-management. This contradicted the anticipated 
finding which was based on the formative focus group interviews, which suggested a 
positive impact was possible. 
Limitations 
This study had several limitations. One such limitation was the lack of 
generalizability which can be generated from the study’s results. This is primarily due to 
the social characteristics of the community which may have influenced the small sample 
sizes for both aspects of the study, especially the quantitative facet. For example, in the 
quantitative study, the number of participants (n = 41) was lacking, in part, due to the 
size of the town where the research was being conducted, which also impacted the less 
than optimal response rates. Potential reasons for less than anticipated response rates 
include: a shift to more of a distance versus on-site educational dissemination approach, 
an unwillingness of patients to acknowledge their disease status, and the difficulties 
coordinating an off-site project of this nature. Despite extensive efforts to recruit 
patients, this limitation proved evident, especially when considering the non-statistically 
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significant effects of contrast 3, which compared all modes of self-management 
education versus usual care.  
A post-hoc power analysis was conducted using G*POWER™ software 
(Erdfelder, Faul, & Buchner, 1996) to determine the power that was available to detect 
statistically significant differences in the outcome variables given the relatively low 
number of participants in this study. The average effect size imputed to conduct this 
post-hoc power analysis was .15, as this figure reflected the average of the statistically 
significant effect size measures (r2s) found within contrasts 1 and 2.  The α level entered 
was .02 to account for the bonferroni-corrected value reflecting the 3 orthogonal, 
nontrend planned contrasts which were tested. The sample size was the total sample size 
in the study (n = 41), while 4 treatment groups (including the control group) and 8 
dependent variables were also input. The result of this post-hoc power analysis indicated 
that power to detect statistically significant findings in this study was extremely low at 
.43. This low power estimate was most likely a primary reason that statistically 
significant findings were not found when analyzing the effects of contrast 3.   
An increase of approximately 26 participants would have resulted in more 
sufficient power (i.e., .80) to detect statistically significant differences when examining 
contrast 3 effects. In light of this, the low number of participants of this study was a clear 
limitation and had an impact on the findings. Studies with more participants can generate 
more statistical power to detect statistically significant differences in outcomes, and are 
very necessary (Rabe et al., 2007). Larger samples of COPD patients from multiple rural 
health centers would be extremely beneficial. Making use of rural health networks would 
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be ideal to implement research endeavors such as the one attempted. Additionally, cross-
sectional applications of a modified form of this research design and protocol could 
greatly augment the current understanding of the effectiveness of COPD self-
management education in rural, underserved areas. Also, it would be important to 
attempt to repeat such research projects with an even more diverse population group of 
COPD patients to ensure adequate representation from those afflicted with COPD. 
When working with rural, underserved communities, where community input is 
so crucial to the success of program implementation, it is vitally important to allocate the 
time and establish the collaborations and networks necessary to facilitate a strong 
community rapport. This includes a comprehensive needs assessment process, which 
emphasizes community involvement at the individual, community, institutional, and 
public policy levels. Such processes are described thoroughly within commonly used 
models operationalized within health education circles (e.g., community-based 
participatory research protocols, health education program planning models, social 
ecological models, etc.). Relationship building takes time (which was limited due to a 
relatively fixed dissertation project period), effort and networking with prominent 
liaisons associated with the public health community, and overall community, one is 
working in. It should be noted that the principal investigator actively attempted to 
establish such an alliance with the Choctaw County health department to help create 
community support, but was unable to do so despite numerous phone calls and emails to 
these officials. In hindsight, it would have most likely been more beneficial to contact 
multiple institutions within the community as opposed to focusing exclusively officials 
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charged primarily with ensuring the health of the local community. Community 
institutions such as churches or other faith based organizations, senior centers, and other 
civic establishments catering primarily to an older demographic should have been 
contacted and notified about this project. This action could have increased the 
probability of (a) attracting more patient participation and (b) establishing more 
community support for this particular self-management education initiative.           
The validity of the participants’ self-reported self-management behaviors was 
another concern in this study. In this research, self-report could have biased the data 
through participants’ intentional or unintentional misrepresentation of their behaviors. 
Another possible limitation was reactivity (i.e., an individual may reduce or alter their 
behaviors in reaction to the daily monitoring of self-management). Possible other threats 
to internal validity included: unintended contamination among individuals within 
different treatment groups, diffusion of educational treatments among participants in 
disparate treatment groups, differential disease status maturation effects and selection 
bias robust against randomization and statistical adjustment. It is important to note that 
the effects of baseline pretest covariates were taken into account to reduce these threats 
to internal validity; however, while steps were taken to avoid such threats, they were 
nevertheless present.  
Differential participant dropout was also a concern given the multi-treatment 
nature of the study design, which resulted in an unequal number of participants in each 
treatment group. Unfortunately, there was limited information available regarding 
reasons why participants could or did not complete the study, although some reasons can 
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be inferred from the previous discussion of the qualitative findings (i.e., rejecting or not 
succumbing to the diagnosis). Some of these limitations were lessened by using a control 
group in the design, however.   
It is important to acknowledge, at this point, that improving knowledge, although 
necessary, is an insufficient sole outcome of a chronic disease self-management program 
and does not always lead to self-management behavior. Furthermore, health educators 
who work in chronic disease self-management should, “ensure that patients acquire the 
confidence and specific skills to manage their disease on a daily basis” (Bourbeau & 
Nault, 2007, p. 623). Building individual self-efficacy among patients at the individual 
level can and should be supplemented on multiple levels, including the interpersonal 
(e.g., support from family and friends), community (e.g., encouragement from church 
groups and other civic minded organizations), institution (e.g., active involvement of 
health care personnel such as those working for home health agencies), and policy (e.g., 
ensuring that funding is available to provide underserved rural patients with the proper 
educational materials they need) levels (McLeroy, Bibeau, Steckler, & Glanz, 1988).  
Furthermore, successful COPD self-management education involves both the 
transfer of knowledge as well as patient acquisition of certain important behavioral 
skills. This behavior change outcome can many times not be attained through simply 
cognitive-based interventions. It is important to note this health education truism and 
take heed to the marked increase in the amount of behaviorally-oriented research studies 
related to COPD self-management (Bourbeau, 2003; Coultas et al., 2005; Monninkhof et 
al., 2003a; Rea et al., 2004).  More ecologically based studies should supplement work 
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of this cognitive nature, given that this research project relied exclusively on self-
management education to produce positive health-related outcomes, without fully 
complementing these planned learning experiences by taking into account the relative 
and contextual elements within the population. Further, Bourbeau and Nault (2007) 
emphasize best practice COPD self-management recommendations to include actual 
interactions between learners and educators and providing education exclusively based 
on individual learning styles. These interactions and practices did not take place in this 
particular study and may have limited the effectiveness of the overall intervention itself.   
Recommendations for Future Research 
 Future research would benefit from identifying more comprehensive qualitative 
research protocols for collecting data designed to inform the development of COPD self-
management education resources. While the present qualitative data was extensively 
analyzed, it was only rudimentarily translated into the development of a COPD self-
management DVD tool. No precise guidelines existed or were implemented to 
systematically assess the most important self-management topics to target and include on 
the edited DVD. Further, the needs assessment process for educational technology 
development as it relates to COPD self-management is an important area for future 
research and development.   
 Additionally, within the qualitative study, the information obtained during the 
focus group interviews may not have been sufficient to guide the editing of the library of 
COPD self-management DVDs. Formative qualitative research designed to inform the 
development of COPD self-management education material may benefit from an 
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alternative research protocol. Perhaps providing participants with the entire collection of 
DVD segments and having them view these segments before the focus groups would be 
best practice. This would allow patients to have more input as to what information 
should be included within the instructional material. In addition, this collaborative 
editing process could produce more targeted education. Using this approach would also 
help identify a translational process that could streamline the editing process using 
qualitative data. Moreover, future research could benefit from systematically outlining 
procedures that empirically identify the most important self-management topics to 
include within educational materials based on more active participation from COPD 
patients.  
 More quantitative studies are needed to build the COPD self-management 
education research base and solidify its true effects on patients. Results from this study 
were able to identify differential effects of distinct instructional methods on a number of 
health outcomes related to COPD. These findings can add to the literature and help, 
“formulate (more) clear recommendations regarding the form and contents of self-
management education programmes in COPD” (Effing et al., 2007, p. 2). The data and 
corresponding findings from this study, however, failed to show that COPD self-
management education was superior to usual care. The overall effect of self-
management education on pertinent COPD self-management outcomes versus usual care 
was not statistically significantly better. The current study reinforces the 
recommendations of Effing et al. in that, “there is an evident need for more large RCTs 
(randomized control trials) with a long-term follow-up, before more conclusions can be 
170 
 
drawn” (p. 2).  If COPD self-management education is proven to be effective, then the 
results from this study suggest that patients may respond to differently to different 
educational interventions, so it is important that an empirical evidence base is built 
which can identify optimal educational dissemination strategies for specific populations 
of COPD patients (e.g., COPD patients living in a rural community).  The choice of 
dissemination strategy and instructional tools could prove crucial to overall 
programmatic success.       
 In light of different educational strategies revealing different effects on health 
related outcome variables (in the present study), more between group studies examining 
self-management education strategies are warranted.  For example, more studies should 
be conducted examining the effects of COPD self-management education on both lung-
specific and generic HRQoL to understand how each outcome is affected by different 
educational strategies and tools. Findings from previous studies looking at the effects of 
self-management education on generic versus lung-specific HRQoL have been 
inconsistent and inconclusive (Blake et al., 1990; Coultas et al., 2005; Emery et al., 
1998; Littlejohns et al., 1991; Rea et al., 2004), thus resembling results obtained from 
the present study. Furthermore, the suggestion that both generic and disease specific 
measures of HRQoL be assessed in order to understand multiple functional outcomes of 
interventions (Curtis, Deyo, & Hudson, 1994) is all the more prudent for studies 
examining the effects of COPD self-management education.  
 In the same vein, there are relatively few empirical research studies examining 
the effects of self-management education on self-efficacy in COPD patients, even 
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though this suggestion has been made in the literature (Effing et al., 2007). Therefore, 
more research should be conducted to confirm/disconfirm the beneficial effects of 
COPD self-management education on self-efficacy among COPD patients. Future 
research would benefit from assessing multiple levels of influence (e.g., ecological 
perspective), such as social support and community influence (McLeroy, Bibeau, 
Steckler, & Glanz, 1988) and examine how each uniquely impacts COPD self-
management self-efficacy.    
 More multivariate studies should be conducted to examine the unique effects of 
self-management education on multiple health-related outcome measures.  The present 
study utilized a multivariate perspective with a priori planned contrasts, a strategy not 
used in previous studies examining the effectiveness of COPD self-management 
education. Because multivariate contrasts were employed, experimentwise inflation of 
type I error was controlled and the probability of making a type II error was reduced, 
thus increasing the statistical power of the analysis. Even more important, the 
complexity of the COPD patient’s reality was honored (Thompson, 1994), given that 
most COPD-related outcomes have multiple causes and most of these causes produce 
multiple effects. Furthermore, additional outcome measures should be examined in 
future COPD self-management education studies. Appropriate outcomes not assessed in 
the present study included: number and severity of shortness of breath exacerbations, 
courses of oral steroids of antibiotics, use of rescue medication, hospital admissions, 
emergency room visits, use of other health care facilities, days lost from work and 
exercise capacity (Effing et al., 2007). Examining the effects of self-management 
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education on numerous outcome variables simultaneously could provide unique insight 
into how the format and content of COPD self-management affects these different 
outcome variables.   
 Finally, there was one quantitative research experience which seemed to 
corroborate the data gathered during the qualitative aspect of this mixed methods study.  
The researcher noted that a small subset of potential participants in this study were 
reluctant to participate due to an unwillingness to characterize themselves as being 
afflicted with COPD. While these patients met the physiological criteria for the disease, 
and were made aware of their diagnosis, some professed not believing that they suffered 
from the disease. These patients most likely were exhibiting a form of the “coming to 
terms with COPD and the lifestyle” theme that emerged inductively from the focus 
group data. Further, there was evidence during both parts of this study that some 
individuals go through a denial period after being told that they suffer from COPD.  
Perhaps this is because these patients are in the formative stages of disease progression 
and do not notice physiological deterioration. While this may be the case, it is important 
that future researchers ensure that all potential patients participating in COPD self-
management education studies are aware, and have accepted, their diagnosis of COPD.  
This research practice can help to ensure the ethical recruitment and retention of COPD 
patients and optimally identify only those patients who are prepared to learn more about 
managing their condition.   
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Recommendations for Future Practice 
 
This research contributes to the literature by specifically comparing the effect of 
different self-management education modalities and strategies on several disease-
relevant outcome variables. While this research supports the need to further examine the 
efficacy of COPD self-management education, it provides practitioners with valuable 
information related to which types of educational treatments may best affect several, 
pertinent health outcomes. For example, the practitioner looking to enhance the self-
efficacy of rural COPD patients may be best served to distribute Pamphlets to patients 
regarding the skills and behaviors necessary for self-managing COPD. Furthermore, to 
enhance self-efficacy for self-managing COPD in a low socioeconomic population, this 
research suggests there should be consideration given to the amount and type of 
educational materials given to patients.  
The DVD modality may be best suited to instruct patients on the skills and 
behaviors necessary to enhance HRQoL either with or without the complement of 
written educational material.  In this study, the concomitant combination of DVD and 
text-based education proved useful for enhancing the generic HRQoL of COPD patients.  
Unlike COPD self-management self-efficacy, the provision of more information as 
opposed to less may be beneficial in improving general HRQoL outcomes in COPD 
patients.  If practitioners are charged with implementing COPD self-management 
education programs that are to be designed to limit shortness of breath and the extent to 
which dyspnea affects normal functioning, practitioners may benefit from providing 
patients with audio-visual education resources as opposed to traditional text based 
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Pamphlets. The audio-visual strategy (e.g., DVD) provides patients with vicarious self-
management experiences as well as displaying actors suffering from and managing the 
same breathing difficulties that the patients face (e.g., shortness of breath exacerbations). 
Another benefit of using DVDs to educate patients is that it simulates actual instruction 
and persuasive directives that could be given face-to-face by a health service provider, 
but it does so in a portable, segmented format, which can be easily disseminated to 
patients for viewing in the comfort and convenience of their own residence. If rural 
patients have access to technologies which support this educational technology, then the 
DVD could prove very useful in providing information which can limit dyspnea 
exacerbations and reduce the need for costly emergency room visits. 
 When working in rural, underserved populations, where patients live in wide-
ranging geographical areas, the educational distribution strategy for instructional 
materials is an important consideration. Given that COPD patients are usually older and 
physically debilitated, it is important to recognize that the efficient dissemination of 
COPD self-management education may prove crucial to the acquisition of skills and 
behaviors necessary to effectively manage COPD. Within the present study, the 
educational distribution strategies and data collection processes (i.e., for the quantitative 
aspect of the study) using regular mail were relatively efficient and might be useful for 
other practitioners working with COPD patients in rural areas. Also, older adults living 
in rural areas may be limited in their ability to travel to and from medical facilities 
and/or health centers on a regular basis. Therefore, home-based educational resources 
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provided to patients in a format they desire could prove ideal when working in rural 
communities.  
 In terms of consulting this work for practice based guidelines, it is important to 
reiterate that there existed a limited sampling pool in this small rural community, and the 
response rate from potential patients greatly limits the external validity of these findings. 
There also exists important physiological differences among patients as COPD 
progresses, thus disease stage is an important variable to assess when working with 
patients. In this study, this particular information was not made available and could not 
be accounted for when assessing the qualitative or quantitative data. Finally, the 
aforementioned practice recommendations are predicated on the tenuous assumption that 
future research with larger sampling pools of rural patients will reveal positive effects 
resulting from the provision of self-management education. While it may be very likely 
that different COPD self-management educational strategies causally produce different 
effects on relevant COPD patient health outcomes, the overall effectiveness of COPD 
self-management education as it relates to improving patient knowledge, behavior-
oriented skills, self-management self-efficacy and HRQoL is still in question. Without 
more research providing additional evidence to support to utility of COPD self-
management education versus usual care, the efficacy of COPD self-management 
education can not be fully supported.   
In sum, if the medical care model shifts from emphasizing institutional diagnosis 
of treatment and ongoing care (which proves quite costly), to stressing more personal 
responsibility for both, we may see more integration of self-management education into 
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out health care system. This shift should not require a new breed of health professionals, 
but rather a reconfiguration of the health care delivery system, which allows for more 
prevention and disease management incorporation (Bourbeau & Nault, 2007). If and 
when this shift takes place, it will be very important to determine: (a) the process used to 
transmit education; (b) the format used during the instructional process; and (c) the 
content to be included within the instruction. Bourbeau and Nault (2007) suggest that the 
development of patient centered self-management education programs requires four 
main planning requirements: (a) interactions between the learners and educators will 
occur; (b) education is based on the learning styles and needs of patients and provided in 
a format highly conducive to behavioral response; (c) mastery of self-management skills 
is placed at a premium; and (d) evaluation of patient outcomes is completed. It is 
important to understand what patients know about their disease, what their concerns or 
problems are related to the disease, and which coping skills they are currently using to 
live with the disease (Weston-Eborn & Sitzman, 2005). Moreover, educational topics of 
interest to the patients must be integrated into instructional sessions, and these sessions 
should be weaved into an educational process that supports the natural diffusion of 
pertinent information. Thus, the practitioner is encouraged to use a variety of educational 
methods to disseminate information, as multiple methods are more likely to ensure 
information retention (Nault et al., 2002).  
Summary 
 The efficacy of COPD self-management education transmitted through a DVD 
proved effective in helping rural patients function better physically with their disease as 
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compared to patients provided with a text-based Pamphlet. However, patients provided 
with a DVD did not report better generic HRQoL as compared to participants receiving a   
Pamphlet alone. When both educational interventions (DVD + Pamphlet) were provided 
to patients concurrently (as opposed to receiving each intervention individually), there 
was a marked improvement in patients’ generic HRQoL. In addition, patients provided 
with Pamphlets revealed greater improvements in COPD self-management self-efficacy 
than did patients who received the DVD. Finally, providing patients with any type or 
combination of COPD self-management education (i.e., including the DVD and 
Pamphlet) showed no statistically significant improvements on the outcome variables 
considered together as compared to patients provided with usual care. In sum, the results 
from this study suggest that COPD self-management DVDs can be effective in helping 
patients experience better physical functioning (a lung-specific HRQoL measure), and, 
in conjunction with text-based Pamphlets, can improve generic HRQoL in rural COPD 
patients more so than exposure to text-based Pamphlets alone. Practitioners should use 
caution, however, when attempting to generalize the findings from this study given the 
small sample sizes within this mixed methods study.  
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APPENDIX A 
 
VOLUNTEERS NEEDED 
FOR A FOCUS GROUP 
 
“Efficacy of DVD Technology in COPD Self-Management 
Education of Rural Patients” 
 
Focus group participants must be over the age of 50 and must suffer from Chronic 
Obstructive Pulmonary Disease (COPD). 
 
The purpose of the focus groups will be to gather information about the COPD self-
management learning needs of COPD patients. 
 
Participation involves taking surveys about your disease and discussing how you would 
like to better manage your disease. 
 
Time Commitment: One session will last approximately 1 hour.  You will be 
reimbursed for your time and travel expenses in the amount of $20. 
 
The focus groups will be conducted at Choctaw Urgent Care in Butler, AL. 
For additional information contact, Wendy Ridgeway at 205-459-4488. 
 
Principal Investigator: Mr. Michael Stellefson, M.S. 
Texas A&M University, Department of Health and Kinesiology 
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APPENDIX B 
 
CONSENT FORM 
 
 Efficacy of DVD Technology in COPD Self-Management Education of Rural Patients  
 
You have been asked to participate in a focus group discussing the self-management of Chronic 
Obstructive Pulmonary Disease (COPD).  You were selected to be a possible participant because you 
suffer from COPD and are a patient of Choctaw Urgent Care in Butler, Alabama.  A total of 12 people will 
be asked to participate in this study. The purpose of this focus group is to assess the self-management 
learning needs of COPD patients treated at Choctaw Urgent Care. 
 
If you agree to be in this study, you will be asked to discuss your disease and talk about ways in which you 
attempt to manage your disease.  This focus group will involve 12 patients, who are over 55 years of age.  
The focus group interview will last approximately 1 hour.  The risks associated with this study are 
minimal.  There are no benefits associated with participation. 
 
You will receive a $20 honorarium for participation in the focus group.   
 
This focus group session will be videotaped and participation will not be permitted should you choose not 
to be videotaped.  The video tapes will be accessed only by the principal investigator (Michael Stellefson) 
and will be used only for educational purposes.  They will be erased following the study’s completion. 
Furthermore, the records of this study will be kept private.  No identifiers linking you to the study will be 
included in any sort of report that might be published.  Research records will be stored securely and only 
Michael Stellefson will have access to the records.  Your decision whether or not to participate will not 
affect your current or future relations with Texas A&M University or Choctaw Urgent Care.  If you decide 
to participate, you are free to refuse to answer any of the questions that may make you uncomfortable.  
You can withdraw at any time without your relations with the University, job, benefits, etc., being 
affected.  If you have any questions, you can contact Michael Stellefson at (979) 458-0097 or 
mstell@hlkn.tamu.edu or James Eddy at (979) 458-2217 or jeddy@hlkn.tamu.edu. 
 
This research study has been reviewed by the Institutional Review Board - Human Subjects in Research, 
Texas A&M University.  For research-related problems or questions regarding subjects' rights, you can 
contact the Institutional Review Board through Ms. Melissa McIlhaney, IRB Program Coordinator, Office 
of Research Compliance, (979) 458-4067, mcilhaney@tamu.edu. 
 
Please be sure you have read the above information, asked questions and received answers to your 
satisfaction.  You will be given a copy of the consent form for your records.  By signing this document, 
you consent to participate in the study. 
     
 
 
Signature of Participant:                                                                     Date:   ___________________ 
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APPENDIX C 
 
FOCUS GROUP RUBRIC 
 
Introduction 
 
Good morning/afternoon, and welcome to our session.  Thank you for taking the time to 
join our discussion of COPD patient education needs and self-care.  My name is Michael 
Stellefson, and I am a doctoral student at Texas A&M University in College Station, 
Texas, and I am studying patient education needs for COPD self-management.  Today 
I’d like to hear from you about how you view caring for yourself and your COPD and 
what types of topics you would like to learn more about pertaining to how you can care 
for your disease.  You were selected for this discussion because you all have a diagnosis 
of COPD and you are treated here at Choctaw Urgent Care.  I am very interested in your 
views of your disease and your experiences trying to manage your breathing. 
 
Today we basically want to learn from you about how you live with COPD and what 
types of disease self-management activities you’d like to learn more about.  Please feel 
free to share your point of view whatever it may be, as there are no wrong answers to my 
questions.  Please try to speak one at a time and speak up whenever you want to add 
something to the discussion.  I am tape recording our conversations so that I don’t miss 
any of your comments.  We will be on a first name basis, and your names will not be 
attached to any of your comments to ensure your confidentiality. 
 
My role here is to ask questions and listen.  I will be asking about 10 total questions, and 
I’ll move the discussion from one question to the next.  As you talk and discuss issues, I 
will be taking notes about what you are sharing, so even if I’m writing, please continue 
with your comments, as I am trying to listen to everything you are saying.  Please share 
as much as you can, but leave time for everyone to have the opportunity to share their 
thoughts and feelings.  Also, please feel free to talk with one another.  I’ve placed name 
cards on the table in front of you so that we can all remember each other’s names during 
the discussion.  We’ll be done by _____, and I’ll leave a little time at the end so you can 
finish the surveys in front of you.  So to start… 
 
Questions 
 
1. Think back and tell us when you were diagnosed with COPD, and how long you 
have been dealing with health problems because of your disease? 
 
2. What types of daily activities do you wish that you could do but don’t feel able to 
do anymore because of having COPD? 
 
3. When you think about trying to take care of yourself with your disease, what 
types of activities do you think about doing? 
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4. Of these activities, what do you do, yourself, do to help take care of your disease 
(i.e. things that you do so you don’t feel short of breath or ill)?  What allows you 
to do these activities? 
 
5. What new and/or different activities did you maybe try to do to manage your 
disease but maybe did not feel comfortable continuing because of discomfort or 
difficulty?  Can you think of any specific barriers that prevent you from trying to 
take care of yourself?          
 
6. What questions do you have regarding what you can do to help limit the 
problems that you experience because of COPD? 
 
7. Of all of these activities that we just discussed, what type of self-treatment 
activity do you consider most important? 
 
8. What would like to learn more about in terms of taking care of yourself with your 
disease? What advice could you give someone who was trying to determine what 
to teach a patient with COPD? 
 
MEMBER CHECK 
 
9. How well does this summary capture what we discussed today?  Does what I said 
sound accurate? 
 
10. Is there anything that we did not talk about today regarding how you take care of 
your COPD that you would like to mention? 
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APPENDIX D 
 
TELEPHONE SCRIPT FOR POTENTIAL PARTICIPANTS 
 
Hello Patient Name, this is CUC staff member from CUC.  I was just calling to let you 
know that you have an opportunity to participate in a research study for patients with 
COPD.  If you agree to participate in the study, you will be asked to complete two 
surveys over a two month period and possibly look over information about how you can 
breathe better with COPD.  For your participation in this study, you will be eligible to 
receive $40 for your participation and also receive free educational material about 
managing COPD.  Dr. Hensleigh greatly encourages her patients to take advantage of 
this opportunity. Would you be interested in participating?  
 
If No – OK, well if you change your mind, please feel free to call me at the clinic at 
(205) 459-4488, and we can get you signed up. 
 
If Yes - OK great.  We will then send you a package in the mail soon containing 
information about this study.  In this package, you will find a blank survey that you are 
asked to complete.  Please fill out this survey, put it in the prepaid envelope that we will 
provide you in the package (at no cost to you).  Then, please send it back to us in the 
mail. 
 
OK.  Please look over the information that is provided to you in the package.  We will be 
contacting you again in a few months with another survey that we will be asking you to 
fill out once again.  If you complete and return the survey that we are sending you now 
and the one we send you in a few months, we will pay you $40 for taking the time to 
complete these surveys and look over this information about COPD.   
 
So it’s very important that you (a) look over any educational material that we mail to 
you and (b) complete and return the surveys that you are asked to fill out.  If you do not, 
then we can not pay you for your time.  Does this sound OK to you? 
 
OK great!  Thank you for participating, and you should receive the first package in the 
next couple of weeks.  Good bye.   
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APPENDIX E 
 
CONSENT FORM 
 
 Efficacy of DVD Technology in COPD Self-Management Education of Rural Patients  
 
You have been asked to participate in a research study about the self-management of Chronic Obstructive 
Pulmonary Disease (COPD).  You were selected to be a possible participant because you suffer from 
COPD and are a patient of Choctaw Urgent Care in Butler, Alabama.  A total of 100 possible people have 
been asked to participate in this study. The purpose of this study is to examine the effects of using 
education to help self-manage COPD. 
If you agree to be in this study, you will be asked to fill out two sets of surveys about your lung function 
and disease (one now and one in 8 weeks).  This study will last over 8 weeks, and you will be asked to 
mail in your responses using prepaid envelopes that will be provided for you.  Each survey will take 
approximately 20 minutes to complete.  The benefit of participation is that you are eligible to receive $40 
for filling out both surveys (one now and one in 8 weeks) and free educational material about COPD self-
management.   
This study is anonymous, and you will be assigned a unique identifying code which will be used 
throughout the study as your identifier. The records of this study will be kept private.  No identifiers 
linking you to the study will be included in any sort of report that might be published.  Research records 
will be stored securely and only Michael Stellefson and Dr. Katherine Hensleigh will have access to the 
records.  Your decision whether or not to participate will not affect your current or future relations with 
Texas A&M University or Choctaw Urgent Care.  If you decide to participate, you are free to refuse to 
answer any of the questions that may make you uncomfortable.  You can withdraw at any time without 
your relations with the University, job, benefits, etc., being affected.  If you have any questions, you can 
contact Michael Stellefson at (979) 458-0097 or mstell@hlkn.tamu.edu.  
This research study has been reviewed by the Institutional Review Board - Human Subjects in Research, 
Texas A&M University.  For research-related problems or questions regarding subjects' rights, you can 
contact the Institutional Review Board through Ms. Melissa McIlhaney, IRB Program Coordinator, Office 
of Research Compliance, (979) 458-4067, mcilhaney@tamu.edu. 
Please be sure you have read the above information, asked questions and received answers to your 
satisfaction.  You will be given a copy of the consent form for your records.  By signing this document, 
you consent to participate in the study. 
 
Signature of Participant:                                       Date:   ___________________ 
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APPENDIX F 
 
SAMPLE INTRUCTIONS SENT TO TREATMENT GROUPS 
 
Please look over the information contained in the Pamphlet and/or on this DVD as 
often as you can over the next few weeks.  This information will help provide you with 
skills that you need to help you self-manage your COPD better. It is very important that 
you take the time to look over this important information until you feel comfortable 
practicing the skills which are shown.  If you have any problems with viewing this 
information, please contact Wendy Ridgeway at (205) 459-4488, and she will be able to 
assist you.   
 
I hope that you find this information beneficial to your health! 
 
 
Sincerely, 
 
 
 
Katherine A. Hensleigh, M.D. 
President, Choctaw County Medical Society 
Medical Director, Choctaw Urgent Care 
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SAMPLE INTRUCTIONS SENT TO TREATMENT GROUPS 
 
Dear Patient Name, 
 
My name is Michael Stellefson, and I am a graduate student studying health education at 
Texas A&M University in College Station, Texas.  I am currently in the process of 
completing my final dissertation project for my PhD degree.  The project is devoted to 
studying patients who have Chronic Obstructive Pulmonary Disease (COPD).  I have 
been studying COPD in hopes that my research will help patients who suffer from the 
disease.   
 
My project is taking place in your area of the country with patients who are cared for at 
Choctaw Urgent Care (CUC).  Dr. Katherine Hensleigh, who is the Medical Director at 
CUC, has been kind enough to provide me with contact information for her patients who 
have COPD.  Your name has been selected as a potential participant in this study.  In 
order to participate, all you will have to do now is:  
1. Complete the enclosed survey and return it in the pre-paid postage envelope that 
I have included in this mailing immediately, and 
2. After completing this survey, please review over the enclosed DVD and printed 
educational material as often as you can over the next 6-8 weeks. 
In approximately 8 weeks, I will mail you another survey for you to complete and return 
in a pre-paid postage envelope.  After you send me back this 2nd and final survey, this 
study will be completed, and you will be eligible to receive free educational products 
along with a $40 check for your participation. If you have any questions about the 
project, please contact Wendy Ridgeway at (205) 459-4488.  Your participation is 
greatly appreciated. Thank you very much! 
 
Sincerely, 
 
Michael Stellefson, M.S.   
Graduate Student 
Texas A&M University 
 
 
Katherine A. Hensleigh, M.D. 
Medical Director, Choctaw Urgent Care 
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APPENDIX G 
 
LINQ 
1. What sentence best describes what you have been told to do if your breathing gets 
worse (e.g., take two puffs instead of one)? 
 
A. I have been told what to do and the doctor/nurse has given me written instructions 
B. I have been told but it is not written on paper 
C. I haven't been told but I know what to do 
D. I haven't been told and I don’t know what to do 
 
2. Have you been told when you should call an ambulance if your breathing worsens?  
 
A. I have been told what to do and the doctor/nurse has given me written instructions 
B. I have been told but it isn't written on paper 
C. I haven't been told but I know what to do 
D. I haven't been told and I am uncertain when an ambulance should be called 
 
 
3. Has someone told you how much physical activity (e.g., walking, brisk walking and 
other forms of exercise) you should do? 
 
A. Yes and I know what to do 
B. Yes but I am unsure what to do 
C. Yes but I am unable to do it 
D. No 
 
4. How much physical activity do you do? 
 
A. As little as possible 
B. I make an effort 
C. I push myself as much as I can 
 
5. Have you any questions or comments about your lung disease (If so, please write them 
in the space below)? 
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SOLQ 
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 SOLQ 
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APPENDIX I 
EQ-5D 
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EQ-VAS 
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APPENDIX J 
SEMCD-6 
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APPENDIX K 
 
PROCESS EVALUATION MEASURES 
 
We would like to learn about how you used the educational material that was provided to you. For each of 
the following questions, please answer the questions as accurately as possible. 
1.  Which of the following educational materials did you receive and review (mark an X for the best 
response)? 
  ___________ Just a DVD 
  ___________ Both a DVD and Pamphlet 
  ___________ Just a Pamphlet 
  ___________ None of the Above 
2.  If you received educational materials, please list the number of times that you referred to the materials 
that you were provided in the past few weeks (in the space provided): __________________  
3.  How useful was the educational material(s) that you were provided? Circle the best response from 1 to 
10  (1 = not at all useful; 10 = extremely useful). 
 
1 2 3 4 5 6 7 8 9 10 
Not at 
all easy 
to use 
        Extremely 
easy to 
use 
4. Did you find the educational material(s) easy to use (i.e., readable, understandable, easy to access)? 
Circle the best response from 1 to 10 (1 = not at all easy to use; 10 = extremely easy to use). 
1 2 3 4 5 6 7 8 9 10 
Not at 
all easy 
to use 
        Extremely 
easy to use 
5. Please write any additional comments in the space below regarding how you felt about the educational 
material that you received (Did you like it? Was it beneficial to you? Would you like more information? 
Etc.): 
Thank you very much (again) for your participation! 
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APPENDIX L 
 
WRITTEN DEBRIEFING FORM 
 
EFFICACY OF DVD TECHNOLOGY IN CHRONIC OBSTRUCTIVE 
PULMONARY DISEASE SELF-MANAGEMENT EDUCATION OF RURAL 
PATIENTS 
 
Chronic Obstructive Pulmonary Disease (COPD) is a serious problem among adults. The 
proportion of individuals suffering from COPD is on the rise, and it is the 4th leading 
cause of death in the United States. Providing COPD patients with self-management 
education can have a positive impact on patient’s confidence and ability to manage their 
disease. The questionnaires you answered included three measures of health related 
quality of life, one measure of lung information needs, and a measure of self confidence 
for managing your disease.  The educational materials participants were exposed to 
included a DVD, Pamphlet or a combination of both. The purpose of this study was to 
measure and specifically compare the effect of these three different COPD self-
management education strategies (and a control strategy which was no educational 
material) on relative differences in generic and disease-specific HRQoL, COPD 
information needs and COPD self-management self-efficacy. 
 
Your generosity and willingness to participate in this study was greatly appreciated. 
Your input helped contribute to the advancement of the field of COPD self-management 
education research.  I have provided your clinic with extra educational materials if you 
would like extra copies or are interested in learning more about COPD.  
 
I ask you to maintain confidentiality about the purpose of the experiment.  Thank you!   
 
If you have any questions about this research, please feel free to contact Michael 
Stellefson at 717-645-3479 or mstell@hlkn.tamu.edu.   
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